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ABSTRACT 
 
Mallory Renée Selzo: Interrogating the Viscoelastic Properties of  
Tissue using Viscoelastic Response (VisR) Ultrasound 
(Under the direction of Caterina M. Gallippi) 
 
Affecting approximately 1 in 3,500 newborn males, Duchenne muscular dystrophy 
(DMD) is one of the most common lethal genetic disorders in humans.  Boys with DMD suffer 
progressive loss of muscle strength and function, leading to wheelchair dependence, cardiac and 
respiratory compromise, and death during young adulthood.  There are currently no treatments 
that can halt or reverse the disease progression, and translating prospective treatments into 
clinical trials has been delayed by inadequate outcome measures.  Current outcome measures, 
such as functional and muscle strength assessments, lack sensitivity to individual muscles, 
require subjective effort of the child, and are impacted by normal childhood growth and 
development.   
The goal of this research is to develop Viscoelastic Response (VisR) ultrasound which can 
be used to delineate compositional changes in muscle associated with DMD.  In VisR, acoustic 
radiation force (ARF) is used to produce small, localized displacements within the muscle. Using 
conventional ultrasound to track the motion, the displacement response of the tissue can be 
evaluated against a mechanical model.  In order to develop signal processing techniques and 
assess mechanical models, finite element method simulations are used to model the response of 
a viscoelastic material to ARF excitations.  Results are then presented demonstrating VisR 
differentiation of viscoelastic changes with progressive dystrophic degeneration in a dog model 
of DMD.  Finally, clinical feasibility of VisR imaging is demonstrated in two boys with DMD. 
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CHAPTER 1 
Introduction 
 
1.1 Purpose 
Affecting approximately 1 in 3,500 newborn males, Duchenne muscular dystrophy (DMD) is 
one of the most common lethal genetic disorders in humans.1  The disease is caused by 
mutations in the dystrophin gene, which codes for the protein dystrophin, an important 
structural component of muscle.  Muscle involvement in DMD is characterized by repetitive 
cycles of injury and repair that result in replacement of muscle cells by fat and fibrous tissue.2 
Boys with DMD suffer progressive loss of muscle strength and function, leading to wheelchair 
dependence, cardiac and respiratory compromise, and death during young adulthood.3  There 
are currently no treatments that can halt or reverse the disease progression.  While a wide range 
of treatments have been proposed in the nearly 30 years since the discovery of dystrophin, 
translating these prospects to clinical trials has been delayed by inadequate outcome 
measures.4,5    
The purpose of this dissertation is to develop Viscoelastic Response (VisR) 
ultrasound - a novel, noninvasive imaging method - for detection of mechanical 
property changes in muscle.  VisR uses acoustic radiation force (ARF) to produce small, 
localized displacements within the muscle.  Returning echoes are processed using ultrasonic 
motion tracking, and the displacement response of the tissue to the ARF can be evaluated 
2 
against a mechanical model.  By repeating this process at a number of locations, images 
depicting viscoelastic properties of tissues can be formed.  
While presented in the context of imaging dystrophic muscles, the work herein addresses 
biomechanical modeling and signal processing techniques that are relevant to many other 
clinical applications. 
1.2 Hypothesis 
To evaluate the hypothesis that VisR ultrasound can noninvasively characterize the 
viscoelastic properties of soft tissue in vivo the following three specific aims were 
addressed in this research 
Aim 1.  Develop, using custom finite element method (FEM) models, VisR mechanical modeling 
and signal processing techniques for assessing tissue viscoelasticity. 
Aim 2.  Demonstrate the relevance of VisR imaging for differentiating viscoelastic property with 
progressive dystrophic degeneration in a dog model of DMD.  
Aim 3.  Assess the clinical feasibility of using VisR imaging to monitor dystrophic degeneration 
longitudinally in one, and cross-sectionally in two juvenile males with DMD.  
1.3 Overview 
This dissertation encompasses the development, preclinical, and clinical elevation of a new 
technique for evaluating the viscoelastic properties of tissue.   
This thesis is organized as follows: Chapter 2 begins with an introduction to skeletal muscle 
anatomy and describes the natural history of DMD.  Additionally, it introduces the GRMD dog 
model used in Chapter 11.  Chapter 3 describes the physical outcome measures currently used in 
DMD clinical trials, gives a brief introduction to MR imaging, and describes current efforts in 
3 
developing MRI as an outcome measure for staging DMD disease progression.  A brief 
background on ultrasound imaging is provided in Chapter 4, along with a description of 
ultrasound techniques that have been applied to imaging dystrophic muscles.  There is also a 
detailed description of the fundamental concepts behind ARF and ARF-based imaging methods.  
In Chapter 5, VisR ultrasound is presented using the Voigt mechanical model and is 
demonstrated in in viscoelastic tissue-mimicking materials as well as in canine muscle, in vivo.  
The results of a pilot study in ex vivo muscle are presented in Chapter 6 and demonstrate that 
VisR’s sensitivity to muscle anisotropy can be controlled by modifying the focal configuration of 
the ARF excitations.  In Chapter 7, the mass-spring-damper model (MSD) is introduced for VisR 
imaging and the importance of accounting for inertia is demonstrated in FEM simulations.  
FEM simulations are expanded upon in Chapter 8 to investigate the impact of using an acoustic 
radiation force to induce displacements and determine whether VisR can generate quantitative 
measurements of viscoelasticity.  Chapter 9 considers the impact of displacement 
underestimation on VisR imaging and presents a technique for using shear waves to mitigate 
underestimation errors.  Isolation of elastic from viscous material properties relative to the 
magnitude of the ARF excitation is demonstrated in Chapter 10.  Chapter 11 contains the results 
of preclinical cross-sectional and longitudinal studies of VisR imaging in affected GRMD dogs 
and normal controls.  Chapter 12 demonstrates the clinical feasibility of VisR ultrasound in two 
boys with DMD.  Finally, Chapter 13 presents the final conclusions of this thesis and discusses 
areas of future development. 
 
2 Clinical	Background	
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CHAPTER 2 
Clinical Background 
 
Skeletal muscle makes up over 40% of the human body’s mass and is crucial for function 
and survival.6  In order to generate force and produce movement, skeletal muscles shorten, or 
contract.  In Duchenne muscular dystrophy (DMD), a missing protein, dystrophin, makes 
muscles especially vulnerable to injury during contraction.7 Muscles will undergo cycles of 
damage and repair until eventually, the muscle mass becomes replaced by fat and fibrous 
tissue.2   
In order to understand the pathologic changes associated with DMD, this chapter begins 
with a summary of the basic anatomy of skeletal muscles and the role of dystrophin in 
maintaining its structural integrity.  This is followed by a discussion of the clinical 
manifestations and progression of DMD, the experimental therapies in development, and the 
animal models aiding in their development.  
2.1 Skeletal Muscle 
Attached to the bone by tendons, skeletal muscles are responsible for voluntary 
movements of the body.  Skeletal muscles (Figure 2.1) are encircled by the epimysium, a dense 
connective tissue that joins with the tendon.  Internally, the muscle is composed of numerous 
muscle fascicles, which are separated from one another by a layer of connective tissue known as 
the perimysium.8  Muscle fascicle consists of bundles of multinucleated muscle fibers which are 
isolated from one another by the endomysium.  Within these fibers are contractile proteins  
5 
 
Figure 2.1: (a) Schematic drawing of the hierarchical structure of striated muscle.  (b) Muscle histology 
stained with hematoxylin and eosin (H&E).  Note the tight packing and relatively uniform diameters of 
the fibers, and the peripherally located nuclei.  Biopsy obtained from a healthy, 3 month old dog. 
 
called myofilaments.  These proteins are responsible for the transduction of chemical energy 
into mechanical work during muscle contraction and relaxation.9 
Muscle fibers make up approximately 85 percent of muscle tissue; nerves, blood supply, 
and connective tissue structures that provide support, elasticity, and force transmission to the 
skeleton constitute the remaining volume.10  Muscle fibers are cylindrical, with a diameter 
6 
ranging from about 10 μm to about 100 μm.  Muscle fiber length is highly variable, depending 
on the muscle’s architecture.  Fiber arrangements fall into two major categories, parallel and 
pennate.11  In a parallel arrangement, fibers run parallel to each other along the axis of the 
muscle, whereas fibers in the pennate arrangement insert obliquely onto a tendon that runs the 
length of the muscle.  The geometric arrangement of fibers in the muscle has a large effect on the 
muscle’s ability to generate force and produce movement.  A muscle with parallel arrangement 
of fibers, for example, will have more basic contractile units in series than a similarly sized 
pennate muscle.  This arrangement allows the parallel muscle to contract quicker, but with less 
force, than the pennate muscle.  Muscles designed for strength (e.g. gastrocnemius) are typically 
pennate, whereas those designed for speed (e.g. sartorius) tend to have parallel fibers.12 
2.1.1 Regeneration of Skeletal Muscle 
Skeletal muscle contains resident stem cells called satellite cells.  These cells are located 
between the sarcolemma of the muscle fiber and the basement membrane.  Satellite cells act as a 
reserve population of cells that can proliferate in response to injury and regenerate muscle, as 
well as maintaining the number of satellite cells throughout one’s life.13 
Healthy skeletal muscle has a remarkable ability to regenerate in response to injury.  In 
the initial phase of skeletal muscle regeneration following injury, muscle damage and disruption 
of muscle fiber integrity lead to an inflammatory response and an infiltration of phagocytic 
macrophages.14  The macrophages persist at the injured site for several weeks removing necrotic 
debris.  Subsequently, satellite cells are rapidly activated and then proliferate to produce 
committed muscle progenitor cells (myobalsts).  Myogenic progenitor cells then expand and 
subsequently fuse with existing muscle fibers or each other to form new muscle fibers.14   
7 
2.1.2 Dystrophin 
The structural integrity of the muscle fiber is maintained by a network of interlinking 
protein fibers within the muscle.15–17  The structural protein dystrophin links the myofilaments 
to the plasma membrane, or sarcolemma, of the muscle fiber, as depicted in figure 2.2.  
Dystrophin associates which several glycoproteins to form the “dystrophin-glycoprotein-
complex” (DGC), and the entire structure acts as a structural link between the contractile 
apparatus and the extracellular matrix, thereby stabilizing the sarcolemma during contraction 
and relaxation.  When dystrophin is absent from muscle cells, this complex does not form, and 
forces are unevenly transmitted through the sarcolemma resulting in a fragile membrane that is 
more easily damaged during muscular contraction.18   
2.2 Duchenne Muscular Dystrophy 
2.2.1 Epidemiology and Genetics 
Duchenne muscular dystrophy (DMD) results from mutations in the dystrophin gene 
located on the short arm of the X chromosome and is characterized by a complete absence of the 
dystrophin protein.19    Becker muscular dystrophy (BMD) is a fundamentally similar disease as 
DMD but involves a decrease in the quantity or quality of the dystrophin protein.20  This results 
in a milder and more slowly progressive course. 
The dystrophin gene, which spans a genetic distance of more than 2.5 million base pairs, is 
the largest isolated human gene.  More than 90% of DMD patients have an absence of 
dystrophin corresponding to a mutation that disrupts the reading frame of the mRNA, which 
results in the early termination of transcription.21  As a result, an unstable dystrophin molecule 
is produced which will undergo rapid decay.  The incidence of DMD has been estimated at 
approximately 1 in 3,500 male births.19  The most common form of inheritance is X-linked 
recessive, but an estimated one-third of cases are spontaneous mutations with no prior family  
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Figure 2.2: A schematic representation of dystrophin and its role in 
linking the myofilaments to the extracellular matrix. 
 
history.   Because the mutation is X-linked, the disease almost exclusively affects males.  
Females with a mutated gene are “carriers” and can pass the mutation onto her children. 
2.2.2 Pathology 
In DMD, the absence of dystrophin in the cell membrane will result in a fragile 
sarcolemma that is more easily damaged during muscle contraction.  Increased membrane 
breakdown allows extracellular calcium to enter the cell causing the fiber to undergo necrosis.7  
As damaged muscle fibers are repaired, they still lack the missing structural component and will 
be torn again by future muscle activity.  Following this relentless cycle of necrosis and 
regeneration, the proliferative capacity of the satellite cell population gradually becomes 
exhausted, and regeneration eventually fails.22,23 As a result, the number of muscle fibers 
progressively decreases, while fibrous and fatty tissue progressively increases.  
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One of the most important histologic features of DMD is loss of muscle fibers.  The size of 
individual muscle fibers displays marked variation, with fibers ranging from 10 to 230 μm.   
Additional histologic features include: regenerating fibers; enlarged, “hypercontracted” fibers 
(which may be caused by abnormally high amounts of calcium); areas of overt necrosis with 
macrophage infiltration; increased endomysial connective tissue; and infiltration of adipose 
tissue.24,25 
Histopathology changes as a function of age, with young patients showing less fibrosis and 
less dramatic changes in muscle, whereas end-stage muscle shows large numbers of very small 
fibers that have failed to fully regenerate, extensive endomysial fibrosis, and a few remaining  
hypertrophic fibers.26  No histopathologic feature is diagnostic for DMD, but 
immunohistochemical analysis of the muscle biopsy can show dystrophin protein content, which 
is considered diagnostic.   
2.2.3 Clinical Diagnosis 
The diagnosis of DMD is based on clinical signs and symptoms and confirmed by raised 
serum concentration of creatine kinase (CK), absence of dystrophin in muscle biopsy, and the 
finding of a mutation in the dystrophin gene.  In all DMD patients serum CK, an indicator of 
muscle damage, is high from birth onwards.27  The level may decline in the later stages of the 
disease, when the greater muscle mass has already deteriorated, and there is less breakdown of 
muscle mass than in the earlier stages.28  
2.2.4 Natural History 
The natural history of untreated DMD follows a predictable course.  However, the disease 
course can be modified with aggressive pharmacologic (corticosteroids) and rehabilitation 
treatments.  The following sequence of events occurs in both treated and untreated patients with 
DMD but at a later age in corticosteroid-treated boys.  
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Affected boys are rarely symptomatic in early infancy; however, elevated levels of serum 
creatine kinase (CK) enzyme are present at birth.29,30  The most common first symptom is a 
delay in independent walking.  Clinical evaluation is often sought when the child begins 
exhibiting gait abnormalities, difficulty rising from the floor, and problems climbing stairs.  On 
average, children with DMD are diagnosed between ages 4 and 5.31    
In general, during the early stages of the disease, the lower limbs are more affected than 
the upper limbs, with certain muscles more predominately affected.27,32  This pattern of muscle 
involvement results in several well-defined physical features associated with the disease. 
Weakness of the knee and hip muscles leads to the Gowers' maneuver, in which the child rises 
from the floor by using his hands to “climb” up his legs.  Hip extensor muscle weakness 
produces a waddling gait, and contractures of the achilles tendon leads to toe-walking.  As the 
posterior hip muscles weaken, the child must arch his back when standing to maintain his 
center of gravity behind the hip joint leading to lumbar lordosis.28  One of the most obvious 
features in the early stages of the disease is an enlargement of the calf muscles.  Muscle 
enlargement is due, at least in part, to an excess of adipose and connective tissue.33  
The ability to stand up from a chair is lost around age 8, followed by the inability to climb 
stairs.34  The combination of muscle weakness and contractures leads to an increasing difficulty 
in walking.  When ambulation is no longer possible, usually around age 10 in untreated DMD 
and about three years later in most steroid-treated DMD boys, full-time wheelchair use is 
required.35–37  After loss of ambulation, joint contractures increasingly develop, particularly 
flexion contractures of the elbows, knees, hamstrings, and hips.  Later movement of the 
shoulders and wrists also become limited.  Cardiac and respiratory involvement often occur in 
this later stage of the disease.3,38 
Patients with DMD are at risk of respiratory complications as their condition 
deteriorates.39  Pulmonary function becomes compromised because of weakness of intercostal 
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and diaphragmatic muscles.  Scoliosis is common in affected boys and usually progresses more 
rapidly after the child becomes non-ambulatory.  This thoracic deformity further compromises 
pulmonary capacity.  DMD patients are also at risk for cardiac disease.  Cardiac disease usually 
consists of dilated cardiomyopathy, which causes a progressive decline in the ejection fraction, 
and generally evolves to heart failure.40  The mean age of death is 19 in untreated patients, with 
approximately ninety percent of deaths attributed to respiratory and ten percent to cardiac 
causes.  Ventilation use extends mean life expectancy to 25.41 
Patients can show other symptoms in addition to skeletal and cardiac muscle involvement.  
Intellectual impairment occurs in most patients.  The IQ of boys with DMD is typically one 
standard deviation below the general population, but cognitive impairment is not progressive 
and not correlated with weakness.42,43  Smooth muscle dysfunction is also present and can lead 
to digestive and urinary tract complications.44 
2.2.5 Treatment 
There is no cure for DMD.  Treatment goals are to maintain function, prevent 
contractures, and provide psychological support for children and their families.3 Main efforts 
are directed towards keeping children standing and walking as long as possible.  Passive 
stretching exercises, use of splints to maintain the feet in a neutral position during the night, 
and use of long-leg braces for walking are important in this respect.  Scoliosis cannot be 
prevented and, if progressive, surgical correction is the only effective way to straighten the 
spine.28 
Corticosteroids 
Daily prednisone stabilizes or improves the strength of boys with DMD and is currently 
the only proven treatment for the disease.  DMD boys treated with prednisone from an early age 
generally remain ambulatory longer, have less incidence of scoliosis and contractures, and 
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maintain normal or near-normal respiratory function.3,37,45  Despite the evidence in favor of 
daily prednisone there are numerous potential side effects caused by this treatment.  Most 
commonly seen are excessive weight gain, behavioral changes, excessive hair growth, 
gastrointestinal symptoms, and decreased linear growth.  The synthetic steroid, deflazacort, has 
shown similar clinical efficacy in slowing the disease, and is thought to have fewer side effects 
than prednisone, particularly with regard to weight gain.46  Deflazacort is available in Europe 
and Central and South America but is not currently available in the United States.   
Experimental Therapies 
Rather than addressing the primary defect, traditional pharmacological strategies reduce 
or postpone symptoms by targeting the secondary effects of the disease.  Thus, there is 
significant interest in developing therapies for DMD that would treat the underlying genetic 
defect and result in the production of functional dystrophin.47  Genetic treatments must 
overcome significant challenges: treatment must restore dystrophin to both skeletal and cardiac 
muscles, patients will need to receive treatment the entirety of their lives, and immune response 
must be minimized.48 
Several therapeutic approaches are being developed, and clinical trials are in progress.  
Approaches currently being investigated include gene replacement of dystrophin using viral 
vectors, and upregulation of proteins, such as utrophin, to act as dystrophin surrogates.  A 
number of gene-specific approaches, which manipulate mRNA processing, are also being 
explored.  These include antisense oligonucleotides to induce exon skipping and restore the 
reading frame in boys with eligible out-of-frame deletions, and agents, such as aminoglycoside 
antibiotics, which promote the read-through of premature stop codons.49–52    
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2.2.6 Animal Models 
The availability of animal models for DMD constitutes a critical asset, as they allow for 
extensive pre-clinical studies on the safety and functionality of the various therapeutic 
approaches as well as understanding the mechanism of muscle degeneration.53  The most 
commonly used models are the mouse and dog model.  The preclinical studies described in this 
dissertation were performed using the GRMD dog model. 
Mouse Models 
Mouse models have been used extensively to understand the pathologic mechanism of 
DMD and have been crucial in the development of therapeutic approaches.  Many mouse models 
with mutations in the DMD gene have been identified.  Among these models, the mdx mouse is 
most commonly used laboratory model of DMD.54  The mdx mutation consists of a single base 
substitution in exon 23, resulting in a premature stop codon in the dystrophin gene.55  This 
mutation leads to the absence of detectable dystrophin in the muscle, except in rare revertant 
muscle fibers.  Despite being a genetic and biochemical homologue of DMD in humans, the mdx 
mouse exhibits a milder phenotype.  Muscle pathology is comparatively moderate, and 
mechanical function is less seriously compromised, resulting in an almost normal lifespan.55 
While the genetic tractability and convenient size of mice make them invaluable tools in 
DMD research, their inability to address certain issues associated with DMD, such as the 
challenges associated with performing gene or cell therapy on large volumes of muscle, and their 
differing pathological expression of the disease, limits their relevance for clinical evaluation in 
therapeutic trials.  In contrast, dystrophin deficient dogs have a body size closer to humans and 
develop a progressive disease similar to DMD.54 
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Dog Models 
Spontaneous mutations of the dystrophin gene resulting in X-linked muscular dystrophy 
have been identified in several breeds of dogs: Golden Retrievers, Rottweilers, Pembroke Welsh 
Corgis, Cavalier King Charles Spaniels, and the German Shorthaired Pointer.56  Of these, the 
Golden Retriever muscular dystrophic (GRMD) dog has been the most extensively studied and 
best characterized.57–65  GRMD dogs have a point mutation in intron 6 in the canine dystrophin 
gene, resulting in a premature stop codon, and consequentially, in a non-functional protein.66   
Dogs with GRMD undergo a clinical progression that closely resembles human DMD.   
CK levels are elevated and extensive muscle necrosis can be identified in GRMD dogs from birth 
onwards.67  By 6 months of age, severe fibrosis and joint contractures develop.  Affected dogs 
have a stiff gait and tire easily.  As the disease progresses, muscle contractures lead to reduced 
range of motion of joints, and dogs frequently develop spinal column and thoracic wall 
deformities.   GRMD dogs frequently develop cardiomyopathy which can lead to heart 
failure.56,67  The histopathological changes in the muscles are also similar to the ones seen in 
humans and include muscle fiber degeneration and regeneration, fiber splitting, numerous 
fibers with centrally located myonuclei, and intense connective tissue replacement.  An 
important confounding factor for studies using the GRMD dog model is the high degree of 
variability in disease severity.   Despite having the same genetic mutation, some dogs with 
GRMD are only mildly affected; while others die soon after birth due to extreme respiratory 
compromise.56 
2.3 Summary 
DMD is a devastating muscle wasting disease caused by mutations in the gene encoding 
dystrophin, a muscle cytoskeletal protein.  The disease is characterized by progressive muscle 
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weakness and degeneration stemming from progressive loss of contractile function.  Current 
drug selections for DMD patients are primarily limited to corticosteroids, however, several novel 
treatments, aided in their development by animal models of DMD, are in early clinical trials. 
3 Outcome	Measures	in	DMD	
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CHAPTER 3 
Outcome Measures in DMD 
 
The increasing number of potential therapies for treating DMD in recent years has 
highlighted the need for validated outcome measures that can reliably assess possible changes 
following treatment.  Defining proper outcome measures is crucial for demonstrating drug 
efficacy in clinical trials; they should have high sensitivity, and reproducibility.  Despite the fact 
that DMD is one of the most common neuromuscular diseases, patient numbers are limited 
often requiring that clinical trials involve multiple trial sites, emphasizing the need for outcome 
measures which can be standardized between institutions.68  Furthermore, treatment options 
may only result in mild improvement, so outcome measures will need to able to detect minimal 
changes in natural history. 
Additional challenges in DMD occur due to the young age of the patient population.  
Obtaining reliable outcome measures in patients with DMD can be difficult because of the 
unique challenges inherent in testing children and because of the associated cognitive deficits 
seen in approximately one-third of DMD patients.  Moreover, loss of muscle function in DMD 
occurs against the background of normal childhood growth and development, this may manifest 
as an improvement in physical ability despite progressive muscle impairment.69  This chapter 
describes the current surrogate biomarkers for DMD currently employed in clinical trials as well 
as imaging techniques that are being developed for outcome measures in DMD.70 
17 
3.1 Physical Outcome Measures 
Physical outcome including the 6-minute walk test, muscle strength tests, and timed 
function tests have been used in the majority of clinical trials.  A limitation of these physical 
tests is that the measurements rely on voluntary efforts of the patient.  Consistency of the 
measurements between trials and between test sessions can be significantly affected by the 
attention, cooperation, and motivation of the child.69,71  The strengths and weaknesses of the 
specific physical tests are reviewed below. 
6-minute walk test 
The 6-minute walk test (6MWT) measures the distance that a patient can walk in a period 
of 6 minutes.  Studies documenting the sensitivity and reproducibility of the 6MWT have led to 
its common use as the primary clinical endpoint in DMD trials worldwide.72,73  Given that 
difficulty walking is an important manifestation of the disease process, improvements in the 
6MWT with treatment relative to placebo constitutes evidence of therapeutic value.  In clinical 
trials, a difference of 30 meters between drug and placebo is generally required for a clinically 
meaningful functional change.74,75  
While the 6MWT is useful, it has a number of limitations.  First, it has inherent variability; 
distance walked can by effected by the patient’s mood and effort.  Parents and clinical evaluators 
have observed that verbal encouragement of the child can significantly increase their distance.76  
In addition, the 6MWT can only be completed in ambulatory boys, severely limiting the length 
of time that the test is applicable.  Moreover, children with DMD under age 7 have demonstrated 
yearly improvements in 6MWT distance despite progressive muscular impairment.77   Evidence 
from recent trials in exon skipping has shown that early intervention may be necessary to 
maximize treatment before extensive muscle loss has occurred.  Thus, the 6-minute walk test 
may not be a suitable primary endpoint in these trials moving forward.78 
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Muscle strength testing 
Manual muscle testing (MMT) is a procedure for evaluating strength and function of an 
individual muscle or muscle group in which the patient voluntarily contracts the muscle against 
the manual resistance of a clinician.  The clinician assigns the muscle strength a grade between 
0-5 based on the on the patient's ability to hold against the applied pressure.  MMT is the 
simplest and most common method used to evaluate muscle strength in a clinical setting.  
However, the questionable reliability and sensitivity of MMT limits its usefulness as an outcome 
measure.79  Additionally, the nonlinearity of the grading limits the use of MMT for following 
disease progression or treatment response in a given patient longitudinally.   
In order to overcome the limitations associated with MMT, isometric hand-held 
dynamometers (HHD) have been developed to provide objective and continuous measurements 
of muscle strength.  HHDs are generally portable, relatively inexpensive, and measure strength 
as a unit of force.  To perform quantitative muscle testing with an HHD, the patient is positioned 
in a standardized position for the muscle group being tested.  The clinician holds the HHD 
stable while the patient exerts their maximum force against it for a period of 3 to 5 seconds.   
The current literature indicates that HHD testing provides reliable measurement in 
children and adolescents with and without neuromuscular disorders.80  However, reliability is 
dependent upon consistent testing techniques and protocols, and accurate positioning of the 
patient.  Like other physical tests, muscle strength testing is critically dependent upon the effort 
and cooperation of the patient.  It is also crucial that the patient understand the required 
movement.  Because of these requirements, HHD testing is difficult to perform in children 
under 5.71 Limitations with HHD testing also occur in later stages of the disease when severe 
contractures restrict the positioning of the patient.81  Furthermore, these tests cannot isolate the 
behavior of an individual muscle, but rather they represent the global behavior of several 
muscles acting on a given joint.   
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Timed function testing 
 The measurement of the time that a child takes to perform a given activity is a commonly 
used means for assessing the functional abilities in boys with DMD.  These activities can include 
the time to climb a short flight of stairs, walk a short distance, or sit and stand up from a chair.  
Muscle degeneration is shown as an increase in the time it takes the patient to perform the 
activity and generally reflect the increasing weakness of the involved muscles.  These tests are 
convenient to use in a clinical setting, easy to administer, and result in a qualitative and 
continuous measure of progression.  However, there is potential error in clinician timing, which 
may reduce the test-retest reliability of the measures.75  Furthermore, the number of activities 
that the patient can perform is reduced as the disease progresses, reducing the relevance of 
these tests in older patients.   
3.2 Imaging Techniques 
3.2.1 Magnetic Resonance Imaging 
Magnetic resonance imaging (MRI) is a noninvasive imaging method which uses a 
powerful magnet to produce high resolution images and is increasingly being used in the 
evaluation of disease severity in neuromuscular diseases. 
Basic Physics of MRI 
The signal acquired from MRI systems predominately comes from the hydrogen protons 
within the body, specifically, those from water and fat.  All protons inherently have a nuclear 
“spin” and a resulting intrinsic magnetic field.  In the presence of a strong external magnetic 
field, the interaction between the external magnetic field and the magnetic field of the proton 
will cause the proton to precess at a frequency directly related to the strength of the external 
magnetic field.  The protons will also align with the external magnetic field, creating a net 
longitudinal magnetic vector directed along the axis of the external magnetic field.82,83     
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A radiofrequency (RF) pulse is then applied which excites the protons to a higher energy 
level.  Simultaneously, there is a gain in the protons’ phase coherence.  This produces a loss of 
longitudinal magnetization and a gain in transverse magnetization, respectively.  When the RF 
pulse is turned off, the excited hydrogen protons undergo relaxation back to their original lower 
energy level. 84  The relaxation process of the protons back into their equilibrium state occurs by 
two mechanisms: longitudinal (T1) and transverse (T2) relaxation.  In T1 relaxation, the proton 
returns to its equilibrium state by transferring energy to the other nuclei in its surroundings, or 
lattice.  This mechanism is also referred to as spin-lattice relaxation, and results in a net increase 
in longitudinal magnetization.   T2 relaxation reflects the loss of phase coherence due to 
interactions between spinning protons.  Also known as spin-spin relaxation, T2 relaxation leads 
to a net decrease in transverse magnetization.83   
Different tissues will exhibit different T1 and T2 relaxation times.  By varying the scanning 
parameters, images are generated so that the signal is primarily due to the T1 or T2 relaxation 
times of the tissue.  The signal intensity of normal skeletal muscle is similar to that of water, and 
lower than that of fat on T1-weighted images.  In T2-weighted images, the signal of skeletal 
muscle is lower than that of both water and fat.  Table 3.1 summarizes the appearance of muscle, 
fat, and water in T1- and T2-weighted images.  Fat suppressed images can be generated by using 
short τ inversion recovery (STIR) or by using a pre-saturation pulse to suppress the fat signal.  
Fat suppressed T2-weighted images are much more sensitive in detecting subtle muscle 
edema.70,85     
Table 3.1: MRI signal characteristics of muscle components 
 T1-weighted T2-weighted
Water Low to intermediate High
Fat High Intermediate
Muscle Intermediate Intermediate
 
21 
MRI in DMD 
Because healthy skeletal muscle and fat exhibit very different T1 relaxation times, T1-
weighted imaging is very sensitive to intramuscular fatty deposition.86    T1 signals have been 
shown to be significantly higher in the muscles of boys with DMD compared to normal 
control.86   T1 intensity has also been shown to  increase during the course of the disease, 
associated with the increasing replacement of muscle by fat.87  However, water has a T1 
relaxation time that is similar to normal muscle, thus T1-weighted images are insensitive at 
detecting increased water in muscle, making T1-weighted images less relevant in young DMD 
patients.  It has been hypothesized that T2-weighted images, which are sensitive to both fat and 
water, may be more appropriate for evaluating DMD patients early in the course of the disease, 
before fatty infiltration is significant.88  Acute muscle damage, inflammation, and fat have been 
characterized in dystrophic muscle using T2-weighted imaging.89 
A number of approaches have utilized MRI to measure muscle size in DMD.  Muscle cross-
sectional area is a quantitative measurement and can show differential involvement of muscle 
groups in disease progression.  Researchers at the University of Florida have used muscle cross-
sectional area to compare boys with DMD to age matched controls.90  They found that muscle 
cross-sectional area of the calf muscles were larger in DMD patients compared with controls.  In 
another study by the same group, tissue within the cross-sectional area was classified as 
contractile (muscle tissue) and non-contractile (fatty tissue) based on T1 signal intensity.  
Comparing 28 boys with DMD and 10 control subjects, they showed that the DMD patients had 
a significantly greater proportion of non-contractile tissue.  The proportion of non-contractile 
tissue in boys with DMD was shown to increase significantly with age.91 
Muscle size is typically calculated by manually tracing individual muscles in axial slices 
from T1- or T2-weighted images.  Because this manual assessment is time consuming, muscles 
are generally only segmented in a limited number of slices.  To address this need, the Neuro 
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Image Research and Analysis Laboratory at the University of North Carolina has recently 
developed a semi-automated segmentation method for segmenting the full length of individual 
muscles.  They found that utilizing the full volume of muscle resulted in significantly less error 
and variability in measurements, compared to the standard, limited range, muscle 
segmentation.92   Further, they showed that distribution of T2 values could be analyzed in three 
dimensions throughout the full muscle to provide information of muscle heterogeneity, and 
have demonstrated that MRI texture features are capable of distinguishing longitudinal 
progression between GRMD and normal dogs.93   
Overall, MRI is a powerful and sensitive technique for evaluating skeletal muscle 
involvement in DMD.  The major disadvantages of MRI as a biomarker for disease progression 
or therapeutic response in clinical trials are associated with the high cost, and the necessity of 
sedation or anesthesia in young children to prevent motion artifacts.94  This is especially 
undesirable in this patient population as anesthesia is potentially more hazardous in boys with 
DMD.95  Furthermore, MRI is not capable of directly measuring fibrosis, which is a critical 
characteristic of degenerated dystrophic muscle.96   
3.2.2 Ultrasound Imaging 
Medical ultrasound, discussed in detail in Chapter 4, provides a safe and relatively 
inexpensive alternative to the high cost of MRI.  Moreover, the rapid acquisition time make 
ultrasound less susceptible to motion artifacts, eliminating the need for sedation in pediatric 
patients.   
3.3 Summary 
The current outcome measures primarily used in DMD include the 6-minute walk test, 
muscle strength tests, and timed function tests.  These tests lack sensitivity to individual 
muscles, are dependent upon the effort and cooperation of the child, and are only applicable for  
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a limited period of time.  MRI and ultrasound imaging techniques that can noninvasively and 
quantitatively describe individual muscle involvement and longitudinal disease progression are 
emerging as new outcome measures.  
4 Ultrasound	Imaging	
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CHAPTER 4 
Ultrasound Imaging 
 
Medical ultrasound is a technique for generating images of soft tissue.  Because ultrasound 
is relatively inexpensive, portable, noninvasive, and real-time, it is attractive modality for a wide 
variety of clinical applications, including imaging muscles affected by neuromuscular diseases 
such as DMD. 
4.1 Basics of Ultrasound Imaging 
The major components of a basic ultrasound system are shown in Figure 4.1.  Ultrasonic 
imaging operates by transmitting high-frequency acoustic pulses into the body.  To generate this 
acoustic wave, computer-controlled electric voltage waveforms are applied across piezoelectric 
elements in a transducer array.  The elements vibrate at megahertz (MHz) frequency, generating 
pressure waves, which emanate from the transducer surface into soft tissue.   As the sound 
waves propagate, they are attenuated, scattered, and reflected, producing echoes from the 
various interfaces.  The transducer receives the returned echoes, which are digitalized and sent 
to the receive beamformer.  The beamformer combines the signals from each of the array 
elements and sums them, forming one signal (A-line) for each transmit pulse.  Focal delays and 
apodization applied within the beamformers are used to independently focus and/or steer the A-
lines on transmit and receive.  Post-processing steps include envelope detection and 
compression of the beamformed signal.    Typically, 2D images are presented in brightness mode  
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Figure 4.1: Major components of a basic ultrasonic imaging system. 
 
(B-mode) images that depict the relative strength and location of received echoes.  These 
images, which are made up of hundreds A-lines, are created by transmitting on a subset of the 
elements and translating the active aperture across the transducer array.97,98 
4.1.1 Spatial Resolution 
Spatial resolution describes the minimum spacing needed between two reflectors to have 
them distinguishable in the image.  Image resolution can be described in the axial, lateral, and 
elevational dimensions as depicted in figure 4.2.  Axial resolution, or the resolution along the 
ultrasound beam, is dependent on the pulse duration of the transmitted pulse and is defined as 
 ܣݔ݈݅ܽ ܴ݁ݏ݋݈ݑݐ݅݋݊ ൌ λ ∙ ݊௖2  
(4.1)
where λ is the wavelength of the pulse and ݊௖ is the number of cycles of the ultrasound pulse.   
The lateral and elevational resolution are determined by the λ, the acoustic focal distance 
(z), and the width of source aperture (D) in the lateral or elevation dimension, respectively, as 
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given by equation 4.2.  The ratio of the focal distance to the aperture width is known as the f-
number (F/#), and describes the focal configuration or spatial geometry of the acoustic pulse.  
Typically, for a 1D imaging linear array transducer, the F/# in the lateral dimension can be 
adjusted for the specific application by changing the number of elements excited (to change D) 
and the focal delays applied to them (to change z).  However, the focusing in the elevational 
dimension is accomplished by a mechanical lens, thus the F/# is fixed and dependent on the 
specific transducer. 
 ܮܽݐ݁ݎ݈ܽ/ܧ݈݁ݒܽݐ݅݋݈݊ܽ ܴ݁ݏ݋݈ݑݐ݅݋݊ ൌ ߣ ∙ ݖܦ ൌ ߣ ∙ ܨ/# (4.2)
 ܨ/# ൌ ݖܦ (4.3)
Depth-of-field (DOF), illustrated in figure 4.3, is another parameter used for describing 
the focal configuration of the acoustic pulse, and is defined by the following equation, 
 ܦܱܨ ൌ 8 ∙ ሺܨ/#ሻଶ ∙ ߣ (4.4)
The DOF describes the axial distance over which the acoustic beam maintains its approximate 
focal size.  Consequently, for a small F/# the resolution at the focal depth will be good, but the 
distance over which this focusing is maintained will be small. 
From equation (4.1) and (4.2), it is clear that resolution in all three dimensions is closely 
related to the wave length of the acoustic wave.  As frequency and wave length are inversely 
 
 
Figure 4.2: Ultrasound coordinate system relative to the 
imaging transducer.  A standard imaging slice represents the 
axial-lateral plane.  
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proportional (݂ ൌ ܿ ߣ⁄  where ݂ is frequency and ܿ is the speed of sound in the medium), the use 
of a higher frequency will produce better spatial resolution.  However, depth dependent 
attenuation of acoustic waves also increases with an increasing frequency.  This tradeoff 
between depth penetration and spatial resolution must be considered for each ultrasound 
application. 
4.2 Ultrasound in DMD 
 Under normal circumstances, skeletal muscle tissue has low echogenicity (Figure 4.4 
(a)).  Perimysial connective tissue between fiber bundles are depicted as echogenetic lines on 
longitudinal scans (transducer parallel to muscle fibers) and small spots in transverse scans 
(transducer perpendicular to muscle fibers), giving the muscle a speckled appearance.  The 
epimysium surrounding the muscle is highly echogenic, clearly demarcating the muscle 
boundaries.  Bones are highly reflective, resulting in well-defined, hyperechoic lines with 
posterior acoustic shadowing.   
Ultrasound can detect pathology and characterize the pattern of muscle involvement in 
skeletal muscle.  In DMD, muscle appears more echogenic due to the increase in the fat and 
fibrous content in the muscle (Figure 4.4 (b)).  Attenuation also increases, resulting in a 
decreased reflection from the underlying bone and poorer visualization of deep tissue.  As the 
 
 
Figure 4.3: Relationship between the aperture width (D), the focal depth (z), lateral resolution, and depth 
of field (DOF).  The DOF describes the axial distance over which the beam maintains its lateral 
resolution; it gets shorter for more tightly focused beams. 
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disease progresses, muscle signal increases, and the bone echo become less defined and bright, 
and eventually cannot be visualized.   
Visual detection of increased muscle echogenicity in DMD can be difficult, and its accurate 
interpretation depends on the experience of the observer.  To overcome this problem, 
techniques are being developed to make quantitative measurements of muscle echogenicity.  
Quantification of muscle echogenicity can be achieved with simple gray scale analysis of 
detected ultrasound data.    Another quantification technique, backscatter analysis, converts 
gray-scale values to decibels by comparing measured echo intensity with phantom 
measurements.  Both gray-scale analysis and backscatter analysis have shown a significant 
increase in the echo intensity of the muscles of DMD boys compared to healthy controls.99,100  
Both techniques were also sensitive to increases in intensity corresponding to patient severity.  
Other studies using radio frequency (RF) data with an entropy-based signal receiver have shown 
larger scatterer sizes in DMD versus control muscles, consistent with the pathologic changes of 
muscle.101,102  These techniques show promise in assessing degradation of dystrophic muscles; 
however, while they are sensitive to both fibrous and fatty deposition, they are unable to 
distinguish between them. 
 
Figure 4.4: The interaction between the ultrasound beam and (a) normal and (b) dystrophic muscle.  
When the ultrasound beam encounters the transition from muscle to fascia, a part of the sound is 
reflected.  Because normal muscle contains little fibrous tissue, only a few reflections occur, resulting in 
relatively low echogenicity.  In DMD, muscle tissue is replaced by fat and fibrous tissue, resulting in many 
transitions with different acoustic impedance and increased reflection of the ultrasound beam. 
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4.3 Ultrasound Elasticity Imaging 
Unlike conventional B-mode ultrasound imaging that differentiates features with 
dissimilar acoustic properties; elasticity imaging methods differentiate features and/or 
structures with different mechanical properties.  Because malignancies and pathologies, such as 
fat and fibrosis, will exhibit different mechanical properties than the surrounding tissue, 
elasticity imaging methods are being developed to examine tissue health and monitor disease 
progression.  To do this, these methods involve the exciting of the soft tissue and then 
monitoring the deformation response.  The source of the excitation used to produce the tissue 
deformation can be applied externally, as in compressive elastography, or can be generated 
internally using radiation force. 
4.3.1 Compressive Elastography 
External methods apply a compressive force on the skin to deform the tissue beneath.  
This is often implemented by pressing down and holding the ultrasound transducer against the 
skin.  A map of tissue strain can be formed by comparing RF data pre and post compression.103  
By assuming the applied stress is uniform and the material is elastic, differences in the 
measured strain are attributed to differences in the elasticity of the tissue. 
Ultrasound elastography has demonstrated promising clinical applications for evaluating 
thyroid, breast, lymph nodes, and prostate lesions.104  Elastography has also been applied to 
muscle disease assessment.  In a case report of a patient with Bethlem myopathy, a congenital 
muscular dystrophy, elastography showed that hyperechoic areas of the affected muscle 
exhibited lower strain than the normal appearing tissue, a finding suggesting increased stiffness 
due to the presence of fibrosis in the affected areas.105 
Elastography is intuitive and can be performed in real-time.  Unfortunately, tissue 
compression causes signal decorrelation, limiting the accuracy of displacement estimates and 
30 
the strain estimates formed from them.  Elastography is also limited because the deformation 
field decreases with depth, making it difficult to make measurements in deep tissue.  
Furthermore, in compressive elastography where pressure is applied by using a free-hand 
technique the measurements are operator dependent, which might affect reproducibility.106,107 
4.3.2 Acoustic Radiation Force 
Rather than applying stress at the skin surface, Acoustic Radiation Force (ARF) based 
methods generate a localized stress field within the tissue. 
Theory 
As an acoustic wave propagates through a medium its intensity decreases, or attenuates, 
with increasing distance.  Attenuation of ultrasound beams is caused by the reflection and 
scattering of waves and by the absorption of ultrasonic energy.  This absorption of energy from 
the traveling wave results in the transfer of momentum and generates a body force, known as an 
acoustic radiation force (ARF).108  In a medium such as soft tissue, the majority of attenuation is 
due to absorption.  By assuming that tissue behaves as an incompressible, linearly viscous fluid 
at ultrasonic frequencies and that the ultrasound wave propagates as a plane wave, the 
magnitude of the radiation force (F) can be described as  
 ܨ ൌ 2ߙܫܿ  (4.5)
where ߙ (m-1) and c (m/s) are the absorption coefficient and speed of sound in the medium, 
respectively, and I  (W/cm2) is the temporal average intensity of the acoustic beam at a given 
spatial location.109,110  The volume and geometry of the force field is spatially distributed under 
the active transducer aperture and is dependent on the material properties and characteristics of 
the transmitted beam.  The geometry of a typical radiation force field is shown in Figure 4.5. 
 In conventional ultrasound imaging, the magnitude of the acoustic radiation force is 
relatively small, producing negligible displacements in tissue (< 1 μm).  To generate measurable 
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displacements, ARF methods use longer and/or higher intensity acoustic pulses than what is 
used for B-Mode imaging.  In practice, acoustic radiation force magnitudes on the order of 
dynes can produce displacements in the range of 1-10 μm.  The amount the tissue displaces and 
the time needed for the subsequent recovery are dependent upon the mechanical properties of 
the tissue, which is exploited in the imaging techniques described in later sections. 
Acoustic Radiation Force Impulse (ARFI) Imaging 
 In Acoustic Radiation Force Impulse (ARFI) imaging, ultrasound is used to induce 
displacement and then monitor the tissue response in the same lateral location, or region of 
excitation (ROE).   Because the measured response is dependent on the magnitude of the 
radiation force, which is unknown in vivo, ARFI methods generally only provide relative 
measures of the tissue mechanics.   
 
 
Figure 4.5: Field II generated 2D (axial versus lateral) image of the 
temporal average intensity of a 192 element, linear array transmitting a 
300-cycle pulse at 4.21 MHz, and focused at 30 mm.  From equation 4.5, 
assuming a constant absorption coefficient and speed of sound, the 
geometry of the acoustic radiation force field is the same as the intensity. 
32 
A typical ARFI imaging sequence consists of three pulse types: reference pulses are used to 
establish a baseline position prior to the acoustic radiation force; an excitation (push) pulse, 
typically between 30 μs to 1 ms in length, is used to generate the acoustic radiation force; and 
finally, tracking pulses applied immediately following the pushing pulse are used to monitor the 
deformation response and recovery of the soft tissue.   This ensemble of reference, pushing, and 
tracking pulses can be translated across the aperture, as in B-Mode imaging, to acquire 
information throughout the field-of-view.  A displacement estimation method, such as 
normalized cross correlation, can be applied to calculate axial displacements between two 
pulses.  By estimating the displacements from a reference pulse to each of the tracking pulses, a 
data set of displacement though time can be generated.  From this data set, parametric images 
can be created by analyzing properties of the individual displacement profiles, such as the peak 
ARFI-induced displacement, the time to peak displacement, and the time to 67% recovery from 
peak ARFI-induced displacement or recovery time.  In general, softer regions will displace 
farther, take longer to reach a maximum displacement, and recover more slowly than stiffer 
tissues.111–113 
ARFI imaging has been shown to be clinically useful in a variety of applications including 
breast,114 atherosclerotic arteries,115 gastrointestinal tract,116 liver, 117 kidney, 117 and 
prostate.118  Nightengale et. al. demonstrated ARFI in vivo in the human vastus medialis muscle 
and showed that muscle stiffness increased with increasing isometric loading.119  Specifically, 
they showed that the peak displacement, the time to reach peak, and the time to recovery 
decreased with the increasing load.   
Shear Wave Imaging 
Along with localized displacement within the region of ultrasonic beam propagation, an 
ARFI excitation produces shear waves that propagate perpendicularly to the direction of the 
ultrasound wave propagation.  The phase velocity of generated shear waves has been shown to 
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be related to the stiffness of the material.   In a homogeneous, linear, elastic medium, the speed 
of the shear wave (்ܿ) can be expressed as 
 ்ܿ ൌ ඨܩߩ ൌ ඨ
ܧ
2ሺ1 ൅ ߭ሻߩ (4.6)
where ܩ is the shear modulus, ܧ is the Young’s modulus, ߭ is the Poisson’s ratio, and ߩ is the 
density of the tissue.   Shear Wave Elasticity Imaging (SWEI) uses an impulse radiation force to 
generate shear waves and quantify tissue stiffness based on their propagation speed.  As with 
ARFI, SWEI imaging sequences consist of reference, pushing, and tracking pulses, except unlike 
ARFI, the tracking beams are positioned outside the ROE.  With the displacement through time 
information at multiple lateral locations separated by a known distance from the pushing pulse, 
the speed of the propagating shear waves can be estimated.120   
In Supersonic Shear Imaging (SSI), multiple acoustic radiation force excitations are 
applied at increasing focal depths to create a quasi-plane shear wave source.  The method relies 
on applying the excitations such that shear waves propagating away from the ROE sum 
constructively to create an axially extended cylindrical shear wave.  Utilizing extensively parallel 
beamforming and plane wave transmits SSI methods are capable of monitoring the deformation 
response simultaneously across a large field of view (FOV) at ultrafast frame rates.  Quantitative 
estimates of tissue stiffness are made from measured shear wave speeds.121 
Clinically, shear wave imaging has been utilized for detecting breast cancer lesions,122 
monitoring liver fibrosis,123 and for assessing  thermal ablations.124  Gennisson et al. 
demonstrated that shear wave imaging was sensitive to muscle anisotropy, and found that shear 
waves traveled four times faster along muscle fibers than across them in a human bicep 
muscle.125 Lacourpaille et al. and Dastgir et al. both investigated shear wave imaging in boys 
with DMD and found an increase in velocity in the muscles of affected boys compared to healthy 
control.126,127 
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Viscosity 
Conventional elasticity methods have largely ignored viscous losses, considering tissue to 
be purely elastic.  All biologic tissues, however, exhibit some combination of elastic and viscous 
characteristics in response to an applied force.  Viscosity is a measure of a material’s resistance 
to flow or deformation, and if ignored, can bias the estimates of elasticity.128  Therefore, a 
viscoelastic model is more appropriate for describing soft tissue deformation.  Recently, a 
number of groups have developed methods for estimating the viscosity of tissue.  In Shear Wave 
Dispersion Ultrasound Vibrometry (SDUV) repeated radiation forces pushes are used to 
generate harmonic shear waves.129  Elasticity and viscosity are derived by measuring shear wave 
velocities at multiple frequencies and fitting to a mechanical model.  Catheline et al. measured 
viscoelastic properties by analyzing the speed and attenuation of a transverse waves generated 
by an external mechanical plate vibrator.130  Shear Wave Spectroscopy (SWS) uses a broad-
band, quasi-plane shear wave source to induce displacements.131  To assess viscous dispersion, 
the method applies Fourier transforms to the propagating shear waves and evaluates the phase 
difference as a function of frequency.  Because these methods all rely on shear wave 
propagation, they all assume homogeneity over a millimeter-scale measurement region, and lack 
the ability to access the viscoelastic properties directly in the ROE.132   
Other approaches to viscoelastic property assessment within the region of excitation apply 
sustained stress to induce displacements and solve for elastic and viscous parameters using 
established viscoelastic models.  Monitored Steady-State Excitation and Recovery (MSSER) 
ultrasound intersperses multiple ARF pulses and tracking pulses to observe tissue as it displaces 
to a steady-state level, then monitors the recovery of the tissue following the cessation of force.  
Tissue displacement and recovery can be fit to a mechanical model to quantify the mechanical 
parameters.133  However, MSSER may suffer from slow frame rate and/or undesired bioeffects 
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from the duration and amplitude of ARF excitations necessary to achieve steady-state 
displacement under physiologically relevant conditions.  
4.4 Summary 
This chapter described the fundamental concepts underlying medical ultrasound imaging.  
These principles are applied to study muscle in the context of muscular dystrophy.  A brief 
review of ultrasound-based elasticity imaging methods including compressive elastography and 
acoustic radiation force is also provided.  In addition, the need for considering biological tissues 
as viscoelastic rather than purely elastic was presented. 
5 Ultrasound	Imaging	
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CHAPTER 5 
Viscoelastic Response (VisR) Ultrasound 
 
5.1 Introduction 
As discussed in Section 4.3.2, monitored steady-state excitation and recovery (MSSER) is 
a method developed by Mauldin et al. that uses acoustic radiation force (ARF) to simulate a 
material creep test.133  In MSSER, many successive ARF impulses are applied to fully displace 
tissue to a steady-state level.  The observed displacement and subsequent recovery are then fit to 
the Voigt or standard linear viscoelastic model to estimate the mechanical parameters of the 
material.  However, due to the duration and amplitude of ARF excitations necessary to achieve 
steady-state displacement in an in vivo environment, MSSER may suffer from slow frame rate, 
motion artifacts, and/or undesired heating. 
Viscoelastic Response (VisR) ultrasound is a faster alternative to MSSER which assesses 
the viscoelastic properties of tissue using two successive ARF impulses and monitoring induced 
displacements in only the region of ARF excitation.  In this chapter VisR methods are 
mathematically derived using the Voigt viscoelastic model and are demonstrated in viscoelastic 
tissue-mimicking materials as well as in canine muscle, in vivo, with spatially matched 
histochemical validation.1 
                                                            
© 2013.  Portions reprinted, with permission, from Selzo, M. & Gallippi, C. Viscoelastic Response (VisR) 
Imaging for Assessment of Viscoelasticity in Voigt Materials. IEEE Trans. Ultrason. Ferroelectr. Freq. 
Control 60, 2488–500 (2013). 
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5.2 Background 
Viscoelastic Creep 
Viscoelasticity is the property of materials that exhibit both viscous and elastic 
characteristics when undergoing deformation.  Biological tissues exhibit a significant amount of 
viscoelastic, or time-dependent, behavior, such as creep.  Creep describes a progressive 
deformation of a material when exposed to a constant force over time.  In a creep test, the 
displacement will tend towards a constant, or steady-state value, as illustrated in Figure 5.1.  
When the force is removed, the material will undergo progressive recovery.  The creep and 
recovery response of a viscoelastic material is time dependent and related to the characteristic 
recovery time parameter, or τ, of the material.134   
VisR Ultrasound 
Rather than pushing the tissue fully to steady-state, as in MSSER, VisR assesses 
viscoelasticity by observing only a short portion of the viscoelastic creep profile predicted by the  
   
 
Figure 5.1: Creep behavior.  If a constant force is instantaneously 
applied to a viscoelastic material (red), the resulting displacement 
will increase (or creep) over time (blue) until reaching a steady-
state level of displacement. 
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Voigt model.  The Voigt model is a mechanical model that describes the response of a 
viscoelastic medium to external stimuli135 and has been used extensively in literature to 
characterize the mechanical properties of soft tissue, including muscle tissue.129,136–138  The 
model consists of an elastic spring in parallel with a viscous damper.  The constitutive relation 
between the applied force, F(t), and displacement, x(t), in the Voigt model is a linear first order 
differential equation, given by: 
 ߟ ݀݀ݐ ݔሺݐሻ ൅ ߤݔሺݐሻ ൌ ܨሺݐሻ (5.1)
where ߟ is the coefficient of viscosity of the damper and ߤ is the elastic constant of the spring.  
This can be rewritten as: 
 ݔሺݐሻ ൅ ߬ ݀݀ݐ ݔሺݐሻ ൌ
ܨሺݐሻ
ߤ  (5.2)
where ߬ is the relaxation time constant for constant stress of the material, and is equal to the 
ratio of viscosity to elasticity. 
Acoustic radiation force can be used to apply a step-stress input that causes creep in a 
viscoelastic medium.  If the ARF excitation is described as a rectangular function of force 
magnitude ܣ and ݐ஺ோி duration, then the two ARF excitations can be described as two 
rectangular pulses of duration ݐ஺ோி  and amplitude A, and separated by ݐ௦ in time, and are 
defined as below: 
 ܨሺݐሻ ൌ ܣ൫ܪሺݐሻ െ ܪሺݐ െ ݐ஺ோிሻ൯ ൅ ܣሺܪሺݐ െ ݐ஺ோி െ ݐ௦ሻ െ ܪሺݐ െ 2ݐ஺ோி െ ݐ௦ሻሻ (5.3)
where ܪሺݐሻ is the Heaviside unit function and is given by: 
 ܪሺݐሻ ൌ ቄ0, ݐ ൏ 01, ݐ ൒ 0 . (5.4)
Substituting (5.3) into (5.2) yields: 
ݔሺݐሻ ൅ ߬ ݀݀ݐ ݔሺݐሻ ൌ ݏ൫ܪሺݐሻ െ ܪሺݐ െ ݐ஺ோிሻ൯ ൅ ܣሺܪሺݐ െ ݐ஺ோி െ ݐ௦ሻ െ ܪሺݐ െ 2ݐ஺ோி െ ݐ௦ሻሻ (5.5)
ݏ ൌ ܣߤ . (5.6)
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Equation (5.5) can be solved for displacement as a function of ߬, and ݏ.  Displacement versus 
time profiles can be fit using to this equation using nonlinear regression in order to generate 
estimates of these two parameters.  Figure 5.2 (a) depicts the tissue response to the two ARF 
excitations. 
An alternative approach to assessing τ exploits only one ARF excitation (as in ARFI).  The 
differential equation describing the response of the Voigt material to a single ARF excitation is 
described by: 
ݔሺݐሻ ൅ ߬ ݀݀ݐ ݔሺݐሻ ൌ ݏ൫ܪሺݐሻ െ ܪሺݐ െ ݐ஺ோிሻ൯. (5.7) 
The performance of VisR using two pushes and (5.6) to estimate τ versus using one push and 
(5.7) to estimate τ will be compared. 
5.3 Methods 
Imaging was performed using a Siemens Acuson Antares imaging system (Siemens 
Medical Solutions USA, Inc., Ultrasound Division), which has been adapted to provide users 
with the ability to modify acoustic beam sequences, and a VF7-3 linear array transducer.  ARF 
excitations were 300 cycles (tARF = 70 µs) in duration centered at 4.21 MHz with an F/1.5 focal 
configuration and 6.5 mm depth of field.  Tracking pulses were conventional B-mode beams 
centered at 6.15 MHz with an F/1.5 focal configuration and 11 kHz pulse repetition frequency.  
VisR beam sequences consisted of two reference tracking lines preceding a first ARF excitation, 
then 4 tracking lines followed by a second ARF excitation and 40 additional tracking lines. 
For comparative purposes, MSSER, conventional ARFI, and single-push VisR imaging 
were also performed.  The MSSER beam sequence consisted of two reference tracking pulses, 
followed by 30 ten-cycle ARF excitations interspersed by 30 tracking pulses for a total of 62 
pulses (5.64 ms).  Conventional ARFI imaging was performed with a beam sequence that used 
the same excitation and tracking beams described for VisR, but with only one ARF excitation 
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followed by an ensemble of 59 tracking lines for a total of 62 pulses.  Double-push VisR, MSSER, 
and ARFI beam sequences are illustrated in Figure 5.2 (b). 
Two-dimensional imaging was achieved by administering the VisR, MSSER, or ARFI 
beam sequence in 40 lateral locations evenly spaced across a 2-cm lateral field of view.  Frame 
rates for 2-D double-push VisR, MSSER, ARFI, and single-push VisR imaging were 27.3, 4.4, 
4.4, and 31.2 frames per second, respectively.  Immediately before each 2-D data acquisition, a 
B-mode frame was acquired.  RF echo data were acquired at a 40 MHz sampling frequency and 
transferred to a computation workstation for processing and analysis.  Displacement tracking in 
the region of excitation was performed using 1-D cross-correlation in the axial dimension 
between sequentially acquired tracking lines.139 Each tracking line was up-sampled using cubic 
spline interpolation by a factor of 4 and divided into a series of 80-µm search regions; the 
location of the peak in the cross-correlation function between a 38-µm kernel in the first  
 
Figure 5.2: (a) Illustration of displacement versus time profile of a Voigt material in response to two ARF 
excitations.  (b) A VisR beam sequence is illustrated in comparison to MSSER and conventional ARFI 
beam sequences.  The large black arrows represent ARF excitation pulses, the gray arrows represent 
tracking pulses, and the pulses are separated in time by the pulse repetition period.  
 
41 
tracking line and a search region in the next tracking line was used to estimate axial tissue 
displacement in that region. 
VisR and MSSER imaging were performed in six cylindrical (6.5 cm diameter × 6 cm 
height), homogeneous tissue-mimicking phantoms, and VisR and ARFI were performed in one 
structured (spherical inclusion) tissue-mimicking phantom (10 cm diameter × 6 cm height).  
The background and inclusion had comparable elasticities, but the inclusion had increased 
viscosity.  Phantom gelatin and xantham gum concentrations were varied to alter elasticity and 
viscosity, respectively,140 and were prepared as follows: 200 mL of deionized water was heated 
to 60°C then gelatin (Type A, Acros Organics, Geel, Belgium) was added and stirred until 
clarified.  5.5 mL of surfactant (Photo-flo 200, Kodak, Rochester, NY), to minimize air bubbles, 
and 0.65 mL of N-propanol (Fisher Scientific, Waltham, MA), to increase sound speed, were 
added.  When the mixture had cooled to 40°C, 2 g of agar powder (Fisher Scientific) for 
ultrasound scattering was added.  At this point, 1 g of xanthan gum (Spectrum Chemicals & 
Laboratory Products, New Brunswick, NJ) was added to viscous phantoms and stirred until fully 
dispersed.  The solution was then poured into a mold for cooling and congealing overnight to 
room temperature.  Phantom gelatin and xantham gum formulations are reported in Table 5.1. 
MSSER estimates of τ were found by fitting MSSER displacement profiles to the equation 
for creep displacement133 
 ݔሺݐሻ ൌ ݏ ቀ1 െ ݁ି௧ ఛൗ ቁ (5.8)
using nonlinear regression.  Mean and standard deviations of MSSER τ were measured in a 20 
mm lateral by 4.5 mm axial region.  In addition, a normalized mean displacement profile was 
found by averaging measured displacements in this region at each time point, and dividing by 
the maximum mean displacement. 
For VisR imaging, τ was estimated using double- and single-push pulse sequences from 
the measured axial displacement profiles using (5.5) and (5.7), respectively.  Parametric images 
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of τ were rendered.  In homogeneous phantoms, VisR τ mean and standard deviation were 
calculated in a 20 mm laterally by 4.5 mm axially region positioned just above the focal depth 
(24 mm).  The VisR τ estimates were then statistically compared with the MSSER-derived τ  
Table 5.1: Phantom formulations 
Phantom 
Number 
Gelatin Concentration 
(g/liter) 
Xanthan Gum 
Concentration (g/liter) 
1 266 0
2 82 0
3 165 0
4 82 5
5 165 5
6 266 5
 
values using paired t-tests.  In addition, predicted normalized creep displacement curves were 
generated from (5.9) using the VisR-derived values of τ and an s of 1.  These VisR-predicted 
curves were compared with the MSSER-observed normalized mean displacement profiles by 
calculating an R2 value.  In the structured phantom, parametric images of double-push VisR τ, 
ARFI displacement (PD) and time to 67% recovery (RT), and single-push VisR τ were generated.  
Contrast-to-noise ratio (CNR) for the spherical inclusion was calculated as 
 ܥܴܰ ൌ |ߤ௜ െ ߤ௕|
ටߪ௜ଶ ൅ ߪ௕ଶ
 (5.9)
where ߤ௜ and ߤ௕ denote the means and ߪ௜  and ߤ௕ denote the standard deviations of the 
parameter inside and outside the inclusion, respectively.  CNR versus distance from the imaging 
focus (34 mm) resulting from single- and double-push VisR τ versus ARFI PD and RT 
parameters were compared using 3 mm lateral by 1 mm axial kernels inside and outside the 
lesion at each depth. 
Using the same imaging methods as in the phantom experiments, double-push VisR 
imaging was performed in vivo in the right semitendinosus (ST) muscle of an approximately 13-
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kg golden retriever cross-bred dog with no known musculoskeletal disorders.  The Institutional 
Animal Care and Use Committee (IACUC) of the University of North Carolina at Chapel Hill 
approved all procedures.  The dog was premedicated with acepromazine maleate (0.2 mg/kg), 
butorphanol (0.4 mg/kg), and atropine sulfate (0.04 mg/kg), masked, and then intubated and 
maintained with isoflurane.  For imaging, the anesthetized dog was positioned in lateral 
recumbency.  The muscle was imaged in a plane approximately transverse to the muscle fiber 
orientation, and the imaging plane was marked with methylene blue dye injected under B- mode 
image guidance.141  The methylene blue dye was visible both macroscopically at necropsy and 
microscopically after sectioning and staining and did not interfere with histochemical 
processing.  The marking was used to spatially align histological sections to the imaging plane.  
The extracted, marked sample was frozen, embedded, sectioned, and stained with hematoxylin 
and eosin, Oil Red O for fat, and Masson’s trichrome for collagen.   Microscopy of the stained 
sections was performed using an Aperio Scanscope microscope (Vista, CA) at 20× 
magnification.  Microscopy and parametric double-push VisR τ images were aligned using the 
methylene blue dye as a fiducial marker and spatially compared. 
5.4 Results 
Representative double-push VisR profiles of axial displacement versus time observed in 
viscoelastic phantoms are illustrated in Figure 5.3.  Figure 5.3 (a) shows profiles measured in 
phantoms with different elasticity but comparable viscosity (phantoms 3 and 1 in Table 5.1), 
whereas Figure 5.3(b) depicts profiles measured in phantoms with comparable elasticity but 
different viscosity (phantoms 3 and 6 in Table 5.1).  The associated double-push VisR τ 
estimates for each profile are listed. 
Representative profiles of axial displacement versus time for ARFI and VisR in a 
viscoelastic phantom (phantom 4 in Table 5.1) are shown in Figure 5.4.  Figure 5.4(a) shows 
ARFI and single-push VisR profiles taken at the focal depth (24 mm), profiles 15 mm above the  
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Figure 5.3: Representative double-push VisR one-dimensional axial displacement profiles measured in 
homogeneous tissue mimicking phantoms.  In panel (a), phantoms have different elasticities, but similar 
viscosities (green: phantom 3, blue: phantom 1).  In panel (b), phantoms have similar elasticities, but 
different viscosities (green: phantom 3, blue: phantom 6). 
 
focal depth, and 5 mm below the focal depth, whereas Figure 5.4(b) shows the corresponding 
double-push VisR profiles at the three depths.  The associated ARFI PD and RT as well as VisR τ 
estimates are listed at each axial depth.  
In Figure 5.5 (a), double- and single-push VisR τ estimates (circles and diamonds, 
respectively) for all 6 homogeneous tissue-mimicking phantoms are plotted in comparison to 
the corresponding MSSER τ estimates (triangles).  Double-push VisR τ estimates are not 
statistically significantly different from those generated MSSER (p < 0.02).  However, single-
push VisR τ values statistically differ from those of MSSER in phantoms 2 and 4.  The 
agreement between VisR and MSSER τ measurements is further illustrated in Figure 5.5(b), in 
which VisR τ values are used to predict creep displacement curves and are plotted against the 
creep displacement curves observed experimentally using MSSER in each of the 6 phantoms.  
The accuracy of the VisR method is indicated by the closeness of fit between the experimental  
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Figure 5.4: Representative (a) ARFI and single-push VisR and (b) double-push VisR one-dimensional 
axial displacement profiles measured in a homogeneous tissue mimicking phantom at the focal depth, 
15 mm above and 5 mm below the focal depth.  For each depth, ARFI peak displacement (PD) and 
recovery time (RT) measures (column a), single-push VisR τ values (column a), and double-push VisR 
τ values (column b) are shown.  Although ARFI PD and RT and single-push VisR τ values vary with 
depth, double-push VisR τ values are more consistent.
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data and predicted data, given by the R2 statistic.  R2 values ranged from 0.955 to 0.999 for the 
double-push method and from 0.944 to 0.986 for the single push method.   
VisR, ARFI, and B-mode imaging results in the structured phantom are shown in Figure 5.6.  
Recall that phantom background and spherical inclusion have comparable stiffness, but the 
background viscosity is lower than that of the inclusion (background is phantom formulation 1 
and the inclusion is phantom formulation 6).  For all three imaging methods, the focal depth 
was 34 mm.  In the B-mode image [Figure 5.6(a)], the spherical inclusion is evident as the 
hyperechoic spherical structure spanning 24 to 39 mm axially and −10 to −1 mm laterally.  The 
two boxes represent the positions of the ROIs within and outside the inclusion for CNR  
 
Figure 5.5: (a) Monitored steady-state excitation recovery (MSSER; triangles), double-push VisR (circles) 
τ values (mean ± standard deviation) estimated in the six examined homogeneous tissue phantoms at the 
focal depth are consistent (p < 0.02, paired t-test).  Single-push VisR τ values (diamonds) are statistically 
different from those of MSSER in phantoms 2 and 4.  (b) Double- (red, dashed) and single-push (purple, 
dotted) VisR τ values predict viscoelastic creep profiles by the Voigt model that follow the creep profile 
experimentally observed during MSSER imaging (blue, solid) in the six homogeneous phantoms.  
Similarity between creep profiles predicted by single- and double-push VisR and experimentally observed 
by MSSER is indicated by the R2 value included in the corresponding panels.
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Figure 5.6: (a) B-mode, (b) double-push VisR τ, (c) ARFI peak displacement (PD), (d) ARFI recovery time 
(RT), and (e) single-push VisR τ images of a tissue-mimicking phantom with a spherical inclusion that is 
comparably stiff but more viscous than the background.  The boxes in the B-mode image represent the 3 
mm laterally by 1 mm axially ROIs used to calculate contrast-to-noise ratio (CNR).  (f) CNR is plotted 
versus distance from the focus for the double-push VisR τ (red), ARFI PD (green), RT (blue) images, and 
single-push VisR τ (purple). 
 
 
calculations.  The boxes were moved axially in 1-mm steps to evaluate CNR as a function of 
distance from the imaging focus.  In the double-push VisR τ image Figure 5.6(b), the lesion is 
clearly delineated across its 24 to 39 mm axial range; however, the lesion is not well 
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distinguished from background in the parametric ARFI peak displacement (PD) image [Figure 
5.6(c)].  The parametric ARFI recovery time (RT) image [Figure 5.6(d)] delineates the spherical 
inclusion better than the ARFI PD image, but CNR diminishes with distance from the focal 
depth, as is described by the graph of CNR versus distance from focus in Figure 5.6(f).  Although 
ARFI RT yields comparable CNR to double-push VisR near the imaging focus, RT CNR drops 5 
mm above the focus and 4 mm below the focus.  This is not the case for double-push VisR, which 
maintains generally constant CNR across the 14 mm axial range of the inclusion.  The single-
push VisR image [Figure 5.6(e)] discriminates the inclusion with generally lower CNR than the 
double-push VisR method, but CNR is improved over that of RT alone from approximately 5 
mm above the focus.   
In vivo double-push VisR imaging in a canine semitendinosus (ST) muscle is shown with 
spatially-matched histochemistry in Figure 5.7.  Figure 5.7 (a) shows the B-Mode image 
acquired during injection of the methylene blue dye to mark the imaging plane.  The needle is 
evident in the upper right portion of the B-mode image (blue arrow).  The corresponding gross 
muscle is shown in the top of Figure 7(b), with methylene blue dye macroscopically visible (blue 
arrow).  Also observable are white anatomical features confirmed by Masson’s trichrome stain 
[Figure 5.7(b) bottom] to be perimysial connective tissue outlining an area where three separate 
fascicles come into contact.  This connective tissue is highly collagenated according to the 
Masson’s stain and hyperechoic in the B-mode image [Figure 5.7(c)].  The connective tissue also 
yields low τ values in the spatially matched VisR image [Figure 5.7(d)].  The VisR image is 
superimposed with transparency on the B-mode image in Figure 5.7(e) to highlight the spatial 
alignment of low VisR τ estimates to the hyperechoic connective tissue in the B-mode image. 
5.5 Discussion 
VisR is a novel approach to elastographic imaging that estimates τ, the viscoelastic stress 
relaxation time constant in the Voigt biomechanical model, by delivering to the same region of  
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Figure 5.7: In vivo double-push VisR imaging in normal canine semitendinosis muscle: (a) The B-mode 
image captured from the system display shows the needle injecting methylene blue dye to mark the VisR 
imaging plane (blue arrow), and hyperechoic structures (white arrows).  The hyperechoic structures and 
position of methylene blue injection are used to align the B-mode image to histology.  The red polygon 
denotes the corresponding tissue in the histology section (panel 5.7b) with the hyperechoic structure 
contained within the histology section outlined in yellow.  (b) In the gross image of the dissected muscle 
(top), the methylene blue mark is apparent (blue arrow).  Also evident is white tissue spatially 
corresponding to the hyperechoic structures highlighted in the B-mode image, which are confirmed by 
Masson’s trichrome stain to be highly collagenated connective tissue (bottom).  The red polygon on the 
gross image denotes corresponding tissue in the Masson’s stain, with the highly collagenated structure 
outlined in yellow.  (c) The B-mode image rendered by envelope detection of the raw RF B-mode data 
acquired immediately before VisR imaging is shown with hyperechoic connective tissue structures again 
apparent (arrows).  Note the injection needle was removed before VisR imaging to avoid disruption of 
ARF propagation beyond the needle.  (d) The VisR τ image shows low τ spatially corresponding to the 
position of the connective tissue structures (arrows).  (e) The spatial correspondence of low VisR τ 
estimates to the connective tissue structures is further demonstrated by overlaying the VisR transparency 
on the B-mode. 
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excitation one or two successive ARF excitations.  Although the single-push VisR approach 
yields τ estimates that are similar to the double-push approach at the focal depth, the double-
push approach supports a larger axial range over which τ estimates are valid.  Figure 5.4 shows 
that in a homogeneous tissue-mimicking phantom, double-push τ values remained relatively 
constant from 5 mm below the focus (0.29 ms) to the focus (0.29 ms) to 15 mm above the focus 
(0.30 ms).  On the contrary, the single-push VisR τ values varied from 3.05 ms below the focus 
to 0.31 ms at the focus to 1.51 ms 15 mm above the focus.  This represents a 10-fold and 5-fold 
increase in single-push VisR τ values 5 mm below and 15 mm above the focus, respectively.  The 
impact of single-push VisR’s depth dependence on two-dimensional imaging is demonstrated in 
Figure 5.6, which shows that double-push VisR yields higher CNR over a larger axial range than 
single-push VisR, although in the axial range of 1 to 5 mm above the focal depth, single- and 
double-push VisR perform comparably in terms of CNR.  These data demonstrate an important 
advantage to double-push VisR, which is the extended axial range over which its τ estimates are 
consistent.  It could be possible to interrogate a 20 mm axial range using single-push VisR in the 
phantoms if an ARF excitation and tracking were performed every 4 mm axially.  However, this 
would require a total of 6 ARF excitations, as opposed to 2 ARF excitations for the double-push 
VisR approach, to interrogate the same axial range. 
Both single- and double-push VisR τ values estimated at the focal depth are compared 
with MSSER (which measures τ by pushing to steady-state displacement) in Figure 5.5.  Figure 
5.5(a) shows that single- and double-push VisR τ estimates are generally similar to each other 
and to MSSER-derived τ values in all phantoms.  Double-push VisR τ estimates were not 
statistically different (p <0.02) from MSSER τ values in any phantom.  However, single-push 
VisR yielded τ estimates that were statistically different from MSSER τ estimates in phantoms 2 
and 4.  Moreover, single-push and double-push VisR τ estimates were statistically different from 
each other in phantom 6.  Overall, the differences between τ estimated at the focal depth using 
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single- or double-push VisR appear minor, which suggests that single-push VisR may be a useful 
tool if the desired axial range for imaging is limited to a few millimeters above the focal depth. 
Although the methods of VisR support important ad vantages, including fast frame rates 
and independence from tissue inhomogeneity surrounding the ARF region of excitation, the 
VisR approach is associated with a critical limitation as it pertains to imaging tissue.  
Specifically, the Voigt model, upon which the VisR method is based, does not account for 
material mass, and therefore, no inertial terms are associated with the observed displacements. 
However, tissue is not massless, and neglecting contributions from inertia distorts VisR τ 
estimates.  This is the topic of Chapter 7. 
Another limitation to VisR is that it does not isolate the viscosity coefficient from the 
elastic modulus.  Rather, VisR estimates τ, the ratio of viscosity coefficient to the elastic 
modulus.  In this regard, VisR may be limited in scenarios in which discriminating changes in 
viscosity coefficient from changes in elastic modulus are diagnostically meaningful.  For 
example, using VisR as described in this Chapter, it would not be possible to determine if a given 
tissue A has half the elastic modulus or twice the coefficient of viscosity of tissue B with a two-
fold difference in τ. 
The statistical sameness of double-push VisR and MSSER imaging methods in Figure 5.5 
demonstrates that VisR, which exploits the Voigt biomechanical model in a manner similar to 
MSSER imaging but with far fewer ARF excitation and tracking pulses, achieves τ estimation 
much more efficiently than MSSER.  Moreover, independence from pushing to a steady-state 
level of displacement and from observing undisturbed progression to steady-state in VisR makes 
its clinical implementation lower energy and more tractable than that of MSSER.   
Another advantage of VisR is its independence from the applied ARF magnitude and from 
the impulsive nature of the ARF excitation.  This is not the case for conventional ARFI imaging, 
in which induced peak displacement is proportional to the applied force magnitude that 
diminishes with distance from the ARF region of excitation.  Further, ARFI recovery time 
52 
measures are distorted away from the region of ARF excitation where the propagating excitation 
is no longer impulsive.  This phenomena is illustrated in Figure 5.4.  Figure 5.4(a) shows that 
with conventional ARFI, a point 15 mm above the focal depth exhibited a PD that was 74% 
smaller and an RT that was 167% longer than a point at the focus; similarly, PD was 67% smaller 
and RT was 81% longer in a point 5 mm below the focal depth compared with the point at the 
focus.  In double-push VisR [shown in Figure 5.4(b)], despite decreases in achieved 
displacement, τ estimates at 15 mm above the focus and 5 mm below the focal depth were 3% 
smaller and equal to τ estimated at the focus, respectively. 
It is important to consider that double-push VisR assumes that the two successively 
applied ARF excitation impulses are identical in a given region of excitation.  Although this 
assumption is generally reasonable, variations in system output and/or shear wave reflections 
that are immediately coincident with (and inconsistently augment) one of the two successive 
excitation impulses may corrupt VisR τ estimates.  In our preliminary experience to date, VisR τ 
estimates were not statistically significantly different (p < 0.2) over 10 repeated measures in the 
examined tissue-mimicking phantoms (data not shown), but a more thorough analysis of 
repeatability with specific attention given to the potential impact of system variation in force 
output on VisR τ estimates is warranted. 
5.6 Conclusion 
VisR, a new ARF-based elastographic imaging method that estimates the relaxation time 
for constant stress (τ) in viscoelastic materials, is presented with mathematical derivation based 
on the Voigt biomechanical model.  Data acquired in tissue-mimicking phantoms highlight the 
key advantages to VisR.  First, τ is estimated using displacement tracked in only the ARF region 
of excitation, so VisR is faster, lower energy, and less susceptible to corruption from tissue 
inhomogeneity than approaches that rely on measuring shear wave propagation over a 
millimeter-scale lateral distance from the ARF region of excitation.  Second, double-push VisR is 
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relatively independent from the magnitude of the ARF excitation, which results in a greater axial 
range than possible with conventional ARFI methods.   Preliminary results in normal canine 
semitendinosus muscle suggest the clinical relevance of double-push VisR to muscle.  VisR 
imaging in muscle is further explored in Chapter 6; specifically, VisR’s sensitivity to muscle 
anisotropy is explored. 
6 VisR	Ultrasound	in	Muscle:	a	Pilot	Study	 	
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CHAPTER 6 
VisR Ultrasound in Muscle: a Pilot Study 
 
6.1 Introduction 
In Duchenne muscular dystrophy (DMD) muscle tissue is progressively replaced by 
fibrous tissue and fat.26  Therefore, serially evaluating muscle composition within a given 
individual is relevant to monitoring disease progression and to assessing the efficacy of 
treatment regimens.  Similarly, comparing affected muscles across groups of individuals at 
various stages of disease progression or following different courses of therapy can offer insights 
to the natural history of the disease or differentiate treatment responses, respectively.  Both 
serial and cross-sectional analyses require consistent tissue interrogation methods to ensure 
that measured changes are predominantly related to differences in the tissue itself rather than 
variations in the measurement technique.      
As discussed in Section 2.1, skeletal muscle is composed of long muscle fibers which are 
aligned parallel to each other.  Due to this geometric structure, the mechanical properties of the 
muscle are dependent on the orientation of the muscle fibers relative to the displacing force.  
Using an asymmetric indenter, Namani et al. demonstrated that fibered materials appeared 
stiffer when the long axis of the rectangular indenter was aligned perpendicular to the dominant 
fiber direction.142,143  Therefore, if inconsistently aligned with respect to the asymmetric 
displacing force, muscle fiber orientation may confound both longitudinal and cross-sectional 
comparisons of muscle mechanical property.  Controlling muscle fiber alignment relative to 
transcutaneous probing devices is nontrivial in an in vivo imaging environment in which 
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muscles anatomically bend and twist.  Rather than trying to control fiber orientation, its 
confounding effects may be obviated by utilizing a symmetric displacing force applied equally 
along fiber directions. 
This chapter presents the results of a pilot study using VisR to image muscle tissue.  VisR 
independence from muscle fiber direction is achieved by utilizing a symmetric focal 
configuration for the ARF excitation pulse. 
6.2 Background 
ARF Spatial Distribution  
The spatial distribution of the applied ARF field is related to the focal configuration of the 
acoustic pulse, or F/# (see Section 4.1.1).  When scaled by the center wavelength, the F/# 
approximates the full width at half max (FWHM) beam width in the lateral or elevational 
dimension.144  For a standard 1-D linear array, lateral F/# (and lateral FWHM beam width) may 
be adjusted by electronically selecting the number of active elements; an F/1.5 lateral focal 
configuration is commonly used for the ARF excitation.115,133,145–147  However, in the elevation 
dimension, F/# is static and set by the height of the transducer elements and the fixed-focus 
acoustic lens.  For example, elements of the Siemens VF7–3 linear array transducer are 7.5 mm 
in height, and the elevation focus is fixed at 37.5 mm, giving the transducer an elevation focal 
configuration of F/5.148  This elevation focus, paired with the F/1.5 lateral focal configuration 
typically used for the ARF excitation, results in an asymmetric pushing beam that is more tightly 
focused in the lateral dimension than in the elevation dimension.   
With respect to using such an asymmetric ARF pushing beam for probing the mechanical 
properties of muscle, when the transducer face is oriented parallel to muscle fibers, as in Figure 
6.1 (a), the long axis (elevation) of the ARF pushing beam will be perpendicular to the muscle 
fibers, and the interrogated tissue will be stiffer, resulting in a smaller VisR τ.  Conversely, when 
the transducer is oriented perpendicular to muscle fibers, as in Figure 6.1 (b), the long axis 
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(elevation) of the ARF pushing beam will be parallel to the muscle fibers, and the interrogated 
tissue will be less stiff, resulting in a larger VisR τ.  On the contrary, a symmetrical ARF pushing 
beam, as in Figure 6.1 (c), will apply the ARF excitation equally along and across fibers, resulting 
in constant values of VisR τ regardless of transducer orientation.  A symmetric ARF pushing 
beam is achieved in this work by using a standard 1-D linear array and adjusting the lateral focal 
configuration to match that of the fixed elevational focal configuration.  VisR τ measures 
obtained for various muscle fiber orientations are compared across increasing ARF lateral focal 
configuration.   
 
Figure 6.1: Simple model of muscle.  (a) The long axis of the asymmetric focal 
region is oriented perpendicularly to muscle fibers.  (b) The long axis of the 
asymmetric focal region is oriented parallel to muscle fibers.  (c) The symmetric 
focal region interrogates the same tissue, regardless of the angle between the 
transducer and the muscle fibers. 
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6.3 Methods 
A Siemens SONOLINE Antares ultrasound system equipped for research purposes 
(Siemens Medical Solutions USA, Inc., Ultrasound Division) and a VF7-3 linear array transducer 
were used for all experiments.  Imaging was performed at an axial focal distance of 34 mm.  ARF 
excitations were 300 cycles (70 μs) in duration and centered at 4.21 MHz with variable focal 
configuration (see below).  Tracking pulses were centered at 6.15 MHz with an F/1.5 lateral focal 
configuration and an 11 kHz pulse repetition frequency.  VisR beam sequences consisted of two 
reference tracking lines preceding a first ARF excitation, then 8 tracking lines followed by a 
second ARF excitation and two additional tracking lines for a total of 14 pulses.  Four different 
ARF pushing beam focal configurations were used for VisR imaging during separate image 
acquisitions and included F/1.5, F/3, F/4, and F/5.  ARF-induced displacement tracking in the 
region of excitation was performed using 1-D cross-correlation in the axial dimension between 
sequentially acquired tracking lines.139  Each tracking line was up-sampled using cubic spline 
interpolation by a factor of 4 and divided into a series of 80 µm search regions; the location of 
the peak in the cross-correlation function between a 38 µm kernel in the first tracking line and a 
search region in the next tracking line was used to estimate axial tissue displacement in that 
region.   
The effect of changing the lateral F/# on the FWHM of the ARF excitation was confirmed 
experimentally.  The transducer was connected to a Newport ESP 300 programmable 
translation stage (Newport corp., Irvine, CA, USA), submerged in a water tank, and aligned with 
an Onda HGL-0200 hydrophone (Onda Corp., Sunnyvale, CA, USA).  The hydrophone was 
connected to a Signatec PDA14A analog-to-digital (A/D) convertor (Signatec Inc., Newport 
Beach, CA, USA), and using a custom program developed in LabVIEW (National Instruments, 
Austin, TX, USA), the transducer was swept across the hydrophone in the lateral and elevation 
dimensions.  In each position, a single 2-cycle A-line centered at 4.21 MHz and focused at 34 
mm was transmitted to generate a 2D (lateral-elevational) map of the acoustic point spread 
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function (PSF).  The pressure values were averaged for 10 measurements, converted to decibels, 
and displayed as a contour map.  The -6 dB level was selected as the FWHM dimensions of the 
PSF.  This process was repeated for F/1.5, F/3, F/4, and F/5 lateral focal configurations. 
To observe the impact of ARF focal configuration on VisR τ measures in isotropic material, 
VisR ultrasound was performed using all four ARF focal configurations in a homogeneous agar-
gelatin, control phantom.  The phantom was produced according to methods described by Hall 
et al. using 200 mL of deionized water, 36 g of gelatin (Type A, Acros Organics), 10 mL of N-
propanol, and 2 grams of agar powder to induce scattering.149 The phantom was placed on a 
turntable (shown in Figure 6.2) with the transducer fixed in place above it.  Imaging then 
proceeded with F/1.5, F/3, F/4 and F/5 focal configurations for angles of rotation ranging from 
0° to 90° with a 10° step.  
In addition to the phantom studies, VisR imaging was performed ex vivo in anisotropic 
porcine muscle (psoas major).  For muscle, the angles of rotation ranged from -10° to 110° in 10° 
steps, with an angle of 0° referring to when the transducer face was parallel to muscle 
 
 
Figure 6.2: Picture of the turntable used in the 
experimental setup.  Pork muscle was placed in center of 
turntable and transducer was mounted overhead. 
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fibers (determined by maximizing the length of hyperechoic lines in B-Mode imaging, Figure 
6.7).  Following the complete rotation, the turntable was returned to -10°, the transducer was 
manually lifted and then placed back down in approximately the same location, and imaging 
was repeated for the full range of angles.  This was repeated for a total of three sets of 
acquisitions, with each set consisting of one VisR frame per angle.  
For both phantom and muscle data, the mean and standard deviation (SD) of VisR τ in a 
20 mm laterally by 2 mm axially region of interest (ROI) located just above the focal depth (34 
mm) were calculated in each VisR frame.  The variability of τ measurements within a single VisR 
frame was calculated as the coefficient of variation (CV), where CV = SD/mean.  The mean, SD, 
and CV were then compared across all rotation angles in a single (the first for muscle) 
acquisition set.  In addition, for each focal configuration and angle of rotation in the muscle, 
VisR τ values within the 20mm x 2mm ROI across the three repeated acquisitions were 
aggregated, and the aggregate mean, SD, and CV were calculated and compared across rotation 
angles. 
Statistical Analysis 
Descriptive statistics are expressed as mean ± SD.  The paired t-test was used for 
comparisons between angles.  A p value of < 0.05 was defined as significant. 
6.4 Results 
The measured PSFs for the F/1.5, F/3, F/4, and F/5 focal configurations are shown in 
Figure 6.3.  The -6dB level is bold, and the associated ratios of the lateral beamwidth to the 
elevation beamwidth are listed.  As expected, the lateral beamwidth is 73% smaller than the 
elevation beamwidth in the F/1.5 case, while the two are approximately equal in the F/5 case. 
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Figure 6.3: Point spread functions (PSF) measured experimentally, 
transmitting at 4.21MHz and using (a) F/1.5, (b) F/3, (c) F/4, and (d) 
F/5 focal configurations.  Symmetry is indicated by the ratio of the 
lateral width to elevation height included in the corresponding panels. 
 
Figure 6.4 panels (a) - (d) depict graphs of VisR τ value versus angle of rotation for the 4 
ARF lateral focal configurations in the isotropic control phantom.  Within any focal 
configuration, VisR τ measures are not statistically significantly different over the full range of 
rotation angles.  Across focal configurations, the mean VisR τ value increases and the SD 
decreases with increasing F/#.  Panel (e) illustrates the VisR τ CV versus rotation angle for the 
four ARF focal configurations.  CV values are consistent across rotation angles for any single 
focal configuration but decrease with increasing F/#.  Numerical VisR τ results in the isotropic 
control phantom are summarized in Table 6.1. 
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Figure 6.4: VisR τ (mean ± SD) measurements at angles of rotations from 0° to 90°, with 10° steps, in the 
homogenous, control phantom using (a) F/1.5, (b) F/3, (c) F/4, and (d) F/5 focal configurations.   For all 
configurations, VisR measurements are consistent through all angles.  (e) Coefficient of variation (CV) is 
highest in F/1.5 (blue), and decreases in F/3 (green), F/4 (red), F/5 (purple) focal configurations. 
 
Figure 6.5 depicts VisR outcomes similarly to Figure 5 but for a single acquisition in 
excised pig muscle; numerical VisR τ results are given in Table 6.2.  For the F/1.5 ARF focal 
configuration (panel a), VisR τ values increase with increasing angle of rotation from 0° to 90°, 
with VisR τ values measured at 30° and higher rotation angles statistically significantly different 
from that at 0°.  A direct relationship between VisR τ values and rotation angle is also observed 
for the F/3 ARF focal configuration (panel b), although the difference between τ measured at 0° 
and 90° is smaller than in the case of the F/1.5 focal configuration.  VisR τ measurements at 
rotation angles greater than 60° are statistically different from the 0° measurement.  The 
difference in VisR τ values with rotation angle is further minimized for the F/4 focal 
configuration, with only measurements at 90° and 100° statistically different from the 0° 
measurement, and no statistically significant difference in VisR τ values with rotation angle is 
observed with the F/5 focal configuration.  Comparing across focal configurations, trends 
toward increasing mean VisR τ values at 0°and decreasing SD with increasing F/# are observed,  
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Figure 6.5: VisR τ measurements at angles of rotations from -10° to 110°, with 10° steps, in a single 
acquisition in the excised pig muscle.  (a) For F/1.5, τ at 0° is significantly smaller than τ at angles > 20°.  
(b) For F/3, τ at 0° is significantly smaller than τ at angles > 60°.  (c) For F/4, τ at 0° is significantly 
smaller than τ at 90° and 100°.  (d) In F/5, τ at 0° is consistent through all angles.  (e) Coefficient of 
variation (CV) is highest in F/1.5 (blue), and decreases in F/3 (green), F/4 (red), F/5 (purple) focal 
configurations.   
*Signifies a statistically significant difference from 0° (p<0.05) 
 
consistent with results in the isotropic phantom.  CVs (panel e) increase with rotation angle 
between 0° and 90° for F/1.5 and F/3 focal configurations but remain relatively stable for the 
F/4 and F/5 focal configurations.  Across focal configurations, CVs decrease with increasing 
F/#.   
Aggregated results from the three repeated VisR acquisitions in the excised pig muscle are 
shown in Figure 6.6.  Measurements of τ at 0° were significantly smaller than measurements at 
angles 50°-110° using F/1.5 (panel a), 80°-110° using F/3 (panel b), and 90° using F/4 (panel c).  
With the F/5 configuration (panel d), τ at 0° was not significantly different from τ at any other 
angle.  Panel (e) shows the combined CVs for the three repeated acquisitions versus rotation 
angle using the four ARF focal configurations.  The CVs of the F/1.5 (solid) and F/3 (dashed) 
configurations had local maxima at 0° and 90° and minimums at 50°.  No significant trends  
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Figure 6.6: VisR τ measurements at angles of rotations from -10° to 110°, with 10° steps, in three repeated 
acquisitions in the excised pig muscle.  (a) For F/1.5, τ at 0° is significantly smaller than τ at angles > 40°. 
(b) For F/3, τ at 0° is significantly smaller than τ at angles >70°.  (c) For F/4, τ at 0° is significantly 
smaller than τ at 90°.  (d) In F/5, τ at 0° is consistent through all angles.  (e) Coefficient of variation (CV) 
is highest in F/1.5 (blue), and decreases in F/3 (green), F/4 (red), F/5 (purple) focal configurations.  
*Signifies a statistically significant difference from 0° (p<0.05) 
 
were observed in the CVs of either the F/4 (dotted) or F/5 (dot-dash) focal configurations.  
Further, F/1.5 had the largest CV at every angle of rotation, followed by the F/3, F/4, and F/5, 
respectively.  Numerical results of the repeated acquisitions in the muscle are summarized in 
Table 6.3. 
Figure 6.7 shows B-Mode images (panel a) in the excised pig muscle with the transducer 
orientated at 0° and 90° relative to muscle fibers.   The corresponding VisR τ images for the 
F/1.5 focal configurations are shown in panel (b), and depict VisR τ values which are appreciably 
larger at 90° versus 0°.  Images generated with the F/5 focal configuration (panel c) show no 
significant differences in VisR τ values between the 0° and 90° transducer orientations. 
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Figure 6.7: (a) B-Mode and VisR τ images in the excised pig muscle for (b) F/1.5 and (c) F/5 focal 
configurations with transducer oriented at 0° and 90° relative to muscle fibers. 
6.5 Discussion 
The expectation that muscle fiber orientation alters VisR τ measurements when using an 
asymmetric ARF excitation impulse was realized in these results.  Figures 6.4 and 6.5 show that 
when using an F/1.5 lateral focal configuration for the ARF excitation, where the long axis 
(elevation) of the PSF is approximately 75% longer than the short axis (lateral), τ measurements 
at 0° were significantly different than 75% of the other examined rotation angles in the muscle, 
while no significant differences were measured in the control phantom; this suggests that VisR 
is sensitive to fiber orientation when using an ARF lateral focal configuration that is small 
relative to the elevational one.  At 0° VisR τ was significantly different than 42%, 17%, and 0% of 
the other measurements when using F/3, F/4, and F/5, respectively, signifying consistency of τ 
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values over a greater range of angles as ARF F/# increased and the ARF PSF became more 
symmetric. 
Figures 6.4-6.6 show that the CVs of τ measurements were largest when using the F/1.5 
ARF focal configuration and that CV decreased with larger F/#s.  This is likely attributable to 
displacement estimation variance, or jitter.  Walker et al. showed that jitter is increased with 
greater displacement magnitude.150  Due to the tighter focusing and increase in the active 
aperture area (and thus transmit power) associated with the smaller focal configurations, larger 
displacements are induced by ARF excitations with lower F/#s; therefore, jitter in the 
displacement measurements are largest in the F/1.5 focal configuration and smallest in the F/5 
focal configuration.  The jitter in the displacement measurements will result in higher SD of τ 
measurements.  Higher SD with smaller F/#s would account for the trend of CV decreasing with 
increasing F/#.   
CV of VisR τ measurements in the muscle are depicted in Figures 6.5 (e) and 6.6 (e).  In 
the single acquisition data set (Figure 6.6 (e)), the CVs of F/1.5 and F/3 were minimized at 0° 
where the muscle is stiffest and undergoes the smallest displacements with the lowest jitter.  
Conversely, the CVs of F/1.5 and F/3 were maximized at 90°, where the muscle is softest and 
undergoes the largest displacements and highest jitter.  In the repeated acquisition data set 
(Figure 6.7 (e)), CVs of F/1.5 and F/3 were large at 0° and 90°.  Since the muscle undergoes 
small displacements at 0°, this high variation in VisR τ measurements cannot be explained by 
jitter alone.  Rather, we believe the higher variation at 0° and 90° in the repeated acquisition 
data is due to small changes in orientation of the muscles fibers after repositioning the 
transducer.  With both the F/1.5 and F/3 configurations, the CV decreases as the angle 
approaches 45° where the muscle fibers are aligned approximately symmetrically within the 
asymmetric ARF PSF.  Further, CVs become more consistent across angles as F/# increases in 
both the single and repeated acquisition data sets, suggesting that as the focal region becomes 
66 
more symmetric, VisR measurements become more repeatable and less sensitive to variations in 
fiber orientations.   
Taken together, these results suggest a critical finding in regard to interrogating 
anisotropic materials with ARF as in VisR ultrasound.  For serial studies and for comparisons 
between individuals, symmetric focal configurations are needed to obviate the confounding 
effects of anisotropic feature alignment with respect to the ARF PSF shape.  However, for 
studies aiming to exploit anisotropy, asymmetric focal configurations are needed to highlight 
different mechanical properties associated with different orientations.  Therefore, focal 
configuration is an important consideration when evaluating muscle or other anisotropic 
tissues. 
A limitation of the present work is that muscle fiber orientation in only the lateral-
elevational 2-D plane was considered.  This is a reasonable approach for the psoas major 
muscle, in which muscle fibers are primarily aligned parallel along a single axis.  However, in 
many muscles and other anisotropic tissues, the orientation of anisotropic features in the axial 
dimension will also impact response to ARF excitation and influence VisR τ outcomes.   
An important consideration is the apparent increase in VisR τ as the F/# increases.  In the 
control phantom statistically significant differences in mean τ between focal configurations are 
measured at each angle (Figure 6.4 (a)-(d)).  For instance, at 0° VisR τ is measured to be 0.53 ± 
0.02 ms, 0.57 ± 0.01 ms, 0.62 ± 0.01 ms, 0.65 ± 0.01 ms using F/1.5, F/3, F/4, and F/5 
configurations, respectively.  As the F/# increases, the volume of the ARF focal region will 
increase.  Palmeri et al. and Czernuszewicz et al. have both shown that recovery times are 
increased when using larger F/# focal configurations due to the increased time needed for a 
larger volume of tissue to stop moving.112,151 This increase in the recovery time makes tissue 
appear more viscous, resulting in higher values of τ.  Equation (5.4) is based on the Voigt model, 
which assumes a massless material; a model which incorporates a mass-term is needed to 
describe these inertial effects.  This is the topic of Chapter 7.    
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6.6 Conclusion 
This study demonstrated the dependence of VisR τ measurements on muscle fiber 
orientation as a function of ARF lateral-elevational PSF symmetry.  Results showed that VisR τ 
values were dependent on fiber orientation with an asymmetric ARF focal configuration, but 
VisR τ measurements became increasingly less dependent on fiber orientation as the focal 
configuration was made more symmetric.   This data also demonstrated a dependence of VisR τ 
estimates on the focal configuration in a homogeneous material, indicating the need for a 
mechanical model which accounts for inertia.  In the next chapter the Voigt model, upon which 
VisR is based, is expanded to include a mass element. 
Table 6.1: VisR in control phantom 
F/# τ  at 0° (ms) τ  at 90° (ms) p-value Mean CV 
1.5 0.532 ± 0.021 0.527 ± 0.018 0.385 0.036 ± 0.003 
3.0 0.574 ± 0.012 0.552 ± 0.011 0.229 0.021 ± 0.002 
4.0 0.618 ± 0.011 0.597 ± 0.010 0.291 0.017 ± 0.002 
5.0 0.648 ± 0.011 0.633 ± 0.010 0.3219 0.013 ± 0.002 
 
Table 6.2: Single acquisition of VisR in porcine muscle 
F/# τ  at 0° (ms) τ  at 90° (ms) p-value Mean CV 
1.5 0.469 ± 0.023 0.760 ± 0.087 0.006 0.074 ± 0.037 
3.0 0.488 ± 0.010 0.557 ± 0.023 0.013 0.033 ± 0.020 
4.0 0.507 ± 0.011 0.550 ± 0.011 0.034 0.021 ± 0.004 
5.0 0.527 ± 0.008 0.544 ± 0.009 0.207 0.016 ± 0.005 
 
Table 6.3: 3 Repeated acquisitions of VisR in pig muscle 
F/# τ  at 0° (ms) τ  at 90° (ms) p-value Mean CV 
1.5 0.472 ± 0.068 0.745 ± 0.104 0.004 0.119 ± 0.074 
3.0 0.475 ± 0.030 0.555 ± 0.077 0.024 0.051 ± 0.027 
4.0 0.515 ± 0.015 0.548 ± 0.011 0.033 0.029 ± 0.010 
5.0 0.535 ± 0.010 0.556 ± 0.011 0.106 0.021 ± 0.005 
7 Accounting	for	Mass	in	VisR	Ultrasound	
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CHAPTER 7 
Accounting for Mass in VisR Ultrasound 
 
7.1 Introduction 
Viscoelastic Response (VisR) ultrasound is a method for quantitatively assessing the 
viscoelastic properties of tissue.  Using two successive ARF impulses and monitoring induced 
displacements in the region of excitation, VisR fits displacements to a mechanical model to 
measure the relaxation time constant, τ, given by the ratio of viscosity to elasticity.  In Chapter 6, 
VisR was demonstrated for characterizing the mechanical properties of gelatin phantoms and 
muscle by fitting displacements using the Voigt model; however the Voigt model assumes a 
massless material.  In reality, all biological tissue has mass.  The mass density of most soft 
tissues is slightly higher than that of water, typically lying in the range of 1.00-1.07 g/cm3.97 
Inertia is the tendency of a body to resist any change in its motion.  In ARF applications, 
inertia will manifest as a delay in the time it takes for the material to reach its peak displacement 
and an increase in time needed to recover.112  When inertial effects are ignored, these changes in 
the response of the material will be interpreted as an increase in the viscosity and/or a decrease 
in the stiffness of the material, both of which will result in an increase in τ.   
This chapter extends VisR to account for inertial forces through the use of the mass-
spring-damper (MSD) model.  Using finite element method (FEM) modeling, the MSD and 
Voigt models are compared for their ability to describe the deformation induced by a focused, 
impulsive force and to discriminate τ in viscoelastic materials.     
69 
 
Figure 7.1: (a) A schematic of the mass-spring-damper (MSD) model and  (b) a graphical 
illustration of the forcing function input 
7.2 Background 
The MSD is an alternative to the Voigt model, which places an inertial component in series 
with the Voigt model.  A schematic for the MSD model is shown in Figure 7.1.  The governing 
differential equation is given by: 
 ݉ ݀
ଶ
݀ݐଶ ݔሺݐሻ ൅ ߟ
݀
݀ݐ ݔሺݐሻ ൅ ߤݔሺݐሻ ൌ ܨሺݐሻ 
 
(7.1)
where F(t) is the applied force, x(t) is the induced displacement, µ is the elastic constant of the 
spring, η is the coefficient of viscosity of the damper, and m is the effective mass of the system.  
In standard form this becomes: 
 ݀ଶ
݀ݐଶ ݔሺݐሻ ൅ ߱
ଶ߬ ݀݀ݐ ݔሺݐሻ ൅ ߱
ଶݔሺݐሻ ൌ ܨሺݐሻ݉  (7.2)
where ߱ is the natural frequency (in radians/ms), and ߬ is the relaxation time constant (in ms).  
These material parameters are defined as: 
 ߱ ൌ ටߤ݉ , ߬ ൌ
ߟ
ߤ . (7.3)
As in Section 5.2, the two ARF excitations, depicted in Figure 7.2, can be described as two 
rectangular pulses of duration ݐ஺ோி  and amplitude A, and separated by ݐ௦ in time, and are 
defined as below: 
 ܨሺݐሻ ൌ ܣ൫ܪሺݐሻ െ ܪሺݐ െ ݐ஺ோிሻ൯ ൅ ܣሺܪሺݐ െ ݐ஺ோி െ ݐ௦ሻ െ ܪሺݐ െ 2ݐ஺ோி െ ݐ௦ሻሻ (7.4)
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where ܪሺݐሻ is the Heaviside unit function and is given by: 
 ܪሺݐሻ ൌ ቄ0, ݐ ൏ 01, ݐ ൒ 0 . 
(7.5)
Substituting (7.4) into (7.2) yields: 
݀ଶ
݀ݐଶ ݔሺݐሻ ൅ ߱
ଶ߬ ݀݀ݐ ݔሺݐሻ ൅ ߱
ଶݔሺݐሻ
ൌ ݏ߱ଶ൫ܪሺݐሻ െ ܪሺݐ െ ݐ஺ோிሻ െ ܪሺݐ െ ݐ஺ோி െ ݐ௦ሻ ൅ ܪሺݐ െ 2ݐ஺ோி െ ݐ௦ሻ൯ 
 
(7.6)
ݏ ൌ ܣߤ . (7.7)
Equation (7.6) can be solved for displacement as a function of ߱, ߬, and ݏ.  Displacement versus 
time profiles can be fit to this equation in order to generate estimates of these three parameters.   
7.3 Methods 
The FEM models used have been adapted from models previously developed by Palmeri at 
al. for investigating the response of an elastic material to an ARF excitation.111  In Chapter 8, 
Palmeri et al.’s methods for simulating the focal geometry of an ARF excitation pulse are 
implemented; however, for clarity, the excitation is approximated as a concentrated force on a 
single node at a given focal depth in this chapter.   
FEM Mesh Generation  
A three-dimensional, rectangular, solid mesh was assembled from 0.5 mm, cubic elements 
using LS-PREPOST (Livermore Software Technology Corp., Livermore, CA).  The mesh 
extended 5 mm in elevation, 7.5 mm laterally, and 40 mm axially.  A 5 elements thick, perfectly 
matched layer (PML) was added to the exterior boundaries of the mesh to absorb any waves 
generated during the simulation and ensure that they were not reflected back into the region of 
interest (ROI).152  As a requirement of the PML, all nodes on outer faces were fully constrained.  
Quarter-symmetry was assumed in both the lateral and elevation dimensions, requiring only a 
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quarter of the field to be modeled, and thus reducing the computational requirements of the 
simulation. 
Material Properties  
Tissue was modeled as a Voigt, viscoelastic material using the MAT_KELVIN-
MAXWELL_VISCOELASTIC material model (See Appendix A).  Young’s modulus of the 
material was varied from 10 to 50 kPa, by steps of 10 kPa, and the viscoelastic coefficient was 
varied from 3 to 7 Pa·s, by steps of 2 Pa·s.  The MAT_PML_ELASTIC material model was 
employed for the PML, with the elasticity set to match that of Voigt material.  The density of the 
material was varied from nearly massless at 0.05 g/cm3 to a physiologically relevant value of 1.0 
g/cm3.  A Poisson's ratio of 0.499 was used for all simulations. 
Forcing Function  
Displacement was induced using a concentrated force on the single node centered laterally 
and elevationally and at an axial depth of 25 mm.  Field II153 was used to simulate the pressure 
field of a linear array transducer transmitting at 4.21 MHz, with an F/1.5 focal configuration, 
and focused at 25 mm, in order to determine the magnitude of the force.  In time, the force was 
described according to Equation (7.4), with ݐ஺ோி equal to 70 μs and ݐ௦ equal to 0.4 ms. 
FEM Implementation and Data Analysis 
The FEM simulations were performed using the commercially available FEM package, LS- 
DYNA, using an explicit, time-domain, integration method.  For each simulation, a dataset 
describing the axial displacements at the focal node was obtained.  Axial displacement versus 
time profiles were fit to the Voigt and MSD models using nonlinear regression (fminsearch in 
Matlab, The MathWorks Inc., Natick, MA) to solve inversely for τ.    
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Statistical Analysis 
VisR τ estimates from Voigt and MSD models were statistically compared with the ratios of 
viscosity to elastic modulus of the materials using the Wilcoxon two-sample test.  A p value of < 
0.05 was defined as significant. 
7.4 Results 
Representative displacement profiles from VisR simulations in the 20 kPa, 5 Pa·s 
viscoelastic material are shown in Figure 7.2 for densities of (panel a) 0.05 g/cm3 and (panel b) 
1.0 g/cm3.  The fitted Voigt and MSD models are shown as blue and green dashed lines 
respectively, while the FEM displacement is displayed in red.  The accuracy of the model in 
describing the dynamics of the deformation was determined by the closeness of fit between the 
FEM simulated displacement and the model predicted displacement, given by the mean squared 
error (MSE) statistic.  For the 0.05 g/cm3 density material, the MSE of the Voigt fit was 0.0029  
 
Figure 7.2: Simulated displacement profiles (blue, solid) in a 20 kPa, 5 Pa·s material 
with a mass density of (a) 0.05 g/cm3 and (b) 1.0 g/cm3 and the predicted displacement 
using the Voigt (green, dashed) and MSD (red, dashed) models. 
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Figure 7.3: Mean squared error (MSE) metric describing the 
similarity between the FEM displacement profile and the 
displacement profile predicted by the Voigt (blue) and MSD 
(green) models in the 20 kPa, 5 Pa·s material at densities 
ranging from 0.05 g/cm3 – 1.0 g/cm3.  Note the log scale on 
the y-axis.  MSEs ranged from ranged from 0.0029 to 0.5794 
μm2 using the Voigt model and from 0.00044 to 0.00075 
using the MSD μm2 model. 
 
μm2 and the MSE of the MSD model fit was 0.00044 μm2.  The MSE values in the 1.0 g/cm3 
density material, increased to 0.5794 μm2 using the Voigt model and 0.00075 μm2 with the 
MSD model.  The MSE values using the two models in the 20 kPa, 5 Pa·s material are plotted 
against mass density in Figure 7.3. 
Figure 7.4 (a-b) shows the VisR τ measurements in all 15 viscoelastic materials plotted 
against the simulated material τ when the density of the materials was (a-b) 0.05 g/cm3 and (c-
d) 1.0 g/cm3.  The elasticity of the material is indicated by color, while the viscosity of the 
material is indicated by symbol.  Using the Voigt model, τ estimates were not statistically 
significantly (p>0.05) different from the programmed material τ values when the density was 
0.05 g/cm3 (panel a), however when density was increased to 1.0 g/cm3 the Voigt model 
produced τ estimates that were significantly larger (p<0.05) than the true τ of the material 
(panel c).  For both densities, the MSD model generated τ values that were consistent with the 
material τ values (panels b & d).   
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Figure 7.4: Scatter plots of VisR τ estimates versus the simulated material τ for the 15 viscoelastic 
materials with a density of (top row) 0.05 g/cm3 or (bottom row) 1.0 g/cm3.  The elasticity of the material 
is indicated by color and viscosity is indicated by symbol.  The dashed black line indicates the line of 
equality.  Estimates of τ in the 0.05 g/cm3 dense materials were consistent with the material τ (p > 0.05, 
Wilcoxon two-sample test) using both the Voigt (a) and MSD (b) models.  In the 1.0 g/cm3 dense 
materials, τ estimations were statistically different from the material τ when made using the Voigt (c) 
model but consistent with the material τ when using the MSD model (d). 
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Figure 7.5: Wilcoxon two-sample test p values of the τ estimates generated by the 
Voigt (blue) and MSD (green) model at each of the density values.  The black line 
represents statistical significance at the 0.05 level.  Voigt model derived τ estimates 
were statistically significantly different from the real τ of the materials for density > 
0.6 g/cm3.  Estimates of τ generated using the MSD model were consistent with the 
material τ values at all densities. 
 
Statistical significance of the τ estimates generated with the two models relative to the 
density of the medium is illustrated in Figure 7.5.  Values below the black horizontal line 
indicate τ values that are statistically significantly different from the true τ values at the 0.05 
level.  When material densities were 0.7 g/cm3 and greater, τ estimates from the Voigt model 
(blue) were significantly different from the material τ values.  Meanwhile, MSD model (green) 
derived τ estimates were not statistically significantly different from the material τ value at any 
density between 0.05 – 1.0 g/cm3.   
The error in τ measurements when density was 1.0 g/cm3 is shown in Figure 7.6.   Using 
the Voigt model τ was overestimated from the true value by 126.804 ± 155.846% on average 
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(panel a).  The average error in τ estimated using the MSD model was 15.344 ± 3.693% (panel 
b). 
7.5 Discussion 
VisR is a novel approach to elastographic imaging that approximates a creep test using 
only two successive excitations.  The accuracy of VisR at estimating τ, the ratio of viscosity to 
elasticity is, however, dependent on the viscoelastic model chosen to describe the response of 
the material. 
The Voigt model assumes a massless material.  This assumption was valid when a density 
of 0.05 g/cm3 was used.  In Figure 7.2 (a) there is very little observable difference between the 
FEM displacement and the Voigt predicted displacement, and as shown in Figure 7.4 (a), the 
Voigt model accurately estimated τ values in all 15 viscoelastic materials.  This was not the case 
when density was increased to 1.0 g/cm3.  The effects of inertia on the dynamic response of the  
 
Figure 7.6: Percent error in estimated τ values using the (a) Voigt and (b) MSD model to generate τ when 
material density was 1.0 g/cm3.  Error in τ values from Voigt model ranged from 17.7%-339.4% with a 
mean 126.8%.  Using the MSD model, error ranged from 4.2%-10.9% with an average of 15.3%.  Note the 
different vertical axes in panels (a) and (b). 
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material can be seen in Figure 7.2 (b) and are manifested as a delay in response to the initiation 
and cessation of force.  The Voigt model is unable to account for the change in the displacement 
profile due to inertia; the delay in the time for the material to reach its peak and to recover is 
attributed to increase in material viscosity and/or a decrease in the stiffness of the material.  
This is reflected in an increase in estimated τ relative to the true value (Figure 7.4 (c)).  This 
supports the results in Chapter 6, which showed that increasing the F/# of the ARF excitation 
(resulting in an increased mass of tissue being displaced) in a homogeneous phantom will result 
in an increase in estimated τ using the Voigt model.  The fact that the Voigt model could only 
generate τ values that were not significantly different from the real values when mass density 
was below 0.7 g/cm3 (Figure 7.5) limits its use for imaging soft tissue, as the density of these 
tissues is between 0.9-1.1 g/cm3. 
Because the MSD model involves an inertial component it is able to compensate for 
changes in the density the medium.  As illustrated in Figure 7.3, there is little difference in the 
model’s ability to describe the dynamics of a material regardless of whether the material has a 
mass density of 0.05 g/cm3 or 1.0 g/cm3.  The MSD model was able to accurately estimate the τ 
values of all 15 viscoelastic materials at all investigated densities.  When the density of the 
materials was 1.0 g/cm3, τ was estimated to within 11% of the true τ values.  The highest error in 
estimated τ was in the 50 kPa, 3 Pa·s material in which τ was estimated to be 0.0066 ms higher 
than the true value 0.060 ms.   
Unlike MSSER, which displaces material to a steady-state level and uses the full creep and 
recovery profile to fit to the mechanical model, VisR only observes displacements prior to 
steady-state displacement where inertia is relevant.  Thus, the Voigt model, which was used 
successfully in MSSER, is no longer appropriate.  Rather, the MSD model, which accounts for 
material mass, should be used for VisR ultrasound.  These data show that when used in concert 
with two successive impulses, the MSD model can quantitatively describe τ, the relaxation time 
constant of a viscoelastic material.  It is important to note, however, that these simulations were 
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performed by applying force to a single node; whether VisR can remain quantitative when using 
a volumetric ARF body force excitation is the topic of Chapter 8. 
7.6 Conclusion 
VisR, a new ARF-based elastographic imaging method that estimates the relaxation time 
for constant stress (τ) in viscoelastic materials, is presented with mathematical derivation based 
on the MSD mechanical model.  The MSD model outperformed the Voigt model in terms of 
fitting displacement profiles and accurately describing τ in FEM simulated viscoelastic materials 
when materials had a density comparable to human soft tissue, signifying the need to account 
for mass in VisR.  These data show that the relevance of the VisR imaging technique is critically 
dependent on the choice of mechanical model; moving forward, VisR ultrasound will utilize the 
MSD model to describe soft tissue.   
8 Quantitative	VisR	Ultrasound	
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CHAPTER 8 
Quantitative VisR Ultrasound 
 
8.1 Introduction 
As previously discussed, Viscoelastic Response (VisR) ultrasound is a method for 
quantitatively assessing the viscoelastic properties of tissue.  It was demonstrated in Chapter 7 
that using two successive force impulses and monitoring induced displacements in the region of 
excitation, displacements could be fit to the mass-spring-damper model to accurately measure 
the relaxation time constant, τ, given by the ratio of viscosity to elasticity.  However, the force 
impulses used in Chapter 7 represented highly idealized point forces with no lateral, elevational, 
or axial extent.  Such highly focused force impulses cannot be generated physically using 
conventional ultrasound linear array transducers.  Rather, the ARF impulses generated using 
conventional linear arrays are volumetric and span millimeters in axial, lateral and elevation 
dimensions, as depicted in Figure 8.1 (a). 
The volumetric nature of the ARF impulses results in force application outside the 
tracking focal position, which, we hypothesize, generates shear and longitudinal waves that 
propagate through the medium and interact with the displacing material at the focus.  This 
interaction extends the duration of the force experienced at the focus beyond that of the applied 
ARF excitation.  An excitation force that persists longer than modeled prolongs the 
displacement and recovery behavior of the material, as depicted in Figure 8.1 (b), and, thus, 
falsely indicates lower elasticity and/or higher viscosity, causing VisR to overestimate τ.    
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Correcting VisR’s τ overestimation would ideally be achieved by appropriately modifying 
the modeled forcing function (Equation 7.2), but this would require a priori knowledge of the 
duration and amplitude of the shear and longitudinal wave interactions at the focus - 
parameters that are materially and geometrically dependent and generally unknown.  Instead of 
relying on a priori material property estimates, this chapter aims to correct VisR τ 
overestimation by using an empirically determined correction factor generated from FEM 
models in representative viscoelastic materials.  This method of error correction is then 
demonstrated experimentally in a gelatin phantom using a high-speed camera to optically track 
the ARF-induced displacements.  Optical tracking is used in this proof of feasibility study 
because acoustically tracked ARF displacements are susceptible to underestimation, which is 
topic of Chapter 9. 
 
Figure 8.1: (a) Spatial distribution of force using a volumetric ARF body force.  (b) Axial displacement at 
focus induced by a single point force (dashed) and induced by a volumetric ARF body force (solid). 
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8.2 Methods 
8.2.1 FEM Simulations 
Mesh Generation 
LS-PREPOST (Livermore Software Technology Corp., Livermore, CA) was used to 
generate a three-dimensional, rectangular, solid mesh consisting of 0.25mm, cubic elements.  
The spatial extent of the mesh was 4 mm (elevation), by 10 mm (lateral), by 45 mm (axial).  As 
in Chapter 7, a 5 element thick PML was added to the exterior to prevent wave reflections from 
boundaries, and quarter-symmetry was assumed. 
Material Properties  
Tissue was modeled as a Voigt, viscoelastic material using the MAT_KELVIN-
MAXWELL_VISCOELASTIC material model.  Young’s modulus of the material was varied from 
5 to 100 kPa, by steps of 5 kPa, and the viscoelastic coefficient was varied from .5 to 9.5 Pa·s, by 
steps of 1 Pa·s.  A density of 1.0 g/cm3 and a Poisson's ratio of 0.499 were used for all 
simulations. 
Acoustic Radiation Force Excitation 
Field II153 was used to simulate the acoustic intensity fields associated for a Siemens VF7-
3 linear transducer (Siemens Medical Solutions USA, Inc., Ultrasound Division).  The 
transducer was simulated as transmitting at 4.21 MHz, with a lateral focal configuration of 
F/1.5, and a lateral focal depth of 25 mm.  This corresponds to the experimental setup currently 
utilized to perform VisR ultrasound.   
Three-dimensional intensity fields were computed, normalized, and scaled to a peak, 
pulse-average intensity value of 1000 W/cm2.  The corresponding radiation body force values, 
as determined by Equation (4.5) assuming a tissue attenuation of 0.5dB/cm/MHz, were then 
82 
converted to nodal point loads by concentrating the body force contributions over an element 
volume.  
FEM Implementation and Data Analysis 
The FEM simulations were performed using LS- DYNA (Livermore Software Technology 
Corporation, Livermore, CA).  For each simulation, a dataset describing the axial displacements 
was obtained.  Axial displacement versus time profiles were fit to the MSD models using 
nonlinear regression (fminsearch in Matlab, The MathWorks Inc., Natick, MA) to solve inversely 
for τ, ω, and s according to Section 7.2.   
Error Assessment 
To create an error correction function, the material τ values were plotted (Figure 8.2) as a 
function of VisR estimated τ and ω values.  The resulting 3D surface was fit (Table Curve 3D, 
Systat, Inc., San Jose, CA) to over 3000 linear and nonlinear equations to determine one 
possible optimal error model, utilizing a minimum number of parameters (e.g. simplest model 
possible) while maximizing the model fit (R2).  The equation for the best-fit surface of Figure 8.2 
was determined to be of the form: 
 ߬௠௔௧௘௥௜௔௟ሺ߬௘௦௧௜௠௔௧௘ௗ, ߱௘௦௧௜௠௔௧௘ௗሻ ൌ ܽ ൈ ߬௘௦௧௜௠௔௧௘ௗ െ ܾ ߱௘௦௧௜௠௔௧௘ௗൗ െ ܿ (8.1)
and with coefficient values of  
 ߬௠௔௧௘௥௜௔௟ሺ߬௘௦௧௜௠௔௧௘ௗ, ߱௘௦௧௜௠௔௧௘ௗሻ ൌ 1.063 ൈ ߬௘௦௧௜௠௔௧௘ௗ െ 2.614 ߱௘௦௧௜௠௔௧௘ௗൗ െ 0.01742 (8.2)
VisR τ and ω estimates were input into Equation (8.2) to calculate “corrected τ” values. 
 K-Fold cross-validation is a model validation technique for assessing how the results of a 
statistical analysis will generalize to an independent data set.  In k-fold cross-validation the data 
is randomly divided into k subsets, the model is fit using (k-1) subsets as the training set, and 
validation is performed on the  one (kth) omitted subset.  The procedure is then repeated k 
times, with each of the k folds used exactly once as validation data.154  K-fold validation (k=10)  
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Figure 8.2: True material τ plotted as a function of the estimated τ and ω material parameters.  The 
resulting 3-dimensional surface fits the error data well, R2 = 0.999. 
 
was performed on the simulated measurements to validate the error correction function and 
determine the stability of the coefficients in Equation 8.1. 
8.2.2 Experimental Validation with Optical Tracking 
Optical Phantom Construction 
A translucent, gelatin-based, tissue-mimicking phantom was constructed according to 
Czernuszewicz et al.151 The phantom recipes consisted of the following ingredients: type-A 
gelatin (Acros Organics, Geel, Belgium), agar (Fisher Scientific, Fair Lawn, New Jersey, USA), 
black polystyrene microspheres (10-µm, Polysciences Inc., Warrington, Pennsylvania, USA), n-
propanol, and deionized water (concentrations are given in Table 8.1).  The agar powder was   
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Table 8.1: Phantom Ingredients 
Type-A gelatin (g)  12
n-propanol (mL) 10
Water (mL) 190
Agar (g) 1
Polystyrene microspheres (drops) 10
 
added to each phantom for acoustic scattering while the polystyrene beads served as markers for 
optical tracking.  
Experimental Setup 
VisR was implemented using a Siemens Acuson Antares Scanner, specially equipped for 
research purposes, and a VF7-3 transducer (Siemens Medical Solutions, UNC Inc. Ultrasound 
Division).  VisR was implemented using two 300- cycle ARF excitations, separated by 0.6 ms in 
time and delivered to the same region of excitation.  Two different focal configurations of the 
ARF excitations were employed (F/1.5 and F/3) in order to vary the volume of displaced tissue. 
The experimental setup used to achieve optical tracking of ARF-induced displacement is 
shown in Figure 8.3 and is described by Czernuszewicz et al.151 The optical focus of a microscope 
fitted with a 10x objective and coupled to a 150 kHz Fastcam SA1 high-speed camera (Photron 
USA Inc., San Diego, California, USA) was aligned with the acoustic focus of the ultrasound 
transducer using a needle hydrophone.   
The high-speed camera was configured to acquire frames at a 150 kHz frame rate, across a 
128 × 128 pixel FOV.   VisR was performed for 10 different polystyrene beads within the 
phantom.  Optical motion tracking was performed by 2D normalized cross-correlation.  
Optically tracking displacement versus time profiles were fit to the MSD to estimate τ, ω, and s 
and Equation (8.2) was used to calculate a corrected τ value. 
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Figure 8.3: Schematic of experimental setup is shown in (a) with a 
photograph of the actual setup in (b). 
 
Statistical Analysis 
Descriptive statistics are expressed as mean ± SD.  The statistical significance was 
assessed using the Wilcoxon two-sample test. 
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8.3 Results 
8.3.1 FEM Results 
Figure 8.4 shows representative ‘uncorrected’ τ estimates measured at the axial focus of 
viscoelastic materials.  As the elasticity was increased in materials with a constant viscosity of 
2.5 Pa·s (panel a), τ estimates decreased as expected.  Similarly, when holding the elasticity of 
the materials constant at 15 kPa, τ estimates increased with increasing viscosity.  However, when 
plotted relative to the real τ of the material, as shown in Figure 8.5, uncorrected τ estimates 
exhibited large errors from the real material τ.  Estimated τ had a median error of 373.7%.  The 
largest error in estimated τ was 4067% and occurred in the 100 kPa, 0.5 Pa·s material, where τ 
was estimated as 0.208 ms in this 0.005 ms material.  
The accuracy of τ estimates was significantly improved after applying the error correction 
function.  Corrected τ estimates are shown in Figure 8.6.  After applying Equation (8.2), τ in the 
100 kPa, 0.5 Pa·s was 0.019 ms reducing the error to 318%.  The median error across all  
 
 
Figure 8.4: Plot of uncorrected τ estimates when (a) the viscosity is held constant (2.5 Pa·s) 
and elasticity is increased and (b) the elasticity is held constant (15 Pa·s) and viscosity is 
increased.  Estimates of τ trend as expected for the ratio of viscosity to elasticity. 
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 Figure 8.5: Uncorrected τ estimates in the 200 simulated viscoelastic materials plotted relative 
to the real τ of the material.  The viscosity of the material is indicated by color and the dashed 
black line indicates the line of equality.  Uncorrected τ estimates were overestimated from the 
material τ and had a median error of 373.7%.   
 
 
 Figure 8.6: τ estimates in the 200 simulated viscoelastic materials after applying the error 
correction function plotted relative to the real τ of the material.  The viscosity of the material is 
indicated by color and the dashed black line indicates the line of equality.  The difference between 
estimated τ measurements and the τ values of the materials was significantly reduced.  The median 
error in corrected τ values across all materials was 5.1%. 
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Figure 8.7: Corrected τ versus axial depth in the 200 simulated viscoelastic materials, where ARF 
excitations were focused at 25 mm.  Corrected τ was within 10% of the material τ for 3.33 ± 2.43 mm 
above the focus and for 3.35 ± 0.54 mm below it. 
 
materials was reduced to 5.1%.  Error in the corrected τ measurement across axial depth is 
demonstrated in Figure 8.7.  In the 200 simulated materials, corrected τ was within 10% of the 
true τ value for 6.68 ± 2.75 mm.   
The results of performing k-fold validation with k=10 on the simulated measurements is 
shown in Figure 8.8.  The coefficients of the best-fit 2D plane where evaluated in each fold: a 
ranged from 1.0516-1.0688 with a median of 1.0628 (panel a), b ranged from 2.5707- 2.6394 
with a median of 2.6124 (panel b), and c ranged from 0.0162-0.0185 of 0.0174 (panel c).  These 
values were all consistent with Equation (8.2), which was determined by fitting the surface to 
the full data set.  The median error of the corrected τ in the validation subsets ranged from 8.1%-
12.8% in the 10 different validation subsets (panel d).   
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Figure 8.8: K-fold cross validation (k=10) on the dataset consisting of 200 
(simulated) VisR τ and ω estimations and the real material τ.  Panels (a)-(c) show 
the a, b, and c coefficients for the best-fit plane corresponding to Equation (8.1) 
for the data in the training set.  In panel (d) the median error for the validation set 
in each fold ranged from 8.1%-12.8%. 
8.3.2 Experimental Results 
Figure 8.9 shows the experimental results of VisR in a gelatin phantom using a high-speed 
camera to optically track the ARF induced displacements.  Panel a shows representative axial 
displacement profiles versus time using an F/1.5 (blue) and F/3.0 (red) focal configuration, and 
their associated MSD model fits.  The uncorrected τ estimates averaged across the 10 optical 
beads were averaged and are shown in panel b.  The estimates of τ when using an F/1.5 focal 
(blue) configuration for the ARF excitation were 0.568 ± 0.085 ms, which were statistically 
significantly smaller (p<0.01) than the τ estimates obtained using an F/3.0 focal (red) 
configuration, measured as 0.816 ± 0.037 ms.  The effect of applying Equation (8.2) to account 
for error in the experimental τ measurements is shown in panel c.  Corrected τ estimates using 
the F/1.5 configuration (0.418 ± 0.064 ms; blue) were consistent (p>0.59) with the F/3.0 
corrected τ estimates (0.439 ± 0.046 ms; red). 
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Figure 8.9: (a) Optically tracked displacement in a gelatin phantom using an F/1.5 (blue) or F/3 
(red) focal configuration and the displacments predicted by the MSD model (F1.5-green, F/3-
purple).  (b) Uncorrected τ was 0.568 ± 0.085 ms and 0.816 ± 0.037 ms using the F/1.5 and F/3 
focal configurations respectively.  (c) After applying error correction function, estimated τ values 
were 0.418 ± 0.064 ms with the F/1.5 and 0.439 ± 0.046 ms using the F/3.   
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8.4 Discussion 
The primary aim of this chapter was to determine whether VisR ultrasound could produce 
quantitative estimates of τ, the ratio of viscosity to elasticity, when using a volumetric ARF body 
force to induce displacement.  Using FEM, VisR was simulated in 200 viscoelastic materials, and 
estimations of τ and ω were generated.  These data showed that differences in the viscoelastic 
properties of tissues were reflected by differences in τ estimates (Figure 8.4).  However, there 
was not a 1-to-1 correlation between the τ measurements estimated by VisR and the real τ values 
of the materials (Figure 8.4).   In order for VisR estimates of τ to be quantitative, inaccuracy in 
the modeled forcing function was mitigated using an error correction function.   
The error correction function was obtained by fitting a 2D plane to VisR estimates of τ and 
ω and the true material τ in 200 representative viscoelastic materials.  The k-fold validation of 
the function, where the training and testing datasets were independent, produced consistent 
coefficients and only a modest increase in error (Figure 8.8).  The mathematical reasoning for 
the form of the error correction function and the specific relationship between the three 
parameters is currently unknown.  A more systematic approach of modeling the volumetric body 
force as a Gaussian with increasing height and width155 may bridge the gap in understanding 
between the single node force from Chapter 7, which produced accurate estimates of τ without 
any correction, and the approximated ARF body force, which did not.   
VisR with τ correction was demonstrated for proof of feasibility in a gelatin phantom.  In 
order to obviate the confounding effects of acoustic tracking (see Chapter 9), optical tracking of 
the acoustically-induced displacements was performed.   It was hypothesized that the increased 
volume of the F/3 configuration would be associated with more force propagation through the 
medium to the tracking focal position and, thus, greater extension of the excitation force, 
resulting in increased VisR estimated τ over the F/1.5 focal configuration.  Indeed, uncorrected τ 
was estimated to be larger in the F/3.0 focal compared to the F/1.5 configuration.  After 
applying the correction function, the estimates were consistent between the two configurations.  
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8.5 Conclusion 
This chapter examined the effect of a volumetric ARF body force excitation on VisR 
estimates of τ.  The magnitude of the error in τ measurements was assessed and the possibility 
for correction of this error was investigated.  While correction of VisR estimated τ values was 
possible using the true ARF-induced displacement, VisR, when performed experimentally, will 
operate on acoustically tracked ARF displacements.  The effect of ultrasonic tracking on VisR 
estimates of τ will be discussed in Chapter 9.  
9 Displacement	Underestimation	Correction	Using	Shear	Waves	in	VisR	Ultrasound	
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CHAPTER 9 
Ultrasonic Tracking of Displacements in VisR Ultrasound 
 
9.1 Introduction 
Because VisR operates by fitting ARF-induced displacements to the mass-spring-damper 
(MSD) model, its ability to estimate τ is directly dependent on its ability to measure tissue 
displacement.  Unfortunately, VisR, like other ARF-based applications, suffers from 
displacement underestimation errors. 2 
Displacement underestimation is a result of using an acoustic pulse to generate force in 
tissue.  As the applied force is proportional to the time-averaged acoustic intensity, the axial 
displacement generated by ARF is non-uniform and highly dependent on the focal configuration 
of the pulse.156  When tracking ARF-induced motion using conventional B-Mode style pulses, 
the measured displacements will correspond to the average displacement of the scatterers 
within the tracking resolution cell.  Because the scatterers centered within the pushing pulse will 
experience more force than the those at the resolution cell edges, the measured displacement 
will underestimate the full extent of the displacement experienced by the center 
scatterers.151,157,158  Figure 9.1(a) depicts scatterers in the ROE within the tracking resolution 
cell at the time of peak displacement and the corresponding displacement estimate.  
Displacement underestimation error can be lessened by broadening the focus of the pushing 
beam relative to the tracking beam in order to achieve more uniform scatterer displacement 
                                                            
© 2014.  Portions reprinted, with permission, from Selzo, M.R., Czernuszewicz, T.C. & Gallippi, C.M. 
Displacement Underestimation Correction using Shear Waves in VisR Ultrasound. International IEEE 
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within the tracking resolution cell.  However, due to the fixed elevation focus of linear array 
transducers, the focal configurations of the pushing and tracking beam will be matched in 
elevation, making it difficult to confine the tracking beam to a region of uniform scatterer 
displacement within the ROE. 
Outside the ROE, displacements occur as a result of shear waves that propagate radially 
out from the ROE.  As shear waves travel through a viscoelastic medium, the width of the wave 
will spread out laterally and elevationally140 leading to more uniform scatterer displacement 
within the tracking resolution cell.  Figure 9.1(b) depicts scatterers located lateral to ROE at the 
time of the elevational peak displacement of the shear wave.  We hypothesize that monitoring  
 
 
Figure 9.1: A depiction of the relationship between scatterer displacement 
and the ultrasound beam used to track the tissue inside the ROE (a) and 
outside the ROE (b).  The scatterers are represented by the blue ellipses, the 
full-width-half-max of the tracking beam is represented by dashed black 
lines, and the measured displacement is represented by the red ‘+’ symbol. 
Scatterer displacements are shown to be more uniform outside the ROE 
than inside the ROE, resulting in less peak displacement underestimation. 
Data generated by FEM and Field II simulation. 
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deformation outside the ROE will provide better estimates of the axial displacement and 
produce τ measurements that more closely represent the material.  In this Chapter, ultrasonic 
displacement tracking is simulated in order to investigate the impact of displacement 
underestimation on VisR.  In addition, a method of displacement underestimation correction 
using shear waves is demonstrated using FEM simulation and experiments in a tissue-
mimicking phantom with optical validation.  
9.2 Methods 
9.2.1 Simulation of Ultrasonic Displacement Tracking 
A uniform scattering phantom was represented as randomly positioned point targets of 
equal echogenicity.  These point locations were taken as the initial, pre-displacement scatterer 
positions.  A reference RF-data tracking line was generated from these scatterer locations, using 
Field II to model a VF7-3 linear array transducer with an F/1.5 focal configuration and 
transmitting at 6.15 MHz.153   
Displacements from the FEM simulations presented in Chapter 8 were used to translate 
the scatterers in three dimensions to simulate the echoes generated following the ARF 
excitations.  In order to simulate fully-developed speckle, more scatterers were needed than 
nodes in the FEM mesh.  Thus, scatter motion was determined by linear interpolation from the 
displacements of the eight nearest nodes.  After repositioning all scatterers, the corresponding 
RF line was simulated using Field II.  The process was repeated for each time step in the 
simulation at a pulse repetition frequency (PRF) of 11 kHz.  Normalized cross-correlation of the 
simulated RF signals was used to estimate the displacements as in normal VisR imaging.139 
Error Assessment 
As in Section 8.2.1, an error correction function for ultrasonically-tracked VisR was 
determined by plotting the material τ values as a function of VisR estimated τ and ω values and 
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fitting the resulting 3D surface to Equation (8.1).  The coefficient values were determined to be: 
 ߬௠௔௧௘௥௜௔௟ሺ߬௘௦௧௜௠௔௧௘ௗ, ߱௘௦௧௜௠௔௧௘ௗሻ ൌ 1.156 ൈ ߬௘௦௧௜௠௔௧௘ௗ െ 2.573 ߱௘௦௧௜௠௔௧௘ௗൗ െ 0.0042 (9.1)
with an R2 value of 0.999. 
9.2.2 Displacement Underestimation Correction Using Shear 
 Waves   
FEM Simulations 
The FEM mesh and point loads from Chapter 8 were used to simulate tissue displacement 
following ARF excitations in the ROE and 4 mm lateral to it.  For this analysis, radiation force 
excitations were applied for 70 µs and separated by 0.4–2.0 ms in time.  Four different Voigt 
materials were simulated with elasticities of 5, 10, and 50 kPa and viscosities of 1 and 3 Pa·s. 
For each material, displacements were tracked in the ROE and 4 mm lateral to the ROE.  
To estimate τ for each simulated material and at each tracking location, the axial displacement 
at the focal depth was fit to the MSD model, and Equation (8.2) was used to correct for error and 
determine τ. 
Experimental Validation 
Displacement underestimation correction was experimentally validated using a Siemens 
Acuson Antares Scanner, specially equipped for research purposes, and a VF7-3 transducer 
(Siemens Medical Solutions, Inc. Ultrasound Division).  VisR was implemented using two 300-
cycle ARF excitations, separated by 0.6 ms in time and delivered to the same region of 
excitation.  ARF-induced displacement was tracked using conventional 2-cycle A-lines centered 
at 6.15 MHz, with a pulse repetition frequency of 20 kHz.  Displacement measurements were 
validated using optical tracking.  The experimental setup used to achieve confocal optical and 
acoustic tracking is described in Chapter 8.  Acoustic motion tracking was performed by one-
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dimensional normalized cross correlation applied to the raw RF data.  Similarly, optical motion 
tracking was performed by two-dimensional normalized cross correlation. 
Optical and acoustic data were captured for 3 different beads positioned at the confocal 
optical and acoustic foci and with the ARF impulses focused on the bead to track displacements 
in the ROE or 4.25 mm lateral to the bead to track shear wave-induced displacements.   Axial 
displacement versus time profiles were fit to the MSD model to solve for τ.  No error correction 
was applied. 
9.3 Results 
9.3.1 Ultrasonic Displacement Tracking Simulated Results 
In Figure 9.2 (a), real τ values of the materials are plotted relative to the uncorrected 
ultrasonically-tracked τ values.  Using ultrasonically-tracked displacements versus the true 
displacement increased the median error of τ increased from 373.7% to 435.9%.  Standard 
deviation of uncorrected τ values relative to the axial distance overwhich it is evaluated are  
depicted in Figure 9.3, and are reported to range from 0.004 ± 0.002 ms over a 1 mm axial 
window to 0.190 ± 0.048 ms over a 20 mm axial window.  Figure 9.2 (b) shows the effect of 
applying Equation (8.2) to the estimated τ values, reducing median error to 73.6%.  Equation 
(9.1) reduced median error at the focus to 8.5% as shown in Figure 9.2 (c), and corrected τ to 
within 10% of the true τ of the material for 5.88 ± 3.91 mm as shown in Figure 9.4.   
9.3.2 Displacement Underestimation Correction Results   
Simulated Results 
Figure 9.5 shows representative FEM displacement (dark blue lines) and acoustically 
tracked displacement (light blue lines) through time for the 10 kPa/1 Pa·s material with 
displacements tracked in the ROE (a) and 6 mm (b) lateral to the ROE.  In the ROE, the tracked 
displacement underestimated the full extent of the axial displacement.  The maximum  
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Figure 9.2: (a) Uncorrected τ estimates in the simulated viscoelastic materials averaged across speckle 
realizations and plotted relative to the real τ of the material.  The viscosity of the material is indicated by 
color and the dashed black line indicates the line of equality.  Uncorrected τ estimates were overestimated 
from the material τ and had a median error of 435.9%.  (b) τ estimates in the simulated viscoelastic 
materials after applying Equation 8.2 plotted relative to the real τ of the material.  Resulting τ estimates 
remained significantly different from true τ of the materials (p<0.02) with a median error of 73.6%.  (c) τ 
estimates in the simulated viscoelastic materials after applying Equation 9.1 plotted relative to the real τ 
of the material.  Resulting τ estimates were not significantly different from true τ of the materials (p=0.9) 
and had a median error of 8.5%.   
 
acoustically tracked displacement following the first push was 67.21 ± 12.55% of the FEM 
displacement.  When tracking shear wave-induced displacement outside the ROE, the acoustic  
tracking underestimation error was diminished.  The percentage of maximum displacement 
following the first ARF excitation measured increased to 101.52 ± 9.84% outside the ROE.   
99 
 
 
Figure 9.3: Standard deviation of uncorrected τ estimates evaluated at axial 
windows surrounding the focus and ranging from 1 mm to 20 mm.   Standard 
deviation ranged from 0.004 ± 0.002 ms over a 1 mm axial window to  
0.190 ± 0.048 ms over a 20 mm axial. 
 
The effect of displacement underestimation is reflected in VisR-derived τ measurements, 
shown in Figure 9.6 (a).  In all simulated materials, VisR-derived τ estimates from 
displacements in the ROE were higher than the true value.  Error in τ measurements ranged 
from 0.041 ± 0.025 ms in the 50 kPa/1 Pa·s material to 0.251 ± 0.097 ms in the 5 kPa/3 Pa·s 
material.  Figure 9.6 (b) shows the τ estimates when tracking displacements outside the ROE.  
Error in τ estimates was reduced to 0.006 ± 0.002 ms in the 50 kPa/1 Pa·s material and 0.019 ± 
0.001 ms in the 5 kPa/3 Pa·s material. 
Experimental Results 
Figure 9.7 (a) shows the optically and acoustically tracked displacement profiles for the bead 
in the ROE.  The acoustically tracked displacements were 64.30 ± 16.95% of the maximum 
displacement measured by the optical gold standard.  Using the optically tracked displacements, 
τ values were 0.75 ± 0.07 ms, which were significantly smaller (p<0.01) than VisR τ estimates 
derived from acoustically tracked displacements (1.40 ± 0.03 ms). 
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Figure 9.4: Corrected τ versus axial depth in the all simulated viscoelastic materials, where ARF
excitations were focused at 25 mm.  Corrected τ was within 10% of the material τ for 5.88 ± 3.91 mm. 
 
Optically and acoustically tracked displacements induced by shear waves are plotted in 
Figure 9.7 (b).  The acoustically tracked maximum displacement measured 4.25 mm outside the 
ROE were 98.044 ± 5.122% that of the optically tracked maximum displacement.  Optically, τ 
was measured to be 0.76 ± 0.05 and acoustically measured to be 0.75 ± 0.09 ms.  Not only are 
the optically- and acoustically-derived estimates of τ made outside the ROE consistent with each 
other (p=0.94), they are also consistent with the optically-derived τ measurement made in the 
ROE (p>.83) in the homogeneous phantom. 
9.4 Discussion 
This chapter investigated whether VisR ultrasound could produce quantitative estimates 
of τ when using a volumetric ARF body force to induce displacement and using ultrasound 
pulses to track displacements.  Ultrasonic displacement tracking was simulated using Field II 
and was used to generate estimations of τ and ω.  These data show that the error correction 
function generated in Chapter 8, can be adapted to correct for error in VisR τ estimates 
generated from ultrasonically-tracked data.    
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Figure 9.5: Displacement through time for the 10 kPa/1 Pa·s material with displacements tracked either in 
the ROE (a) or 4 mm outside the ROE (b).  FEM displacements are represented by the blue lines, and 
acoustically tracked data are represented by the green lines.  Note that displacement underestimation is 
larger when tracking displacements inside the ROE than outside it, and while larger, jitter is more 
constant through time when tracking displacements outside the ROE.  Data generated by FEM and Field 
II simulations. 
 
Figure 9.6: True τ of the modeled material (blue) compared to the VisR τ values (green) computed from
displacement profiles tracked (a) inside and (b) outside the ROE.  Error bars indicate one standard 
deviation.  Values of τ generated inside the ROE were overestimated by at least 0.04 ms.  Outside the ROE 
mean τ was within 0.01 ms of the true τ for all materials.   
Data generated by FEM and Field II simulations. 
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While the correction function was shown to significantly reduce error at the focal depth, 
its use for correcting error τ above and below the axial focus is limited.  As shown in Figure 9.4, 
there was a 5.88 ± 3.91 mm window over which corrected τ estimates were within 10% of the 
true material τ.  While this may be relevant for applications where focal tissue characterization is 
meaningful, such as staging liver fibrosis,159,160 it is not relevant for applications such as DMD, 
where 2D imaging is necessary to appreciate the heterogeneity of the disease process.  In order 
to extend this correction function to 2D imaging, multiple focal depths would be needed.  
Rather than correcting for both displacement underestimation and the inaccuracy in the 
modeled forcing function, this chapter also demonstrated displacement underestimation in, 
versus outside of, the ROE and the associated impact on VisR derived τ estimates.  These data 
show that displacement underestimation leads to error in τ measurements in FEM simulations 
when tracking displacements in the ROE.  However, tracking displacements outside the ROE 
improved both the displacement estimates and τ measurements.  These FEM results were 
supported by results in the gelatin phantom with optical tracking. 
 
Figure 9.7: Displacement through time measured optically (blue) and acoustically (green) for
displacements tracked (a) inside and (b) outside the ROE.  The associated τ measurements inside and 
outside the ROE are shown in (c).  Acoustically-derived τ estimates were significantly higher than the 
optically-derived τ estimates when displacements were tracked inside of the ROE but comparable when 
tracked outside of the ROE.  Moreover, optically-derived τ estimates were consistent inside and outside the 
ROE in the homogeneous phantom.  Data generated experimentally using confocal ultrasound and optical 
imaging. 
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One of the main challenges associated with performing VisR using shear waves involves 
the choice in distance from the ROE to monitor displacement.  If shear waves are tracked too 
close to the ROE, they will not have time to spread out, and little improvement in displacement 
tracking will be appreciated.  However, shear waves tracked too far from the ROE may suffer 
from low signal-to-noise ratios (SNR) due to attenuation, causing error in displacement 
estimates and the model fit.  A priori knowledge of the approximate mechanical properties of 
the tissue may inform the choice of tracking location.  Furthermore, this challenge could be 
addressed using plane wave tracking methods which are capable of monitoring the deformation 
response simultaneously across a large field of view. 
9.5 Conclusion 
Acoustic displacement underestimation in VisR was shown in FEM simulations.  The 
magnitude of the error in τ measurements due to both ultrasonic displacement tracking and 
volumetric ARF impulses was assessed and the possibility for correction of this error was 
investigated.  In addition, displacement underestimation was mitigated by tracking 
displacements induced by propagating shear waves outside the ROE.  
In concert with inertia compensation (Chapter 7), quantitative assessment of τ can be 
achieved over a narrow axial range either by applying a correction function which accounts for 
both non-modeled force propagation and acoustic displacement underestimation, or by 
minimizing acoustic displacement underestimation by exploiting shear wave propagation and 
correcting for non-modeled force propagation (Chapter 8).   Although τ, the ratio of viscosity 
coefficient to elastic modulus, may be quantitatively evaluated by VisR, isolating viscous and 
elastic material properties may only be qualitatively performed, which is the subject of Chapter 
10. 
10 Distinguishing	Viscous	from	Elastic	Properties	in	VisR	Ultrasound	
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CHAPTER 10 
Distinguishing Viscous from Elastic Properties in VisR 
Ultrasound 
 
10.1 Introduction 
It has been demonstrated that VisR can be used to quantitatively estimate τ in viscoelastic 
material, but because τ is a ratio, it cannot differentiate changes in elasticity from changes in 
viscosity.  To isolate elastic from viscous material properties, the MSD model may be fit to VisR 
displacement data to solve for the elasticity and viscosity of the material relative to the 
magnitude of the applied radiation force (μ/A and η/A, respectively).  Because these parameters 
depend on the ARF amplitude (A), which is unknown but assumed to be constant over the 
measurement region, these parameters will herein be referred to  as the ‘relative elasticity’ and 
‘relative viscosity.’ It is hypothesized that, although qualitative, the relative elasticity and relative 
viscosity can provide greater differentiation of viscoelastic materials than τ measures alone.  The 
significance of measuring relative elasticity and viscosity, in addition to τ, in VisR ultrasound is 
demonstrated in simulated and experimental data. 
3 
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10.2 Methods 
10.2.1 FEM Simulations 
The FEM mesh and point loads that were presented in Chapter 8 were again used to 
simulate VisR in viscoelastic materials.  ARF excitations were applied for 70 µs and separated by 
0.8 ms in time.  
The built-in material model *MAT_KELVIN_MAXWELL _VISCOELASTIC was used to 
model tissue as a viscoelastic, isotropic material.   Elasticities were varied from 10 kPa to 100 
kPa (steps of 10 kPa), and viscosities were varied from 2 Pa·s to 12 Pa·s (steps of 1 Pa·s) for a 
total of 110 simulated materials.  Simulated materials were modeled as nearly incompressible, 
using a Poisson’s ratio of 0.499, and had a density of 1.0 g/cm3.  For each simulated material, 
axial FEM displacements at the focus were fit to the MSD model, and error in τ was corrected for 
using Equation (8.2). 
10.2.2 Experimental Validation in Gelatin Phantom 
Experimentally, imaging was performed on a gelatin tissue-mimicking phantom 
containing a spherical inclusion.   The spherical inclusion phantom was constructed by filling a 
latex balloon with 8.2% gelatin gel (by mass) and embedding it in a 10 cm diameter × 6 cm 
height cylinder of 16.5% gelatin gel. 
Data was acquired using a Siemens Acuson Antares™ imaging system specially equipped 
for research purposes (Siemens Medical Solutions USA, Inc. Ultrasound Division) and a VF7-3 
transducer.  VisR was implemented using two ARF excitations of 300 cycles spaced 0.8 ms apart 
in time, with a center frequency of 4.21 MHz.  Motion tracking was performed at 6.15 MHz with 
a pulse repetition frequency (PRF) of 11 kHz.  Both ARF and tracking pulses were focused axially 
at 34 mm and used an F/1.5 focal configuration.  This beam sequence was repeated in 40 lateral 
locations spanning a 2 cm lateral field of view to generate a two-dimensional image.  Motion 
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tracking was performed on the RF data using one-dimensional cross-correlation in the axial 
dimension between sequentially acquired tracking lines.  
Statistical Analysis 
Regions of interest spanning 5 mm laterally and 4 mm axially were selected inside and 
outside the inclusion.  Descriptive statistics of the parameter are expressed as mean ± SD.  
Contrast-to-noise ratio (CNR) for the inclusion relative to the background was calculated as  
 ܥܴܰ ൌ |ߤ௜ െ ߤ௕|
ටߪ௜ଶ ൅ ߪ௕ଶ
 (10.1)
where means are denoted by ߤ௜ and ߤ௕, and standard deviations are denoted by ߪ௜and ߪ௕ of the 
parameter inside and outside the lesion, respectively. 
10.3 Results 
10.3.1 FEM Results 
VisR derived measurements of relative elasticity, relative viscosity, and τ in materials with 
the same elasticity and viscosities ranging from 2-12 Pa·s, are plotted against the material 
elasticity in Figure 10.1.  Relative elasticities were statistically significantly different (p<0.02) 
between all material stiffnesses (panel a).  Relative viscosity (panel b), however, were similar for 
all ten elasticities (p>0.88).  In addition, due to the large range of viscosities, there was 
substantial overlap in τ measurements between materials with different elasticities (panel c).    
In Figure 10.2, values were grouped according to the material viscosity.  Measured relative 
elasticity (panel a) was consistent for all investigated viscosities (p>.79).  Conversely, 
statistically significantly different relative viscosity (panel b) were measured in the measured in 
materials with different viscosities (p<0.05).  Estimates of τ (panel c) could not differentiate 
between viscosities across the full range of elasticites (p>0.02). 
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Figure 10.1: Box-and-whisker plots of measured (a) relative elasticity, (b) relative viscosity, and (c) τ for
materials grouped by elasticity and with viscosities ranging from 2-12 Pa·s.  The red horizontal line 
indicates the median, the box covers the 25-75% percentiles, and the whiskers span the range of the 
observed τ measurements.  Relative elasticities were significantly different between materials with 
different elasticities (p<0.05), while relative viscosities were not (p<0.05).  There is substantial overlap in 
τ values measured in materials with different elasticities relating to the large range of material viscosity. 
10.3.2 Experimental Results 
VisR derived τ, relative elasticity, and relative viscosity imaging results in the gelatin 
phantom are shown in Figure 10.3.  In the estimated τ image (panel a) the inclusion is evident as 
the structure spanning 20 to 40 mm axially and -10 to -3 mm laterally.  Estimated τ in the 
inclusion was 1.18 ± 0.13 ms compared to 0.78 ± 0.17 ms in the background.  The inclusion is 
clearly delineated across its 20 to 40 mm axial range in the relative elasticity (panel b) image, 
with measurements in the inclusion of 40.95 ± 9.18 1/mm and outside of the inclusion of 56.63 
± 8.54 1/cm.  In the relative viscosity image (panel c), the inclusion is not well distinguished 
from the background.  Values of relative viscosity were 65.62 ± 11.56 ms/mm and 60.11 ± 20.13 
ms/mm inside and outside the inclusion respectively.  CNR of the lesion relative to the 
background was 1.15, 0.84, and 0.08 using τ, relative elasticity, and relative viscosity, 
respectively. 
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Figure 10.2: Box-and-whisker plots of measured (a) relative elasticity, (b) relative viscosity, and (c) τ for 
materials grouped by viscosity and with elasticities ranging from 10-100 kPa.  The red horizontal line 
indicates the median, the box covers the 25-75% percentiles, and the whiskers span the range of the 
observed τ measurements.  Relative elasticities were not significantly different (p>0.05), however, relative 
viscosities were significantly different between materials with the same range of elasticities and different 
viscosities (p<0.05).  There was substantial overlap in τ values measured in materials with different 
viscosities attributable to the large range of material elasticities. 
10.4 Discussion 
Because it is a ratio, τ estimates will not be unique to a specific elasticity or viscosity.  
While differences in the viscoelastic properties of the material will manifest as differences in τ 
measurements, these changes cannot be attributable to either elasticity or viscosity.   Relative 
elasticity and viscosity measurements can, however, differentiate materials based on their 
material elasticity and viscosity.  It is important to remember that relative elasticity and 
viscosity are relative to the applied force magnitude and their values should only be used where 
the applied force can be assumed to be constant.  In this sense, VisR estimates of relative 
elasticity and viscosity are qualitative. 
Experimentally, the estimated τ values inside the spherical inclusion were higher than the 
τ estimates in the surrounding material.  On its own, this would suggest that the inclusion had 
either higher viscosity, or lower elasticity than the background or some combination thereof.  
However, coupled with the lower relative elasticity and comparable relative viscosity  
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Figure 10.3: Parametric VisR images of (a) estimated τ, (b) relative elasticity, and (c) relative viscosity in a
tissue-mimicking, gelatin phantom.  The phantom contained a spherical inclusion with comparable 
viscosity but lower elasticity than the background material.  Box-and-whisker plots show the median (red-
line), 25th and 75th percentiles (box), and full range of observed (d) estimated τ, (e) relative elasticity, and 
(f) relative viscosity inside the spherical inclusion (rectangular ROI spanning from -9 to -4 mm laterally) 
and outside the inclusion (rectangular ROI spanning from 4 to 9 mm laterally).  While VisR τ values 
contrast the inclusion (a & d), they do not suggest if the inclusion's mechanical property difference from 
the background is related to elasticity, viscosity, or both.  VisR parametric relative elasticity values (b & e) 
reveal that there is disparity in the elastic properties of the inclusion and background, while relative 
viscosity values (d & f) suggests that the inclusion and background have similar viscous property. 
 
measurements in the inclusion, the increased τ values in the inclusion can be attributed to lower 
elasticity of the inclusion rather than a difference in viscosity.  This analysis is consistent with 
the higher concentration of gelation used in the formulation of the background and 
demonstrates the utility of separating elasticity and viscosity in order to interpret τ estimates. 
10.5 Conclusion 
Previous chapters have shown that VisR, an elastographic imaging method based on the 
MSD model, can estimate the relaxation time for constant stress (τ) in viscoelastic materials.  
One disadvantage to VisR (as demonstrated herein) is its inability to distinguish between the 
elastic and viscous contributions to τ.  In this chapter, it was shown that VisR can be used to 
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estimate the elasticity and viscosity of a material relative to the magnitude of the applied ARF.  
It was demonstrated in simulation and experimentally that these relative measures can be used 
to discriminate the viscous and elastic properties of materials. 
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CHAPTER 11 
Noninvasive Discrimination of Muscle Degeneration in Canine 
Models of Duchenne Muscular Dystrophy by VisR Ultrasound 
 
11.1 Introduction 
As described in Chapter 2, Duchenne muscular dystrophy (DMD) is an X-linked disorder 
affecting approximately 1 of 3,500 newborn human males in whom absence of the protein 
dystrophin causes progressive degeneration of skeletal and cardiac muscle. 161–163  Muscle 
degeneration is accompanied by muscle fiber necrosis and subsequent progressive replacement 
of muscle by fibrous tissue and fat.164  Because muscle mechanical properties are related to 
composition and structure,165 interrogating the mechanical properties of muscle may be useful 
for stratifying degrees of functional muscle degeneration and support early detection of subtle 
degenerative changes in DMD. 
In this Chapter, VisR ultrasound is applied for imaging the mechanical properties of 
dystrophic versus control muscles in the Golden retriever muscular dystrophy (GRMD) canine 
model of DMD.56,57,166  VisR was performed in a cross-sectional study of 10 GRMD and 10 
controls dogs age 3 to 60, and in a longitudinal study, where four littermates (2 GRMD, 2 
control) were imaged serially over the course of 7.5 months.  Imaging results were compared 
with MRI and morphometric histological findings.    
11.2 Methods 
All procedures were approved by the Institutional Animal Care and Use Committees of the 
University of North Carolina at Chapel Hill and Texas A&M University. 
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11.2.1 VisR Imaging 
VisR imaging was performed in vivo on the rectus femoris (RF), cranial sartorius (CS), 
and vastus lateralis (VL) muscles.  In the cross-sectional study, imaging was performed in 20 
(n=10 control and 10 GRMD) age-matched dogs, with imaging time points at 3, 6, 12, 24, and 60 
months of age.  Because RF histology was not available for this population of dogs, results only 
will be presented for the CS and VL muscles.  In the longitudinal study, imaging was performed 
serially in 4 (n=2 control and 2 GRMD) littermates over the course of a year, with imaging time 
points at 4.5, 6, and 12 months of age. 
Dogs were sedated for ultrasound imaging using acepromazine (0.02 mg/kg IM) and 
butorphanol (0.4 mg/kg IM) and positioned in lateral recumbency.  Imaging was performed 
using a Siemens Acuson Antares™ imaging system equipped for research purposes and a VF7-3 
transducer (Siemens Medical Solutions USA, Inc. Ultrasound Division).  One spatially registered 
B-Mode frame was automatically acquired immediately prior to each acquisition.  VisR was 
implemented using two 300-cycle, F/1.5, ARF excitations (70 μs) administered 0.8 ms apart in 
time and delivered to the same region of excitation (ROE).  Eight tracking lines were acquired 
between the two ARF excitations, and 48 tracking lines were acquired after the second excitation 
for a total of 56 tracking lines.  This ensemble was repeated in 40 locations spaced 0.53 mm 
apart laterally for a 2.1 cm lateral field of view (FOV).  The ensembles were collected using 
wiperblading, whereby successive ensemble acquisitions alternated from the left to the right side 
of the imaging FOV, to avoid motion interference.  Data sets were acquired with three repeated 
acquisitions in immediate succession. 
Acquired raw RF data was transferred to a computational workstation for processing and 
analysis.  One-dimensional axial displacements were measured along each acquired ensemble 
using normalized cross-correlation.139  The interpolation factor was 4, the search window length 
was 80 µm, and the kernel length was 3 times the center wavelength.  Physiologic motion was 
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rejected using a linear filter applied to the measured ARFI displacement profiles.167   
Estimates of τ were calculated from VisR displacement profiles using the MSD model as in 
Section 7.2 using a custom-written C++ program.  Images of τ were median filtered using a 0.29 
mm (axial) by 1.06 mm (lateral) window.  Analysis of VisR τ measurements were then 
performed by calculating the standard deviation (SD) of τ estimates within the hand-delineated 
muscle boundaries. 
Statistical Analysis 
In the cross-sectional study, SD of VisR τ estimates from the GRMD and control muscles 
were statistically compared using the Wilcoxon two-sample test.  A p value of < 0.05 was defined 
as significant.  Due to small sample size, no statistical analysis, was performed in the 
longitudinal study. 
11.2.2 MR Imaging 
MRI was performed at each imaging time point of the cross-sectional study and at the 6 
and 12 month time points in the longitudinal study.  Dogs were anesthetized and placed in 
ventral recumbency (prone position).  The pelvic limbs were extended caudally and positioned 
in the head coil centered at midfemur.  T2-weighted (T2w) imaging was performed using the 
sequencing outlined by Wang et al.92,168  Measures of T2 inhomogeneity were also performed.  
Included in this chapter is run percentage (RP) which measures the number of ‘runs’, or groups 
of consecutive voxels of the same intensity.  More heterogeneous tissue will yield a higher 
number of runs and a higher RP.  Image analysis was performed by Dr. Jiahui Wang under the 
direction of Dr. Martin Styner at the University of North Carolina at Chapel Hill. 
11.2.3 Histology 
Muscle tissue samples of the CS and VL were acquired by open surgical biopsy at each 
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time point in the cross-sectional study.  For the longitudinal study, the RF, CS and VL muscles 
of the left limb were surgically biopsied at 6 months, and muscles of the right limb were 
harvested at necropsy (affected/carrier) or surgically biopsied (control) at 12 months of age.   
Muscle sections were stained with Hemotoxylin and Eosin (H&E) and Masson’s trichrome 
or picrosirius red for collagen.  Microscopy of the stained sections was performed using an 
Aperio Scanscope microscope (Aperio Technologies, Vista, CA) at 20× magnification.  The 
collagen percent and fat percent were calculated for each muscle section as demonstrated in 
Figure 11.1 using Aperio ImageScope software.  Analysis was performed by Dr. Eric Snook under 
the direction of Dr. Joe Kornegay at Texas A&M University. 
11.3 Results 
Figure 11.2 shows representative parametric VisR τ images acquired in the rectus femoris 
(RF) muscle of a 12 month-old GRMD/control littermate pair and the histology harvested from 
the muscles shortly thereafter.  Qualitatively, the VisR τ image in the GRMD RF muscle (panel 
a) appears more heterogeneous compared to the control RF muscle (panel b).  Quantitatively, 
standard deviation (SD) of τ measurement was approximately 75% larger in the GRMD (panel a, 
0.430 ms) than in the control RF (panel b, 0.245 ms).  Histologically, the RF of GRMD dog 
(panel c) shows areas of necrosis, regeneration, collagen deposition (13.1%), and fat infiltration 
(1.5%).  Conversely, the RF of control dog (panel d) appears more homogenous and with less 
collagen (3.2%) and fat infiltration (0.5%).   
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Figure 11.1: (a) Masson’s trichrome stain in muscle section from a control dog at 12 months; 
muscle tissue is stained red and collagen blue.  A hand drawn region of interest selecting the 
boundary for analysis is shown in green.   
(b)  Histological analysis was performed as the following: 
1) The image was threshholded based on color to classify tissue as muscle or fat.  Tissue 
identified as muscle is shown in blue and tissue identified as collagen is shown in red. 
2) Fat was identified based on morphology and regions determined to be fat were hand-
delineated, shown in orange. 
3) The total area of the section was equal to the sum of the areas identified as muscle, 
collagen, and fat. 
4) The calculations of collagen percent and fat percent for the tissue section were calculated 
as:   
ܥ݋݈݈ܽ݃݁݊	݌݁ݎܿ݁݊ݐ ൌ 	ܣݎ݁ܽ௖௢௟௟௔௚௘௡ܣݎ݁ܽ௧௢௧௔௟ ൌ
ܣݎ݁ܽ௖௢௟௟௔௚௘௡
ܣݎ݁ܽ௠௨௦௖௟௘ ൅ ܣݎ݁ܽ௖௢௟௟௔௚௘௡ ൅ ܣݎ݁ܽ௙௔௧ 
 
ܨܽݐ	݌݁ݎܿ݁݊ݐ ൌ 	 ܣݎ݁ܽ௙௔௧ܣݎ݁ܽ௧௢௧௔௟ ൌ
ܣݎ݁ܽ௙௔௧
ܣݎ݁ܽ௠௨௦௖௟௘ ൅ ܣݎ݁ܽ௖௢௟௟௔௚௘௡ ൅ ܣݎ݁ܽ௙௔௧ 
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Figure 11.2: VisR τ images in the right rectus femoris (RF) muscles of (a) GRMD and (b) control 
littermate at 12 month of age, and corresponding histology from the (c) GRMD and the (d) control 
RF muscle.  VisR imaging was performed in the plane transverse to muscle fibers and the white 
line indicates the RF muscle boundary.  Standard deviation (SD) of τ was higher in the GRMD 
(0.430 ms) relative to the control RF (0.245 ms) indicating a higher degree of heterogeneity in τ 
values.  Histologically, collagen and fat deposition was higher in the GRMD RF (13.1 vs .32% and 
1.5 vs 0.5% respectively) compared to the control RF. 
11.3.1 Cross-Sectional Study  
Figure 11.3 reports τ SD measured in the VL muscles of the cross-sectional study.  
Measurements in the control VL muscle are shown as blue squares and the GRMD VL muscles 
are red circles.  SD of τ was consistently larger in the GRMD versus the control VL at each age 
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group.  Averaged across age, SD of τ showed significant group differences between control and 
GRMD VL muscles (p=0.001). 
The histological analysis and MRI results in the VL muscles are shown in Figure 11.4.  At 
each age, GRMD dogs were shown to exhibit a higher percent of collagen (panel) in VL muscle 
biopsies than their age matched controls.  VL muscle biopsies also showed a low percentage of 
fat (panel b).  MRI T2 values in the VL (panel c) were generally higher and more heterogeneous, 
as measured by the RP (panel d), in the GRMD dogs relative to the age matched controls.   
Because fat percentages were generally low, the increased T2 values in the GRMD VL muscles 
are likely due to inflammation associated with necrosis. 
SD of τ measurements in the CS muscle is shown in Figure 11.5.  With the exception of a 
60 month control which fell between the two GRMD measurements, τ SD was larger in GRMD 
versus the control CS at each time point.  The difference between control and GRMD averaged 
across time was significant (p=0.001). 
Figure 11.5 shows the histological analysis and MRI results in the CS muscles.  GRMD 
dogs consistently exhibited a higher percentage of collagen (panel a) in CS muscle biopsies than 
their age matched controls.  In the majority of dogs, less than 7% of the tissue was identified as 
fat (panel b), however, 12% fat was measured in one 24 month control CS biopsy.  MRI results 
showed higher T2 (panel c) in the 3-6 month old GRMD relative to the control CS; in dogs older 
than 6 months T2 values were not correlated with phenotype.  Likewise, MRI heterogeneity 
(panel d) in the CS did not exhibit a trend between GRMD and control.  
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Figure 11.3: VisR imaging results in the cross-sectional VL muscles.  Scatter plot illustrating the 
standard deviation (SD) of τ estimates versus the age of the dog at the time of imaging.  Control VL 
muscles are indicated by blue squares and GRMD by red circles.  SD of τ was larger in the GRMD 
compared to control VL in each age group.  Averaged across age groups, SD of τ was significantly 
larger (p=0.001, Wilcoxon two-sample test) in the GRMD (0.423 ± 0.049 ms) relative to the 
control (0.299 ± 0.048 ms) VL muscle. 
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Figure 11.4: Histology and MRI results in the cross-sectional VL muscles.  Control VL muscles are 
indicated by blue squares and GRMD by red circles.  The percentage of the biopsy samples that 
stained for collagen (panel a) was high in the GRMD relative to the control VL muscles at all ages.  
Averaged across age groups, percentage of collagen by histology was 26.13% ± 4.63 and 7.61% ± 
5.39 in the GRMD and control VL respectively (p<0.001, Wilcoxon two-sample test).  No 
significant differences (p=0.24) in fat percentage (panel b) was measured between the control 
(0.93% ± 1.14) and GRMD groups (1.01% ± 0.72).  T2-values assessed with MRI (panel c) were 
higher in the GRMD relative to control VL at 3, 6, and 24 months indicating increased fat/water 
signal.  Averaged across time, T2 values were significantly higher (p=0.01) in the GRMD (53.82 ± 
6.54) than in the control (45.17 ± 12.94).  MRI run percentage (RP) (panel d), were also 
significantly higher (p=0.007) in the GRMD (0.366 ± 0.084) versus control VL (0.256 ± 0.065) 
averaged across time. 
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Figure 11.5: VisR imaging results in the cross-sectional CS muscles.  Scatter plot illustrating the 
standard deviation (SD) of τ estimates versus the age of the dog at the time of imaging.  Blue 
squares indicate control CS muscles and red circles indicate GRMD CS muscles.  With the 
exception of one 60-month-old control, SD of τ was larger in the GRMD compared to control CS 
at each age.  Averaged across age groups, SD of τ was significantly larger (p=0.001, Wilcoxon 
two-sample test) in the GRMD (0.432 ± 0.082 ms) relative to the control (0.249 ± 0.080 ms) 
CS muscle. 
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Figure 11.6: Histology and MRI results in the cross-sectional CS muscles.  Control CS muscles are 
indicated by blue squares and GRMD by red circles.  The percentage of the biopsy samples that 
stained for collagen (panel a) was high in the GRMD relative to the control CS muscles at all ages.  
Averaged across age groups, percentage of collagen by histology was 34.10% ± 8.50 and 13.59% ± 
3.68 in the GRMD and control CS respectively (p<0.001, Wilcoxon two-sample test).  Fat 
percentage (panel b) of histology did not appear to be corrected to phenotype (p=.89).  2.85% ± 
4.01 fat was measured in the control CS, compared to 2.13% ± 2.15 fat in the GRMD CS.  T2-values 
assessed with MRI (panel c) did not show significant group differences (p=0.31) between control CS 
(51.46 ± 14.63) and GRMD CS muscles (53.76 ± 8.51).  Group differences were measured by MRI 
RP (panel d, p=0.01, control: 0.38 ± 0.07, GRMD: 0.28 ± 0.08). 
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11.3.2 Longitudinal Study  
SD of τ measurements in the RF muscle through time for the four dogs included in the 
longitudinal study are shown in Figure 11.1.  Values were higher in the two GRMDs relative to 
the two control RF muscles.  The histology and MRI measurements in the RF are shown in 
Figure 11.8.  Histology was not obtained for GRMD2 (purple) at 12 months.  In addition, the RF 
biopsy sample of Control2 (green) at 6 months could not be processed.  Collagen percentages 
(panel a) were higher in the GRMD compared to the control RF.  Intramuscular fat percentages 
were small in all samples (panel b), but were higher in the GRMD RF samples.  T2 values (panel 
c) in the GRMD RF were higher than in the control RF and were also more heterogeneous (panel 
d).  The highest SD of τ measurements were measured for GRMD2 (purple) at each time point, 
consistent with high percentages of collagen and fat relative to the other dogs at the 6 month 
time point.   
Figure 11.9 shows τ SD measured in the VL muscle through time.    In both GRMD dogs, τ 
SD measurements were higher than for the control VLs.  Histological and MRI results in the VL 
are shown in Figure 11.10.   GRMD1 (red) exhibited the highest percentages of collagen (panel a) 
and fat (panel b) at both time points.  T2 values (panel c) were also high in GRMD1 (red) at both 
time points, relative to the other three dogs.  Heterogeneity (panel d) of the T2 values was 
largest in GRMD1 (red) at 6 months and in GRMD2 (purple) at 12 months.  Larger SD of τ in the 
VL of GRMD1 (red) at 6 mos is consistent with higher percentages of collagen and fat, higher T2 
values (suggesting inflammation associated with necrosis), and higher RP values in GRMD1 at 6 
months.  At 12 months SD of τ was higher in GRMD2 than GRMD1, and the same was true of 
RP. 
VisR imaging results in the CS muscle through time is illustrated in Figure 11.11.  SD of 
estimated τ was highest in the two control CS muscles at 4.5 months.  After 4.5 months τ SD was 
highest the two GRMD CS muscles.  Figure 11.12 shows the histological analysis and MRI results 
in the CS muscles.  GRMD CS muscles exhibited a higher percent of collagen (panel a) and 
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higher T2 values (panel c) relative to the control CS muscle.  The largest fat percentage (panel b) 
was seen in Control1 (blue), closely followed by GRMD1 (red).  Control1 (blue) also exhibited the 
highest heterogeneity of MRI signal (panel d).  SD of τ in the CS was highest in GRMD1 at 6 and 
12 months, consistent with collagen and T2 measurements.   
 
Figure 11.7: VisR imaging results in the longitudinal RF muscles.  Plot shows standard deviation (SD) of τ 
estimates versus dog age at the time of imaging.  Control RF muscles are indicated by squares and GRMD 
by circles, individual dog results are indicated by color.  SD of τ was larger in the GRMD compared to 
control RF at each point in time. 
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Figure 11.8: Histology and MRI results in the longitudinal RF muscles at 6 and 12 months of age.  
Plots show percent of collagen (a) and fat (b) from histology; and T2 value (c) and RP (d) from MRI.  
Available histology showed higher collagen and fat percentages in the two GRMD dogs at both time 
points.  T2 values and RP were also larger in the two GRMD dogs at both times. 
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Figure 11.9: VisR imaging results in the longitudinal VL muscles.  Plot shows standard deviation
(SD) of τ estimates versus dog age at the time of imaging.  Control VL muscles are indicated by 
squares and GRMD by circles, individual dog results are indicated by color.  SD of τ was larger in 
both GRMD compared to control VL at each point in time. 
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Figure 11.10: Histology and MRI results in the longitudinal VL muscles at 6 and 12 months of age.  
Plots show percent of collagen (panel a) and fat (panel b) from histology; and T2 value (panel c) 
and RP (panel d) from MRI.  Histology showed higher collagen and fat percentages in the GRMD 
VL relative to control at both time points.  The two GRMDs also exhibited higher T2 RP than the 
control VL muscles. 
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Figure 11.11: VisR imaging results in the longitudinal CS muscles.  Plot shows standard deviation 
(SD) of τ estimates versus dog age at the time of imaging.  Control CS muscles are indicated by 
squares and GRMD by circles, individual dog results are indicated by color.  SD of τ was larger in 
the GRMD compared to control CS at each point in time at 6 and 12 months, but smaller in the 
4.5 month time point. 
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Figure 11.12: Histology and MRI results in the longitudinal CS muscles at 6 and 12 months of age.  
Plots show percent of collagen (panel a) and fat (panel b) from histology; and T2 value (panel c) 
and RP (panel d) from MRI.  Collagen percentage and T2 values were high in both GRMD CS 
muscles relative to the control CS.  Fat percentage and RP, however, were high in the Control1 CS 
relative to the other 3 CS muscles. 
 
11.4 Discussion  
Dystrophin-deficient muscles express variable pathologic changes, presumably due to 
their function over the course of life.  Flexor muscles, such as the CS, tend to have earlier 
changes, perhaps due to their role in crawling, 67 while extensor muscles, including the RF, 
demonstrate somewhat delayed changes associated with eccentric contractions during weight 
bearing.162  In particular, the CS muscle has been shown to undergo hypertrophy, whereas the 
quadriceps (including the RF and VL) atrophies.59   CS enlargement initially occurs due to an 
increase in muscle (true hypertrophy) followed by connective tissue and fat 
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(pseudohypertrophy).   We expect that necrosis could lead to decreased tissue stiffness and 
increased τ, while collagen deposition will be associated with increased tissue stiffness and 
decreased τ.  Because the pathologic changes of DMD and GRMD occur as multifocal areas of 
small group muscle fiber necrosis and regeneration,169  these compositional changes should 
increase the SD of the estimates of τ made within a muscle.  Furthermore, we predict that an 
increase in contractile tissue and disordered muscle regeneration in true hypertrophy will result 
in higher variations in estimated τ values. 
Our expectations for the impact of dystrophic changes on the SD of τ are generally realized 
in these initial results.  In the cross-sectional study, with the exception of one 60 month old 
control CS, SD of τ was larger in all GRMD VL and CS muscles relative to the age matched 
controls; this was consistent with higher percentages of collagen measured by histology.     
In the longitudinal study, SD of τ was high in the GRMD RF and VL relative to the control 
muscles for all time points.  In the CS, SD of τ was higher in the control CS than the GRMD at 
4.5 months.  After 4.5 months, SD of τ was high in the GRMD CS relative to control.  While we 
would not expect SD of τ to be larger in the control muscle than in the GRMD muscle, the 
difference between the two groups is small compared to the difference between the groups at 6 
and 12 months, and we appreciate that given more samples it may not be significant. 
A potential confounding factor in this analysis is the error in τ estimates as discussed in 
Chapter 8 and 9.  Because we are not accounting or correcting for error in τ due to 
misrepresenting the physical excitation force experienced by the tissue, we do not expect τ 
measurements to represent the true τ of the tissue.  In addition, the effects of non-modeled force 
propagation will introduce error into τ measurements over axial depth.  On average the muscles 
imaged in this chapter spanned 11.95 ± 4.35 mm.  According to Figure 9.3, an axial window of 12 
mm will result in 0.047 ± 0.015 ms of deviation.  Because all measured standard deviations of τ 
were greater than 0.15 ms, we believe that the observed variations in τ were due to 
compositional variations rather than an effect of unmitigated error in τ measurements. 
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In this current analysis, only VisR images acquired at the midplane of muscle were 
considered, correlating to the approximate location of the biopsy site.  VisR images were also 
acquired approximately one- and three-quarters distance between the hip and knee; including 
these images will provide future analyses with more data points on which to draw conclusions.  
Also, data collection is ongoing.  Additional longitudinal cohorts will allow for a more thorough 
discussion of disease progression in GRMD.   Furthermore, the SD statistic used in this chapter 
is based only the absolute values of τ within the muscle; textural analysis techniques, such as 
those employed in the MRI processing, take into account both the value and spatial distribution 
of measurements.  Using these techniques, it may be possible to improve the discrimination 
between control and GRMD dogs.   
11.5 Conclusion  
In this chapter VisR was demonstrated for delineating dystrophic muscle degeneration.  
These preliminary results showed more variation in VisR τ estimates in dystrophic versus 
control VL and CS muscles, consistent with inflammation, fibrosis, and fat deposition.  VisR 
results were corroborated by MRI and histological processing and substantiate further 
investigation of VisR in dystrophic muscles and other viscoelastic tissue imaging applications.   
In Chapter 12, VisR is demonstrated clinically in boys with DMD. 
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CHAPTER 12 
VisR Ultrasound Assessment of Viscoelastic Properties in 
Human Duchenne Muscular Dystrophy, In Vivo  
 
12.1 Introduction  
The current outcome measurements in DMD are suboptimal.  Muscle biopsy is invasive 
and limited by specimen size.  Various functional and muscle strength assessments require 
subjective effort and are susceptible to rater variation. 170  Moreover, loss of muscle function in 
DMD occurs against the background of normal childhood growth and development, this may 
manifest as an improvement in physical ability despite progressive muscle impairment.69   
In the previous Chapter, VisR ultrasound was applied to a preclinical dog model of 
muscular dystrophy; in this Chapter VisR clinical feasibility is demonstrated in two boys with 
DMD. 
12.2 Methods 
12.2.1 Subjects 
This study was approved by the Institutional Review Board (IRB) at the University of 
North Carolina at Chapel Hill.  Written informed consent was obtained from the participants’ 
parents.  VisR imaging and physical testing was performed in two subjects with a clinical 
diagnosis of DMD.  Subject 1 was 6.2 years old at the start of the study and was imaged three 
times over the course of 15 months.  Subject 2 was imaged once at 8 years old.  Subject 2 was on 
corticosteroid treatment at the time of imaging, while Subject 1 had never used corticosteroids. 
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12.2.2 VisR Imaging  
VisR images of the right sartorius (SART) and gastrocnemius (GAST) muscles were 
acquired in vivo.  Imaging was performed using a Siemens Acuson Antares imaging system 
equipped for research purposes and a VF7-3 linear array transducer (Siemens Medical Solutions 
USA, Inc. Ultrasound Division).  In patient 1, a 2 cm, non-attenuating, stand-off pad was placed 
between the transducer and skin to optimize the depth of the target muscle.  ARF excitations 
were 300 cycles (70 μs) in duration and centered at 4.21 MHz with an F/3 focal configuration.  
Tracking pulses were centered at 6.15 MHz with an F/1.5 focal configuration and 11 kHz pulse 
repetition frequency.  VisR beam sequences consisted of two reference tracking lines preceding a 
first ARF excitation, then 4 tracking lines followed by a second ARF excitation and 52 tracking 
lines.  Two-dimensional imaging was achieved by administering the VisR beam sequence in 40 
lateral locations evenly spaced across a 2.1 cm lateral field of view.  The ensembles were 
collected using wiperblading, whereby successive ensemble acquisitions alternated from the left 
to the right side of the imaging FOV, to avoid motion interference.  One spatially registered B-
Mode frame was acquired immediately prior to each VisR acquisition.  VisR images acquired at 
the midplane of muscle (medial) and halfway between midplane and the hip (proximal). 
Acquired raw RF data was transferred to a computational workstation for processing and 
analysis.  One dimensional cross-correlation was applied to the acquired RF data to measure 
induced axial displacements, and the data was processed with a linear filter to reject physiologic 
motion.  Parametric images of τ were rendered from the acquired VisR data.  Muscles were hand 
delineated in B-Mode images, and the delineations were applied to the corresponding matched 
VisR images. 
12.2.3 Physical Testing  
Following ViSR imaging, the subjects underwent quantitative muscle testing (QMT) , the 
6-minute walk test (6MWT), and timed function tests (TFT) (see Section 3.1).  QMT was 
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perfomed using a PowerTrack II Commander hand-held dynamometer (JTech Medical 
Industries, Salt Lake City, UT)  according to the standardized positions listed in Table 11.1, and 
was averaged across two repeated trials.   TFTs included time to stand (5 times sit to stand) and 
time to walk 30-feet time.75,171,172  
Table 12.1: Standardized Patient Positioning for QMT 
Muscle/Muscle groups Standardized Position
RF Sitting with knee at 90° flexion, HHD at distal lower 
leg 
Hip flexors Supine with hip/knee at 90° flexion, HHD proximal to 
knee 
Hip abductors Supine with hip neutral, leg stays on table, HHD 
proximal to knee 
GAST Supine with ankle at neutral dorsiflexion, HHD at 
medial head  
 
12.3 Results 
12.3.1 VisR Imaging  
Figure 12.1 shows the parametric VisR τ images acquired in the right SART muscles of 
Subject 1 at (a) 6.2 years of age and (b) 15 months later when the boy was 7.4 years old.  Images 
were acquired with the transducer perpendicular to the muscle fibers, in the proximal imaging 
plane.  VisR τ values ranged from 1.399 ± 0.539 ms and 1.674 ± 0.487 ms at 6.2 and 7.4 years, 
respectively.  Median τ was 1.3203 ms at 6.2 years and 1.6412 ms at 7.4 years. 
VisR τ images in the GAST muscle of Subject 1 at 6.2 years of age at shown in Figure 
12.2(a).  VisR τ values ranged from 1.033 ± 0.340 ms with a median of 1.0170 ms.  In Figure 
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Figure 12.1: VisR τ estimates overlaid on B-Mode images in the right sartorius (SART) muscle of Subject 1 
at (a) 6.2 years and (b) 7.4 years.  Median τ was 1.3203 ms at 6.2 years and 1.6412 ms at 7.4 years.
  
 
Figure 12.2: VisR τ estimates overlaid on B-Mode images in the right gastrocnemius (GAST) muscle of 
Subject 1 at (a) 6.2 years and (b) 7.4 years.  Median τ was 1.0170 ms at 6.2 years and 1.6012 ms at 7.4 years.
   
(a) 6.2 years (b) 7.4 years 
(a) 6.2 years (b) 7.4 years 
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Figure 12.3: Median τ measurements in the (a) sartorius (SART) and (b) gastrocnemius 
(GAST) of Subject 1 over time in the proximal (green) and medial (blue) imaging planes.  
Estimates of τ in the SART increased from the first to third time point by 19.5% and 13.7% in 
the proximal and medial imaging planes respectively.  Estimates of τ in the GAST increased 
from the first to third time point by 36.5% in the proximal and 35.9% in the medial imaging 
planes. 
 
12.2(b), Subject 1 was 7.4 years old with τ values ranging from 1.629 ± 0.471 ms, with a median 
of 1.6012 ms.  Median τ values are depicted in Figure 12.3 for the (a) SART and (b) GAST 
muscles at the three imaging time points.  VisR imaging in the proximal plane are shown in 
green, and the medial plane in blue. 
Figure 12.4 shows the parametric VisR τ images acquired in the right SART and GAST 
muscles of the Subject 2 at 8 years of age.  In the SART τ ranged from 1.535 ± 0.271 ms with a 
median τ of 1.5432 ms.  VisR τ values of 1.649 ± 0.284 ms and a median of 1.6556 ms, were 
measured in the GAST of Subject 2. 
Figure 12.5 shows the median τ values in the (a) SART and (b) GAST muscles of Subject 1 
at baseline (6.2 years) compared to Subject 2 (6.2 years).  Estimates of τ in the SART of Subject 1 
were 86% and 73% of those measured in Subject 2, in the proximal (green) and medial planes  
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Figure 12.4: VisR τ estimates overlaid on B-Mode images in the (a) sartorius (SART) and (b) 
gastrocnemius (GAST) muscle of Subject 2.  Median τ was 1.5432 ms in the SART and 1.6556 ms in the 
GAST.  
 
 
 
Figure 12.5: Median τ values in the (a) SART and (b) GAST muscles of Subject 1 at baseline and Subject 2.  
In the SART, median τ values were 1.163 and 1.3203 ms in the medial (blue) and proximal (green) 
imaging planes respectively for Subject 1, and 1.543 and 1.5825 ms for Subject 2.  Median τ values  in the 
GAST were 0.819 and  1.017 ms in the medial and proximal imaging planes respectively for Subject 1, and 
1.175 and 1.656 ms for Subject 2.   
 
  
(a) Sartorius (b) Gastrocnemius 
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(blue) respectively.  In the GAST, τ values in Subject 1 were 61% of Subject 2 in the proximal 
plane (green), and 69% of Subject 2 in the medial plane. 
12.3.2 Physical Testing  
QMT for Subject 1 is shown in Figure 12.6 for the (a) RF, (b) hip flexors, (c) hip abductors, 
and (d) GAST.  Of the four muscle/muscle groups, the hip flexors were the only muscle group 
which showed a diminished ability to produce force from baseline testing.  The 6MWT and TFT 
results are shown in Figure 12.7.  Over the course of 15 months, Subject 1 exhibited 
improvements in 6MWT and time to walk 30 feet.  However, the time it took him to rise from a 
chair five times increased by 300%. 
 
 
Figure 12.6: QMT testing in Subject 1 in the (a) rectus femoris (RF), (b) hip flexors, (c) hip abductors, and 
(d) gastrocnemius (GAST).   
 
138 
Figure 12.7: 6MWT and TFT results for Subject 1.  An increase in distance in the (a) 6MWT and a decrease 
in the time needed to (b) walk 30-feet are both associated with increased physical abilities.  However, the 
time Subject 1 needed to (c) rise from a chair (x5) increased from 17 seconds to 51 seconds over the course 
of the study. 
 
In Figure 12.7, QMT in Subject 1 at baseline is compared to Subject 2.  Subject 2, the 8-
year-old boy, had higher mean force measurements in all four muscles/muscle groups than 
Subject 1, produced higher forces than Subject 1 in all four muscles/muscle groups.  The 6MWT 
and TFT results for the two boys are shown in Figure 12.8.  Subject 1 walked 23% further in 6 
minutes  and performed the 30-foot walk 24% faster than Subject 2.  In addition, Subject 1 
completed the sit to stand test in 17 seconds, whereas Subject 2 could not stand from a seated 
position without the use of his arms and was therefore unable to perform the test. 
12.4 Discussion  
As in GRMD, there is phenotypic variation among muscles in human DMD.   The SART 
muscle is thought to be relatively spared,173 while the GAST undergoes pseudohypertrophy, 
whereby muscle enlargement is due, at least in part, to an excess of adipose and connective 
tissue.33,174  MRI studies have shown significant intramuscular fat in the GAST.175,176 
In Subject 1, median τ value in the GAST muscle increased by 36.5% and 35.9% over the 
course of 15 months in the proximal and medial imaging planes respectively.  This increase in τ 
would suggest an increase in viscosity and/or decrease in stiffness of the muscle over time, both  
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Figure 12.8: QMT testing in Subject 1 at baseline and Subject 2 in the (a) rectus femoris (RF), (b) hip 
flexors, (c) hip abductors, and (d) gastrocnemius (GAST).   
 
 
 
Figure 12.9: 6MWT and TFT results for Subject 1 at baseline and Subject 2.  In the (a) 6MWT, Subject 1 
walked 1060 feet versus 817 feet walked by Subject 2.  Subject 1 performed the (b) time to walk 30-feet in 
6.16 seconds versus 9.25 seconds for Patient 2.  In the time to stand test (c), Subject 1 needed 17 seconds.  
Subject 2 was unable to rise from the chair without using the armrests to assist him, and thus he could not 
perform the test.   
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consistent with an increase in fat.  Meanwhile, τ values in the SART increased by 19.5% in the 
proximal plane and 13.7% in the medial plane.  This higher degree of change in the GAST versus 
the SART is consistent with the expected phenotypes of the muscles.   
Despite increasing τ values suggesting compositional changes in his muscles, Subject 1 
experienced improvements in QMT, 6MWT, and the time to walk 30 feet test.  This is not 
surprising, as functional decline in motor performance, such as reduced distance walked in the 
6MWT, is often not observed in DMD until after age seven due to normal growth and 
development.177  Furthermore, time to rise from a chair, which is one of the first functional 
abilities lost in DMD boys, increased by 300% between 6.2 years of age and 7.4 years of age 
suggesting loss of muscle function. 
Subject 2 performed slower in the TFTs and covered less distance in the 6MWT than 
Subject 1.  These results, in conjunction with the higher τ values estimated in both of Subject 2’s 
muscles, suggest that an increase in fatty deposition may be associated with a decline in physical 
performance. 
12.5 Conclusion  
This in vivo study demonstrated the feasibility of VisR imaging for delineating dystrophic 
muscle degeneration in two boys with DMD.  Consistent with the known, distinct phenotypic 
response of the two muscles, our results suggested larger changes in composition of the GAST 
relative to the SART muscle both longitudinally and cross-sectionally.  Further, a larger 
percentage of high τ values were associated with lower functional testing scores.  These findings 
suggest VisR may be relevant as a novel outcome measure for diagnostics and clinical trials in 
DMD.  Importantly, VisR measured changes in muscle composition, while degeneration was 
masked by growth and degeneration in physical testing. 
13 Conclusions	and	Future	Work	 	
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Chapter 13 
Conclusions and Future Work 
 
13.1 Conclusions  
The goal of this dissertation was to evaluate the hypothesis that Viscoelastic Response 
(VisR) ultrasound can noninvasively characterize the viscoelastic properties of soft tissue in 
vivo.  A number of key accomplishments were made. 
First, the deformation of a viscoelastic material in response to an impulsive force was 
modeled using FEM.  From these simulations it was determined that inertial contributions are 
not insignificant and must be accounted for by the mechanical model.  Further FEM simulations 
revealed, however, that using an ARF excitation to generate the force will result in error in the 
measurement of the relaxation time constant, τ.  A correction function was generated which 
supports quantitative imaging of τ, but only over a narrow axial range.  The effects of acoustic 
displacement underestimation on VisR were also demonstrated, and it was shown that by 
tracking displacements induced by propagating shear waves outside the region of excitation 
(ROE), displacement underestimation can be reduced; applying the correction function allows 
for quantitative assessment of τ in an acoustically tracked material.  It was also shown that, 
using VisR, the viscous and elastic materials properties of tissues can be isolated relative to the 
magnitude of the ARF excitations. 
Secondly, VisR was demonstrated for delineating dystrophic muscle degeneration in a dog 
model of Duchenne muscular dystrophy (DMD).  Results showed more variation in VisR τ 
estimates in dystrophic versus control muscles and were corroborated by MRI and histology.  A 
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clinical feasibility study was also completed in two boys with DMD.  VisR estimated τ was shown 
to increase with time suggesting increasing muscle degradation.  Cross-sectionally, increased τ 
was associated with lower functional testing scores.  These preclinical and clinical results, while 
preliminary, were consistent with previously reported MRI results92,93,168,175,176  and suggest 
that VisR can be used to assess the local composition of individual dystrophic muscles.  In 
addition, the reduced time and cost of VisR ultrasound compared to MRI, makes it a pertinent 
outcome measure in the evaluation of DMD. 
13.2 Future Work  
The results in this dissertation warrant continued development.  In particular, a more 
accurate description of the ARF excitation that accounts for the volumetric nature of the impulse 
and allows for wave propagation from the surrounding medium would facilitate quantitative 
VisR imaging.  Developing this description is complicated by the material dependence of the 
wave propagation, and will likely rely on a priori knowledge of the mechanical properties of the 
surrounding medium.  This may be accomplished by leveraging other imaging techniques, such 
as shear wave velocity measurements, to provide additional information about the material.  
Failing to develop a better model for describing the forcing function, it may be possible to 
improve the error correction function.  Incorporating additional parameters, such as estimated 
relative elasticity, into the function may provide for error correction over a larger axial distance, 
extending the relevance for 2D imaging. 
Chapter 6 shows that by using a symmetric ARF excitation, VisR measurements can be 
made independent of muscle fiber orientation.  However, this study was completed after the 
VisR data was being acquired in the dog model presented in Chapter 11.  Therefore, VisR 
imaging was performed only with an F/1.5 focal configuration in the presented pre-clinical 
studies.  As shown in Chapter 6, not only was τ more consistent across angles, which we 
anticipate will benefit longitudinal measurements, but standard deviation of τ at each angle was 
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reduced.  VisR imaging in additional longitudinal cohorts is ongoing, and is currently being 
performed with an F/3 focal configuration.  We hypothesize that with the larger focal 
configuration, standard deviations in τ measurements due to fiber orientations will be reduced.  
This should improve the discrimination between control and GRMD dogs. 
Future analysis of the preclinical dog data presented in Chapter 11 and the clinical human 
data presented in Chapter 12 should look at other parameters in addition to τ, such as relative 
elasticity and relative viscosity.  We believe that when used in concert with τ, these force-
dependent parameters will help achieve our goal of differentiating and identifying normal 
muscle, fibrotic, and fatty tissue. 
Other future work involves developing real-time VisR imaging.  Using custom C++ code, 
we have reduced the time to generate a VisR τ image to an average of 3 minutes.  We believe that 
leveraging GPU processors and other optimizations, we can further reduce the computation 
time.  Real-time VisR would allow sonographers and clinicians to further optimize imaging, by 
utilizing feedback to perfect alignment of the muscle with the imaging plane.  Real-time 
feedback would also allow the sonographer to visualize the quality of the VisR images and 
determine objectively when images are corrupted due to low correlation or large motion 
artifacts.  Currently in the clinic, acquisitions are repeated if patient motion is suspected.  
Knowing whether repeat acquisitions are necessary could reduce unnecessary exposure.  
Additionally, an adaptive scheme to automatically alter the imaging parameters during the 
experiment could optimize the VisR sequence for specific tissue. 
Lastly, VisR imaging will benefit from 2D matrix arrays capable of focusing in both lateral 
and elevational dimensions.  These arrays will allow for better concentration of the excitation 
pulses and increased focal displacements.  Two-dimensional arrays would also support 
reduction of the tracking beam’s elevational dimension relative to the pushing dimension so that 
displacement underestimation may be reduced.  In addition, a symmetric PSF in the lateral-
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elevational plane could be achievable with a smaller focal configuration.   This would improve 
mechanical resolution of VisR, while still maintaining insensitivity to muscle fiber orientation. 
Although substantial work remains before it can be translated into wide clinical use, this 
work suggests that discrimination of muscle degeneration in DMD is possible with VisR 
ultrasound. 
  
145 
APPENDIX A 
Validation of Voigt Material Model  
 
A.1 Introduction 
As described in this dissertation, Viscoelastic Response (VisR) ultrasound assesses the 
viscoelastic properties of tissue using two successive ARF impulses and monitoring induced 
displacements in the region of ARF excitation.  The mass-spring-damper (MSD) model, which 
consists of the Voigt model connected in serial with a mass component, is used to determine the 
relaxation time constant for constant stress (τ) of the material.  In order to simulate VisR in 
FEM, a Voigt model of a nonzero density material is needed.  While LS- DYNA (Livermore 
Software Technology Corp., Livermore, CA) does not include a Voigt material model, it has 
implemented a material model of the Zener model.  We hypothesize that through the use of the 
appropriate material parameters the Zener model can be used to simulate a Voigt model in 
compression.  In this chapter, the Voigt model and the Zener model will be described, and the 
response of these models under creep compression will be defined.  It will also demonstrate that 
a Voigt material can be simulated in LS-DYNA over a range of elastic and viscous properties.   
A.2 Background 
A.2.1 Voigt Model 
The Voigt model, which is illustrated in Figure A.1, consists of a spring (with elastic 
constant ߤଵ) and damper (with coefficient of viscosity  ߟ) in parallel.  The governing equation for 
this model is given by: 
 ߪሺݐሻ ൌ ߤଵߝሺݐሻ ൅ ߟ ݀ߝሺݐሻ݀ݐ  (A.1)
where ߪ is the stress and ߝ is the strain.   
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Figure A.10: A schematic of the Voigt model
 
When a stress of ߪ଴ is applied instantaneously and held constant, the Voigt model predicts 
an exponential behavior approaching a steady-state strain of ߝ௦௦ represented by the following 
equation: 
 
ߝሺݐሻ ൌ ߪ଴ߤଵ ൭1 െ ݁
ି௧ ቀఎ ఓభൗ ቁ൘ ൱ (A.2)
 ߝ௦௦ ൌ ߪ଴ߤଵ. (A.3)
The exponential term, ߟ ߤଵൗ , is the relaxation time parameter, ߬, of the material.  The ߬ parameter 
is the time required for the Voigt material to deform to 63.21% (or 1-1/e) of its total deformation.   
A.2.2 Zener Model 
The Zener model, which is illustrated in Figure A.2, consists of the Voigt model in series 
with an additional spring (elastic constant ߤଶ).  The governing equation for this model is given 
by: 
 ሺߤଵ ൅ ߤଶሻߪሺݐሻ ൅ ߟ ݀ߪ
ሺݐሻ
݀ݐ ൌ ߤଵߤଶߝሺݐሻ ൅ ߟߤଶ
݀ߝሺݐሻ
݀ݐ . 
(A.4)
 
When a stress of ߪ଴ is applied instantaneously and held constant, the Zener model predicts 
an instantaneous deformation followed by an exponential behavior approaching a steady-state  
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Figure A.2: A schematic of the Zener model 
 
strain of ߝ௦௦, and is represented by the following equation: 
 ߝሺݐሻ ൌ ߪ଴ߤଶ ൅
ߪ଴
ߤଵ ቀ1 െ ݁
ି௧ ఛൗ ቁ (A.5)
 ߝሺ0ሻ ൌ ߪ଴ߤଶ (A.6)
 ߝ௦௦ ൌ ߪ଴ߤଵ ൅
ߪ଴
ߤଶ (A.7)
where ߬ ൌ ߟ ߤଵൗ .  It can be shown by evaluating Equation (A.5), that if ߤଶ approaches infinity, 
ߝሺݐሻ reduces to the Voigt creep compliance (Equation A.2): 
 limఓమ→ஶ 		
ߪ଴
ߤଶ ൅
ߪ଴
ߤଵ ቀ1 െ ݁
ି௧ ఛൗ ቁ ൌ ߪ଴ߤଵ ቀ1 െ ݁
ି௧ ఛൗ ቁ. (A.8)
A.3 Methods 
Compression Test 
LS-PREPOST (Livermore Software Technology Corp., Livermore, CA) was used to 
generate a three-dimensional, rectangular, solid mesh consisting of 125 nodes and 64 elements.  
The spatial extent of the mesh was 0.4 mm (x), by 0.4 mm (y), by 0.2 mm (z).  The bottom 
surface of the mesh was fully constrained.  A stress of 0.1 Pa was applied to top surface of the 
mesh at time t=0 and held constant for 10 ms.  Displacement of the top surface was measured 
(∆ݖ) and used to calculate strain through time as: 
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 ߝሺݐሻ ൌ ∆ݖݖ ൌ
∆ݖ
0.2 (A.8)
where ݖ is the original height of the mesh and was equal to 0.2 mm. 
After 10 ms, the material was assumed to have reached steady-state strain (ߝ௦௦ሻ, which 
was used to validate the elasticity of the simulated material as: 
 ߤଵ ൌ ߪ଴ߝ௦௦ ൌ
0.1 Pa
ߝ௦௦  (A.9)
The ߬ of the material was validated as the time at which strain reached 63.21% of ߝ௦௦, as 
illustrated in Figure A.3. 
Material Properties  
In LS-DYNA, the MAT_KELVIN-MAXWELL_VISCOELASTIC material describes a 
Zener model with elasticities of ߤଵ and ߤଶ, and viscosity ߟ.  In order to determine the value of ߤଶ 
necessary for the model to behave as a Voigt material, compression tests were performed on a 
material with a ߤଵ of 10 kPa, ߟ of 1 Pa·s, and ߤଶ ranging from ߤଵ to 1000 ൈ ߤଵ.  Percent error in ߬ 
and computational time were measured for each value of ߤଶ, and the ߤଶ where error in ߬ fell 
below 1% was considered sufficiently large for modeling a Voigt material.  Compression tests  
 
Figure A.3: Diagram showing strain versus time curve of a Voigt material 
under constant stress.  Steady-state strain (ߝ௦௦ሻ is measured as the strain at 
t=10 ms and τ is measured as the time needed for the strain to reach      
63.21% ߝ௦௦. 
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were then performed on materials with elasticities of 5 and 100 kPa and viscosities of 1 and 10 
Pa·s in order to validate the range of materials utilized throughout this dissertation.  A density of 
1.0 g/cm3 and a Poisson's ratio of 0.499 were used for all simulations.   
A.4 Results 
Figure A.4 shows the results of compression simulations in a material with ߤଵ of 10 kPa 
and an ߟ of 1 Pa·s, with the ratio of  ߤଶ ߤଵ	ൗ ranging from 1 to 1000.  Panel (a) shows that as ߤଶ is 
increased the percent error in measured ߬ was reduced, with error falling below 1% when ߤଶ ൌ
200 ൈ ߤଵ.  Computational time for each simulated value of ߤଶ is shown in panel (b). 
Strain curves for materials under constant stress are shown in Figure A.5 for materials 
with  ߤଶ ൌ 200 ൈ ߤଵ  and (a) ߤଵ of 5 kPa and ߟ of 1 Pa·s, (b) ߤଵ of 5 kPa and ߟ of 10 Pa·s, (c) ߤଵ of 
100 kPa and ߟ of 1 Pa·s, and (d) ߤଵ of 100 kPa and ߟ of 10 Pa·s.  Elasticity and ߬ of the simulated 
materials were measured from the observed strain profiles and are summarized in Table A.1.  In  
Figure A.4: (a) Error in measured ߬ and (b) computational time of simulation versus ratio of ߤଶ to ߤଵ  
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all four cases error in elasticity measurements was less than 0.1%.  Furthermore, all ߬ 
measurements were within 0.02 ms of the material ߬ with error in ߬ less than or equal to 2%.   
Table A.1: Comparison of simulated and measured material parameters 
Simulated Parameters Measured Parameters 
ߤଵ (kPa) ߤଶ (kPa) ߟ (Pa·s) ߬ (ms) ߤଵ (kPa) ߬ (ms) 
5 1,000 1 0.20 5.000 0.2023 
5 1,000 10 2.00 5.003 1.9890 
100 20,000 1 0.01 100.000 0.0102 
100 20,000 10 0.10 100.000 0.1010 
A.5 Discussion and Conclusion 
The aim of this chapter was to determine whether the Zener model can be used to simulate 
a Voigt material in LS-DYNA, and whether this model was valid over the range of material 
properties employed in this dissertation.  These results suggest that as the stiffness of ߤଶ 
increases, the creep response of the Zener model approaches that of the Voigt model as 
indicated by the decrease in ߬ error.  Greater values of ߤଶ, however, require a smaller explicit 
time step, resulting in increased simulation computation times.  This results in run times that 
are approximately 72% longer for the ߤଶ ൌ 200 ൈ ߤଵ model than for ߤଶ ൌ 500 ൈ ߤଵ.  Therefore, a 
ߤଶ ൌ 200 ൈ ߤଵ was chosen for all materials.   
The FEM material model presented in this chapter allows for the simulation of a Voigt 
material in response to an applied stress.  This material model can be used in simulations of 
VisR ultrasound to simulate a Voigt material with density.   
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Figure A.5: Strain profiles for simulated materials under constant stress of 0.1 Pa.  Materials 
were simulated with elasticities of 5 kPa (panels a & b) and 100 kPa (panels c & d) and 
viscosities of 1 Pa·s (panels a & c) and 10 Pa·s (panels b & c).  
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